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1. INTRODUCTION 
 
 
 
1.1 Carbohydrates 
Carbohydrates are the most aboundant group of natural products. They are found in nature as 
monomers, oligomers or polymers; furthermore they can be components of biopolymers 
(glycolipids, glycoproteins, proteoglycans) and other naturally occurring substances. In this last 
case, they play a role in conferring physical, chemical and biological properties to their carrier 
molecules. It has been known for a long time their role as energy and biosynthetic resources 
(glycolysis, etc.), skeletal component (chitin), and key structural elements in the formation of 
biological architectures (2-deoxyribose for DNA). Carbohydrates and related structures are also 
involved in biochemical and bioorganic processes such as the molecular recognition for the 
transmission of biological informations. Indeed, it is reported that the presence of sugars modifies 
the biological activities and absorption of all drugs. Again, human blood groups are differentiated 
by relatively simple changes in oligosaccharide structures (Figure 1.1).1 
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       Figure 1.1: Human blood groups oligosaccharide structures 
 
 
It is also well established that protein- and lipid-bound saccharides play a role in a number of 
cellular processes such as cell-cell recognition, and cell-external agent interactions.2 These 
interactions can start both advantageous biological events and damaging disease processes; for 
instance, they can stimulate fertilization cell-growth and differentiation (embryogenesis) and 
immune response, as well as, inflammation, viral and cancer metastasis bacterial infections.1 
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1.2 Bacteria 
The term “bacteria” has traditionally been generally applied to all microscopic, single celled 
prokaryotes. Although this term remains in everyday use, the scientific nomenclature changed after 
the discovery that prokaryotic life actually consists of two very different lines of evolution. 
Originally called Eubacteria and Archeabacteria, these evolutionary domains are now called 
Bacteria and Archea.  
Bacteria play important roles in the cycling of nutrients in the environment, and many important 
steps in the nutrient cycle are catalyzed exclusively by bacteria, such as the fixation of nitrogen 
from the atmosphere. Bacteria are also important in numerous industrial processes, such as 
wastewater treatment and industrial production of antibiotic. Besides, bacteria are significant to 
human health, as they are the causative agent of many infectious and disease, including cholera and 
tuberculosis. Bacteria display a wide diversity of shapes and sizes. Despite this diversity, each 
bacteria species tends to display a characteristic morphology, which is the basis for their 
classification. Many bacterial species exist simply as single cells, while others tend to associate in 
diploids (pairs) or can even form complex associations (in natural environment most bacteria are 
found associated with surfaces in biofilms).  
 
1.2.1 Bacterial cell structure3 
A bacterial cell is bound by a lipid membrane, or plasma membrane, which encompasses the 
contents of the cell (cytoplasm) and holds nutrients, protein and other essential molecules within the 
cell. The cell membrane is surrounded by a cell wall which maintains the overall shape of a 
bacterial cell and is essential for the survival of the bacteria. Basically, bacterial cell walls are 
composed of peptidoglycans (carbohydrate polymers cross-linked by proteins). However, there are 
two different arrangement of the cell wall in bacteria and this difference is the base for the most 
simple and familiar bacteria classification: some bacteria possess a thick cell wall containing many 
layers of peptidoglycan and teichoic acid; they retain a purple colour when stained with a dye 
known as crystal violet and are, therefore, known as Gram-positive (after the Danish bacteriologist 
who developed this staining procedure). In contrast, other bacteria have a relatively thin cell wall 
consisting of a few layers of peptidoglycan surrounded by an outer lipid membrane containing 
lipopolysaccharides (LPS) and lipoproteins; they do not stain purple with crystal violet and are 
known as Gram-negative (Figure 1.2).  
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                        Figure 1.2: Schematic section of Gram-negative and Gram-positive bacterial  
                                           cell structure 
 
Most bacteria have the Gram-negative cell wall. Gram-negative bacteria cells have a cellular 
compartment, called periplasmic space, containing enzymes and other proteins that help digest and 
move nutrients into the cell. Surrounding the cell wall of many bacteria, there is the capsule, a layer 
of polysaccharides (sometimes proteins) which protects the bacterial cell from environmental 
aggressions (phagocytosis by eukaryotic cells) and plays a role in bacterial attachment to surfaces 
and biofilms formation. 
Superficial structures are directly involved in cell-cell and cell-environment interactions. During an 
infection, these structures are in contact with host cells and can interact with their immunity system. 
In Gram-negative bacteria, lipopolysaccharides (LPS) are key molecules for these functions as they 
cover roughly 75% of the outer membrane. 
 
1.3 LPS: a little of hystory 
In the eighteenth century the association of fever and desease-producing substances with unhygienic 
conditions was referred to pyrogenic materials, putrid poisons or toxins Around the end of the 
century, a Danish pathologist named Panum reported a non-volatile water-soluble, pyrogenic toxin 
obtained from putrid matter. Later, with the pure-culture techniques developed by Koch it was 
possible to show that specific bacteria cause different diseases. From the same laboratory in 1892, 
Pfeiffer reported that the agent of cholera, Vibrio cholerae, produced a pyrogenic, non-secreted 
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toxin that was heat-stabile, in addition to a secreted, heat-labile toxin. He called it “endotoxin”, a 
term still used today for the lipopolysaccharides, amphiphilic macromolecules that were found to 
constitute them.4 LPS are responsible for manifestation of infections caused by Gram negative 
bacteria; they are released as consequences of lyse, death or reproduction of microbic cells into the 
host organism. This means that their presence is a sign of a bacterial proliferation.5 The introduction 
of extraction methods,6 the amphipathic nature of LPSs, and, consequently, the possibility to 
separate a lipid region after a weak acid hydrolysis, gave rise the elucidation of a general 
architecture consisting of two or three regions.7 
 
1.3.1 LPS: structure 
From the bacterial membrane outwards, a LPS structure comprises a lipid moiety, called Lipid A, 
connected with an oligosaccharide core region by means a Kdo (3-deoxy-oct-2-ulosonic acid) 
residue. Bacterial LPSs can show a rough or a smooth appearance depending on sugar composition. 
More precisely, rough-type bacteria produce LPSs containing an oligosaccharide core of 
approximately 10 monosaccharides, whereas LPS produced by smooth-appearing bacteria are 
enriched of a polysaccharidic portion called O-Chain (Figure 1.3). 
Lipid A is considered the endotoxic component of a LPS and it is locked into the bacterial 
membrane by means of hydrophobic and electrostatic interactions. A common general lipid A 
structure can be described consisting of a biphosphorylated β-(1→6)-linked glucosamine 
disaccharide. Aminic and hydroxyl functions present on position 2, 3, 2’, 3’ are generally acylated 
by fatty acids (primary fatty acids) which may be themselves substituted with fatty acids ester-
linked (secondary fatty acids).8 Even though Lipid A is considered the most conservative element of 
the LPS there are some structural variations related to acyl and phosphate groups. 
Core is a complex oligosaccharide where it is possible to distinguish a fraction made up of common 
sugar (Glcp, Galp, GlcpNAc, GalpNAc), called outer core, and an internal fraction, called inner 
core, composed of more peculiar sugars such as L-glycero-D-manno-heptose and Kdo. In smooth-
type bacteria core region is, generally, a diminutive portion of the entire sugar moiety so that its 
characterization is not always easy to be accomplished. 
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         Figure 1.3: Schematic structures of LPS 
 
O-Chain is a polysaccharide made up of repeating subunits and each subunit consists of one to 
eight sugar residues; the length of an O-Chain is variable from bacterium to bacterium but it can be 
stated that in an O-Chain there may be up to 50 identical sub-units and they can be linear or 
branched. Subunits are polymerised and adjoined to the core during the biosynthesis. Sometimes the 
polymerisation can be interrupted by a substituent on the last sugar of the chain; for instance, the O-
Chain of Vibrio cholera serotype O1 Ogawa shows an O-methyl substituent on the terminal 
perosamine residue which is not present in the O1 Inaba serotype.9 Considering synthetic aspects 
(substitution and configuration of sugars, different possibilities of glycosidic linkage) and genetic 
capacities of different organisms, nature gives a wide range of unique O-chain structures showing 
its well known greatness. Indeed, O-chain is considered the most structurally changeable portion of 
a LPS. As the O-chains extend outward from the bacterial cell surface up to 10 nm, they are 
exposed to the cell-cell environment and thus involved in the defence system of a potential host. 
The O-chain is also called “O-antigen” because of its antigenic activity mirrored in specific 
recognition antigen-antibody; definitely, the O-chain can be considered a finger-print for Gram-
negative bacteria, determining the specificity of each bacterial serotype. Further, pathogenic effects 
of bacteria may be directly related to the nature of the O-Chain; this is, for example, the case of the 
O-chains of Proteus whose acidic group are suspected to contribute its capacity to form stones in 
bladder or kidney.10 
 
1.3.2 LPS: biological activity 
During an infection, the bacterial O-Chains are in direct contact with the host. Once in the host-
cells, LPSs prompt production of molecules responsible to eradicate bacterial infection and 
consecutively to wipe out bacterial cells.11 However, if there is a massive presence of bacterial cells, 
Lipid A       Inner Core         Outer Core        O-Specific Chain 
n 
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over-production of antibacterial molecules can prompt negative effects on the guest leading even to 
lethal septic shock. Again, one of the studied functions of LPSs is shielding bacteria from some 
antibiotic effects; actually rough-type strains showed a relative higher sensitivity to antibiotics 
compared to smooth-type strains.12 
 
1.3.3 LPS from phytopathogenic bacteria 
Even though O-Chain polysaccharide is the most variable portion of LPS, O-chains from 
phytopathogenic bacteria show a quite regular pathway in their structures. Structural studies showed 
that they are almost exclusively constituted of a small range of monosaccharide.13 A more 
interesting information is that the repeating subunits consist of linear backbones made up, mainly, 
of D- and L- rhamnose residues, very frequently connected by α-(1→2) and α-(1→3) linkages; very 
often single monosaccharides, within a small range, are present as branch on the linear backbone 
(Figure 1.4). 
 
                
O
HO
HO
O
HO
HO
OH
O
HO
HO
AcHN
OH
OH
O
OH
AcHN
OH
OH O
OH
HO
HO
O
OH
OH
OH
HO O
OH
OH
HO
D-xylose
(D-Xylp)
L-xylose
 (L-Xylp)
D-rhamnose
   (D-Rhap)
L-rhamnose
   (L-Rhap)
2-acetamido-2-deoxy- D-glucose
            (D-GlcpNAc)
OH
3-acetamido-3,6-dideoxy-D-galactose
                     (D-Fucp3NAc)
OHHO
OH
D-fucose
 (D-Fucf)
OH
 
 
         Figure 1.4: Monosaccharides consisting O-chain from phytopathogenic bacteria. 
 
An evidence of these structural restrictions lies in the fact that almost 80% of O-chains from 35 
different phytopathogenic strains of Pseudomonas syringae and Xanthomonas campestris species 
show just the four following structurally different linear backbones: 
→3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→2)-α-L-Rhap-(1→2)-α-L-Rhap-(1→ 
→3)-α-D-Rhap-(1→3)-α- D-Rhap-(1→2)-α-D-Rhap-(1→2)-α- D-Rhap-(1→ 
→3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→2)-α-L-Rhap-(1→ 
→3)-α-D-Rhap-(1→3)-α-D-Rhap-(1→2)-α-D-Rhap-(1→ 
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In most cases, these O-chains differentiate each other, simply by bearing different branch 
monosaccharides on the same position or the same branch monosaccharide on different positions of 
an identical linear backbone; few examples are shown below: 
          
Pseudomonas syringae pv. savastanoi ITM 519 (VII)14 
        →3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→2)-α-L-Rhap-(1→ 
                                                                                                                   3 
                                                                                                                   ↑ 
                                                                                                                   1 
                                                                                                      α−D-Fucp3NAc 
 
 
 
 
Pseudomonas syringae pv. tabaci IMV 223 (VII)15 
        →3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→2)-α-L-Rhap-(1→ 
                                                       2 
                                                       ↑ 
                                                       1 
                                         α−D-Fucp3NAc 
 
 
 
 
Pseudomonas syringae pv. ribicola NVPPB 1010 (VIII)16 
 
→3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→2)-α-L-Rhap-(1→2)-α-L-Rhap-(1→ 
                                                                                                                             3 
                                                                                                                             ↑ 
                                                                                                                             1 
                                                                                                                β−D-GlcpNAc 
 
 
 
 
Pseudomonas syringae pv. holci IMV 8300 (I)17 
 
→3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→2)-α-L-Rhap-(1→2)-α-L-Rhap-(1→ 
                                                                                                                             3 
                                                                                                                             ↑ 
                                                                                                                             1 
                                                                                                                α−D-Fucp3NAc 
 
 
 
One of the most interesting aspects of LPS-phytopathogenic O-chains is the absence of any direct 
relationship between O-chain structures and bacteria-host recognition; this is illustrated, for 
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instance, by three different strains of P. savastanoi pv. savastanoi which show the same O-chain 
structure of P. syringae pv. tomato albeit the former attack olive and oleander and the latter are 
pathogenic for tomatoes. Even though bacterial human- and plant-pathogens share a common LPS 
structure, host cells have different recognition and defence system. Indeed, biological functions and 
molecular mechanisms have been quite widely investigated for human pathogenic bacteria but still 
very little is known about LPS-plant interactions. Actually, the most confirmed proposed 
mechanism for plant defence activation by LPS is based on recognition of peculiar structures of the 
pathogen (PAMPs, standing for pathogen-associated molecular patterns) which are crucial in its 
growth within the host;18 this mechanism is analogue to the innate immunity system of animals.19 
Certainly, one of the most widely studied effects of LPSs on plants cells is the ability, induced by 
avirulent bacteria, to prevent the hypersensitive response (HR), a programmed cell death response.20 
A recent work showed that the Lipid A moiety may be partially responsible for LPS perception by 
plant cells;21 however, oligosaccharides have also been proved to play key roles in plant innate 
immunity. More precisely, biological tests of oligosaccharides A, B and C (Figure1.5) on 
Arabidopsis thaliana leaves were performed;22 the results of these tests evidence that 
oligosaccharides A, B and C were effective in inducing PR-1 gene expression, a plant immune 
response, and in suppressing HR. 
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         Figure 1.5: Oligosaccharides tested on Arabidopsis thaliana leaves 
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Once inoculated with aqueous solution of oligosaccharides, plant leaves were treated with different 
phytopathogenic Gram-negative bacteria. HR suppression was pointed out and it was manifested in 
decreasing expanse of yellow spots on plant leaves (Figure 1.6).  
 
 
                               Leaves not treated             Leaves treated with          Leaves treated with  
                                                                                    B (0.1 mg/ml)                 C (0.1 mg/ml) 
 
                             Figure 1.6: Comparing biological activity of B and C on  
                                                Arabidopsis thaliana leaves 
 
The plant response depends on the length of the chain and, in contrast with the case of 
oligosaccharides A and B, HR suppression induced by oligosaccharide C was not concentration-
dependent. A similar response was observed in PR-1 gene expression. Additionally, combination of 
NMR and molecular modelling elucidated coiled structures for oligosaccharides B and C, proposing 
them as PAMPs in plant-bacteria recognition (Figure 1.7).  
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1st coil
1st coil
2nd coil
 
                                           Figure 1.7: 3D structures of A,B and C 
Even though this is an helpful demonstration that short oligosaccharides can prompt plant immune-
response, still more has to be done in description of molecular mechanisms involved in plant-LPSs 
interaction. Beside a detailed determination of the minimal oligosaccharide fraction involved in 
host-guest interaction processes, this work would require the synthesis of adequate quantity of 
them. In this matter, my Ph.D. project concerned the synthesis of model oligosaccharides related to 
phytopathogenic bacteria O-Chains mimicking natural structures to employ, in future, in biological 
experiments. 
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2. SYNTHETIC ASPECTS 
 
 
2.1 O-Glycosylations 
The key step in the synthesis of oligosaccharides is the building of a glycosidic linkage by means of 
an O-glycosylation reaction; this involves the coupling between a glycosyl donor (a sugar bearing a 
suitable leaving group at the anomeric carbon) and a glycosyl acceptor (a sugar containing a free 
hydroxyl group); a promoter agent is used to activate the donor in building the new bond. Very 
often dehydrating agents are used to avoid competitive reaction by water. The following Scheme 
2.1 shows a generic glycosylation reaction and a list of the most used glycosyl donors and 
activating agents: 
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X
+     ROH OPO
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O
Cl3C
NH
SR
S
R
O
F Br
Glycosyl trichloroacetimidate
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Glycosyl sulfoxide
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NPh
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.OEt2, TsOH
Cl  
 
Scheme 2.1: Generic scheme of a glycosylation reaction and the most used glycosyl donors and 
promoters 
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Because of the number of factors involved in the reaction and the instability of the intermediates a 
glycosylation process is complex to describe.  
Besides chemical synthesis, more recently enzyme-catalyzed procedures have been developed but 
they are still limited to certain types of glycosidic linkages at a preparative useful scale. 
 
 
2.2 Regioselectivity and stereoselectivity in glycosylations 
The efficiency of an O-glycosylation reaction requires high yield, regioselectivity and 
stereoselectivity but these aims are not very easy to achieve. Indeed, carbohydrate building blocks 
are able to exist in more than one form (pyranose and furanose forms, α and β anomers) and so it is 
important to control which form is available for the reactions. Again, carbohydrates have a number 
of alcoholic functions whose reactivity does not follow any universally applicable rules, but usual 
generalization for which primary>secondary>tertiary and equatorial>axial. Thus, there is the need 
to isolate them, alternatively, in a reactive form to avoid mixture of products and so to render the 
reaction as regioselective as possible. This goal can be pursued by using suitable protecting groups 
which mask temporarily OH-functions. This involves a number of chemical manipulations so it is 
essential that the protecting groups are introduced and removed with excellent yields; furthermore, 
they need to leave unaffected other parts of the molecule and must be stable in succeeding reaction 
conditions. Besides this aspect, protecting groups can also fine-tune reactivity of both donor and 
acceptor moieties by means of their electronic density. This is true also for protecting groups on the 
anomeric position of the acceptor: for instance, thioglycoside acceptors are, generally, less 
nucleophile then their corresponding O-glycosides.1 
Stereoselective problems also need to be considered: the formation of a new bond between two 
carbohydrate units can afford two anomeric isomers. Conventionally, in the D-series, the α−anomer 
 is the one in which the aglycone projects downwards in Haworth formula; α−L compounds have 
the aglycone projecting upwards in Haworth formula. The β form have the opposite configuration at 
the anomeric centre, i.e. the aglycone projects upwards and downwards for β−D and β−L 
compounds, respectively. A simplified mechanism of a glycosylation reaction showing α- and β-
anomers formation is the one reported in Scheme 2.2: by action of an activating agent, a transient 
contact ion pair (CIP), or a solvent separated ion pair (SSIP), is formed. In conditions which favour 
the CIP formation, such as unpolar solvent, the nucleophilic acceptor might attack on the tight ion 
pair in a SN2-like pathway; more likely, due to the anomeric effect (polar substituents such as 
halide, OR, or SR derivatives prefer an axial orientation),2 the reaction proceeds, mainly, through 
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the SSIP leading to the α-linked glycoside which is, actually, the main product coming from any 
oxacarbenium ion.3 
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   Scheme 2.2: Abbreviated glycosylation mechanism 
 
As the first step is the rearrangement of the sugar and the development of a positive charge, the 
outcome of a glycosylation will be affected by any factor which can influence changing in sugar-
conformation.4 Stereoselectivity can be controlled by the presence of a neighbouring participating 
group (anchimeric assistance).5 Generally, a carbonyl functionality at C-2 of the glycosyl-donor 
(ester, carbonate, phtalimide, etc…) can support the departure of the leaving group attacking the 
incipient oxonium ion and forming the thermodynamically more stable acyloxonium species 
(Scheme 2.3); the position of the equilibrium will depend upon the nucleophilicity of the carbonyl 
oxygen.6 The attack of the acceptor will occur anti to the carbonyl bond resulting in generation of 
the 1,2-trans glycoside. This tool to direct the stereoselectivity will lead to a β-configurated 
anomeric bond using a Glc/Gal-configurated glycosyl donor; if the glycosyl donor has a Rha/Man-
configuration it will result in an α-configurated anomeric bond. 
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               Scheme 2.3: Anchimeric assistance in glycosylation reaction 
 
In the case that some steric barrier will occur between donor and acceptor, disfavouring reaction on 
the dioxonium species, the reaction will proceed through the incipient oxonium ion with 
concomitant loss of stereoselectivity.7  
Due to combination of the anomeric effect (which favours α configuration) and neighbouring 
participation groups (which favours 1,2-trans adduct) the generic stereoselective outcome of a 
glycosylation reaction can be illustrated in the following Scheme 2.4. 
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   Scheme 2.4: Increasing synthetic difficulty in stereoselective glycosylation 
 
However, electron-withdrawing protecting groups, such as acyl-type protecting group, depress 
anomeric reactivity (as compared with ether groups) on ion-pair formation, translating this effect on 
the rate of the reaction; this kind of protected glycosyl donors is named “disarmed”.8 In contrast, the 
rate of the reaction may be accelerated using a glycosyl-donor with an ether-type protecting group 
at C2; this kind of glycosyl donor are indicated as “armed”. 
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On the other hand, not all the time it is possible to functionalize the C-2 of the donor with a 
participating protecting group. This is the case when 1,2-cis glycoside formation is reuired. Thus, 
stereoselectivity can be controlled by choosing a suitable reaction solvent: 9 with non-polar solvents 
a SN2 mechanism is preferred (nucleofilic attack by the acceptor proceeds with inversion of 
configuration at the anomeric position of the donor) while in polar solvents the oxonium ion is 
better solvated and the reaction proceeds following a SN1 pathway (causing loss of 
stereoselectivity). Deeply speaking, diethyl ether can form a more stable β-orientated diethyl 
oxonium ion whose stability is due to the exo-anomeric effect. 10 This is the tendency of positively 
charged substituents at C-1of a pyranose ring to adopt the equatorial configuration; acceptor, then, 
will attack on the solvated ion to give the α-linked glycoside (Scheme 2.5).  
On the other hand, nitriles as participating solvents are able to activate, selectively, highly reactive 
glycosyl donors towards β-linked glycosides formation. The reaction occurs through the formation 
of a nitrilium-nitrile-conjugate intermediate: the fast α-intermediate formation providing the β-
glycoside precedes the formation of the thermodynamically more stable β-intermediate which 
furnishes the α-glycoside; additionally the equilibrium between α and β nitrilium-ions is quite slow 
so the accumulation of the β-configurated glycoside is favoured. 
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   Scheme 2.5: Participating solvents in glycosylations 
 
Other factors affecting stereoselectivity include long-range participation, protecting groups at C-
6,11temperature,12  etc.  
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2.3 β-Mannosylations and β-rhamnosylations 
As showed in Scheme 2.4 the β-mannosides are the most difficult glycosides to be synthesized. 
However, D-mannose is a common constituent of naturally occurring oligosaccharides, playing an 
important role in many biological processes13 and although the most common linkage is the α-
configurated one, a significant amount of the β-counterpart is found.14 This creates the cue for its 
synthesis which is still a challenging goal for two main reasons: besides the anomeric effect already 
described in the previous paragraph, which favours the formation of α-mannosides, 1,2-cis 
arrangement of the equatorial aglycone and the axial functionality at C-2 in β-mannopyranosides 
shows a repulsive steric effect. Again, once formed, the β-mannoside linkage might anomerize in 
acidic conditions. Other complications in the synthesis of β-mannoside linkages are due to 
difficulties of α and β anomers characterization: actually, they are not easily differentiable by their 
3JH-1,H2 coupling constant because of the gauche relationship between the H-1 and H-2 protons in 
both anomers. 
As mannose and 6-deoxy-mannose (rhamnose) share structural relationship they can also share 
similar behaviour. However, synthesis of β-rhamnoside is more complex than the synthesis of β-
mannoside due to the 6-deoxy function which influences the conformation of the intermediates 
affecting directly the glycosylation mechanism. Herein some of the common strategies used to build 
β-mannosides/β-rhamnosides are reported.  
The first direct β-selective mannosylation was performed in 1961 by Gorin and Perlin15 who 
condensed a 2,3-O-carbonate–protected mannosyl bromide with a highly reactive primary alcohol 
under silver oxide conditions. Later several examples reporting the same effect have been collected 
in literature.16 The effect is usually explained by a combination of two factors: the carbonate 
destabilizes the potential oxacarbenium ion disfavouring a SN1-like mechanism and, silver cations 
on the surface of insoluble catalysts absorb the bromide preferentially on the α-side: the acceptor is 
therefore forced to attack in a SN2-like fashion from the β-side. The mechanism of silver insoluble 
catalyst is described in Scheme 2.6. 
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Scheme 2.6: Mechanism proposed for silver insoluble catalyst mediation in glycosylations 
 
Actually, the proposed mechanism involves the equilibrium between α- and β-ion pairs: when the 
acceptor is not sufficiently reactive, the surface-bound glycosyl donor is liberate into the solution to 
give the more reactive oxacarbenium ion which can couple with the acceptor to give preferentially 
the α-glycoside. The oxacarbenium can also associate again with the negatively-charged surface; in 
this case the reaction proceeds in a non-selective way giving α- and β-ion pairs. Thus, it is so clear 
that to minimize the stereochemical scrambling of the anomeric centre, a not sterically hindered and 
highly reactive acceptors are required. The stereochemical outcome of this strategy is also affected 
by the protecting groups on the glycosyl donor: as the success of this protocol requires a rapid 
nucleophilic displacement, mannosyl donors having acyl protecting groups (disarmed) should be 
less β-selective. 
High β-stereoselectivity can also be induced by torsional effects, as described by Crich17 who used 
a triflic anhydride-mediated activation of 4,6-O-benzilidene-protected mannosyl donors to afford β-
mannosidic linkage with high stereocontrol. It has been proved by NMR analysis that the reaction 
proceeds via an α-mannosyl triflate which is generated in situ after activation of the donor by triflic 
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anhydride. Successive addition of the acceptor provide the formation of β-mannoside by a SN2-like 
process. The success of this stereocontrol depends on the order of addition of the reactants, the 
steric hindrance at C2 of the donor, the solvent as well as the presence of a 4,6-benzylidene group. 
In point of fact, deeper investigation revelead that 4,6-benzylidene group is crucial to reach high β-
selectivity. This may be rationalized saying that the energy of the oxacarbenium ion is higher than 
the one related to covalently bound triflate; this is due to twist and torsional strain on the acetal ring 
imposed by the sofa conformation of the intermediates (Scheme 2.7). This effect is not present in 
the per-ether protected systems. 
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Scheme 2.7: β–Mannosylation reaction via glycosyl-triflate 
 
In order to profit by 4,6-O-benzylidene-mediated stereocontrol even on rhamnose series, Crich and 
co-workers developed different synthetic pathways involving a 4,6-O-benzylidene-protected 
mannosyl donor and consecutive cleavage of the benzylidene acetal to get the deoxy function. He 
introduced the (4,6-O-[α-(2-(2-iodophenyl)ethylthiocarbonyl)benzylidene] group as a surrogate for 
the 4,6-O-benzylidene group which is highly β-directing in mannosylations. This benzylidene is 
then removed in a reductive radical fragmentation, by using Bu3SnH, to obtain β-D-
rhamnopyranoside systems.18 The radical fragmentation allows to bypass the NBS-based cleavage 
of 4,6-O-benzylidene ring, which is an established tool in carbohydrate chemistry19 but not 
compatible with benzyl and allyl-type protecting groups because of competitive cleavage of this 
groups.20 More recently, based on the chemistry of cyano groups applied on synthesis by 
Rychnovsky,21 Crich and co-workers launched a new-generation of 4,6-O-benzylidene-protected 
glycosyl donors bearing a 4,6-O-[1-cyano-2-(2-iodophenyl)ethylidene] group.22 Its introduction 
undergoes by using mild conditions, over short reaction times, and it is compatible with a wide 
 26
variety of other protecting groups. Additionally, its removal is performed by tin-mediated radical 
fragmentation providing β-D-rhamnopyranosides in high yields and stereoselectivity. 
On the basis of torsional effects on stereoselectivity and Gorin and Perlin’s experience, Crich and 
co-workers attempted the synthesis of a β-mannosydic linkage invoking the combination of both 
2,3-O-carbonate and 4,6-O-benzylidene protecting group on a thiomannosyl donor.23 However, only 
α-anomers were obtained under such homogeneous conditions, in contrast to the expectation that 
the two protecting groups would reinforce each other providing for a highly β-selective system. 
Further investigations performed on rhamnosyl donors highlighted that shifting the carbonate group 
to the 3,4-positions, a positive β-directing effect was achieved in both homogeneous and 
heterogeneous conditions; this effect come up from the combination of the electron-withdrawing 
nature of the carbonate which destabilizes the anomeric oxacarbenium ion and its inability to take 
part in neighbouring participation due to its cyclic nature. 
However, there are also several other non-requiring 4,6-O-benzylidene protecting group successful 
protocols for more direct synthesis of β-mannosides/β-rhamnosides. Among these, a strategy 
employing 2-O-sulfonate ester protecting group has been demonstrated to be β-stereoselective in 
glycosylation of L-rhamno-pyranosyl chlorides by Schuerch and co-workers;24 they demonstrated 
that the 2-O-sulfonyl group is able to stabilize an α-mannosyl sulfonate, obtained in situ from the 
chloride, and therefore to direct the glycosylation towards β-mannosyl adducts. Successively this 
strategy has been applied to thioglycosides by Crich and co-workers.25,3 
In order to better define the role of non-participating 2-O-sulfonyl groups, Schmidt and co-workers 
speculated on reactivity of 2,3-di-O-alkyl-4,6-O-benzylidene-protected mannosyl donors with 
various acceptors obtaining high β-stereoselectivity in glycosylations. To rationalize the good 
results, they postulated a mechanism where anomeric stereocontrol is caused by a conformational 
effect enforced by the 4,6-O-benzylidene group on the pyranosyl ring, which favours generation of 
a flattened twist-boat conformation A as the intermediate (Scheme 2.8).26 Because of 
stereoelectronic and steric reasons A will be preferentially attacked from the β side, which gives a 
twist-boat intermediate B that equilibrates to the 4C1 conformer. Non-participating strongly 
electron-withdrawing groups P at 2-O atom should facilitate β-mannopyranoside formation because 
generation of the twist-boat intermediate A would gain from a strong dipole effect.  
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Scheme 2.8: Mechanistic proposal for preferred β-mannopyranoside formation. TB = twist-boat 
conformation. 
 
However, this approach requires an excellent leaving group at the glycosyl donor and a good  strong 
electron-withdrawing 2-O-protecting group such as benzylsulfonyl group which is easily installed 
and removed compatibly with other ether-based protecting groups. They found that coupling 3-O-
allyl-2-O-benzylsulfonyl-4,6-O-benzylidene-protected mannopyranosyl trichloroacetimidate 1 with 
4-O-unprotected glucosamine derivative 2 provides mainly  β(1-4)-linked disaccharide. This 
approach was also tested without a 4,6-O-benzylidene ring giving even better results showing that 
the presence of a 4,6-O-benzylidene is not crucial (Scheme 2.9). 
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            Scheme 2.9: Examples of β-mannopyranoside formation reported by Schmidt 
 
A totally different approach for stereospecific building of β-mannopyranosyl and β-
rhamnopyranosyl linkages is the one first discovered by Srivastava and Schuerch in 1979,27 
successively developed by Hodosi and Kováč in 1996,28 called “glycosylation via locked anomeric 
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configuration“. The role of glycosyl donor and acceptor are reversed: 1,2-O-cis-stannylene sugar 
acetals, as powerful nucleophile displaces, via SN2 process, good leaving groups on activated 
acceptors; indeed, five-membered cyclic dibutylstannylene acetals formed on vicinal cis-axial-
equatorial pair of hydroxyl groups selectively enhance the nucleophilicity of the equatorial oxygen 
in O-alkylation reactions.29 This method does not involve any formation of the oxacarbenium ion as 
intermediate and the stereospecific formation of 1,2-cis-glycosidic linkage occurs because 1,2-O-
stannylene acetals of sugars favour the cis-arrangement around the anomeric centre (Scheme 2.10).  
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                                    Scheme 2.10: 1,2-cis stannylene acetal arrangement  
 
Sometimes epimerization can occur at C-2 during dibutylstannylene complex formation; this 
process can be minimized by conducting the acetalation under milder conditions (diluted solution 
and low temperature).30 Alternatively, one can profit by this to obtain rare sugars.31 Another 
problem which can occur by using this strategy is the isomerization of the acetal ring from 1,2-
position to 2,3-position that gives formation of undesired disaccharide; this can be prevented by 
using 3-O-protected analogues. Besides these disadvantages, one of the great aspects of this method 
is that specific protection of hydroxyl groups on the glycosyl donor is not necessary. This procedure 
achieves excellent stereocontrol with both primary and secondary triflates, however it is more 
effective with rhamnose than with mannose.  
One of the most elegant-considered protocol to achieve selective β-mannosylations/β-
rhamnosylations is “intramolecular aglycone delivery” method (IAD). It is based on an 
intramolecular glycosylation which has initially been employed in the stereocontrolled synthesis of 
a β-C-mannoside32 and then extended to the synthesis of O-linked β-mannosides. This strategy 
makes use of a β-manno-configurated donor bearing the acceptor already linked to an acetal at C-2 
(Scheme 2.11). Successive activation of the donor releases the aglycone which is structurally 
disposed to direct SN2-like substitution at the anomeric centre affording then the β-mannoside. 
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Scheme 2.11: Theoretical approach33 of intramolecular aglycone delivery method 
 
However, these described herein are just few of the numerous methods developed in the last 
decades to solve out the challenging problem of β-selective mannosylations and rhamnosylations, 
which is still outstanding for carbohydrate chemists.  
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3. DISCUSSION AND RESULTS 
 
 
 
In this section first syntheses of building blocks and three oligosaccharide repeating units from 
phytopathogenic LPS O-chains are described. It is noteworthy that all the syntheses described 
herein have never been accomplished before and the strategies employed make use of orthogonal 
protecting group patterns, which could allow, in the future, the further elongation of the targets.  
 
 
3.1 Synthesis of 3-acetamido-3,6-dideoxy-D-galactopyranosyl donors and related 
tests of glycosylation1,2 
 
The first structure to be considered was the 3-acetamido-3,6-dideoxy-D-galactopyranose (D-Fucp3-
NAc) which is one of the most frequently sugar unit found in phytopatogenic Gram-negative 
bacterial O-chains (see Figure 1.3).3 An interesting aspect of its natural distribution is that it is 
always present with an α-configurated linkage imposing some structural restriction in its synthesis. 
At the first time two conventional routes to convert an alcoholic function to an amino one were 
chosen but they proved to be unsuccessful. The initial idea was to perform a SN2 displacement of an 
epimerized activated hydroxyl function at C3, to get the azido-sugar with the right configuration, by 
using sodium azide as nucleophile. In order to obtain the deoxygulose derivative (antiarose), the 
planned strategy involved the stereoselective reduction of a 3-keto derivative. Thus, starting from 
D-fucose, intermediate 6 was obtained by a sequence of Fischer glycosylation, acetylation and α-
anomerization with FeCl34 (Scheme 3.1). The enrichment of the anomeric mixture with the α-
anomer would favour the subsequent stereoselective reduction of the 3-keto derivative: reasonably, 
the steric hindrance of the axial ethyl group at the anomeric position would force the hydride anion 
to attack from the pseudo-equatorial side of the carbonyl. Thus, after deacylation of 6 to obtain triol 
7, the synthetic strategy would require the selective protection of the hydroxyl functions at position 
C2 and C4 of the sugar; a useful procedure to obtain regioselectively and orthogonally protected 
building blocks is the one developed by Binkley and co-workers5 and improved by Field and co-
workers.6 This procedure involves several reaction steps (orthoesterification, alkylation, orthoester 
hydrolysis) in a single pot and purification only at the final stage by chromatography. The strategy 
significantly reduces the time for making building blocks, and overall yields are higher compared to 
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those obtained by stepwise reactions. Thus, a one-pot sequence of orthoesterification, allylation and 
orthoester regioselective opening afforded alcohol 8 in 51% yield over three steps. Moffatt 
oxidation conditions7 on 8 afforded the ketone derivative 9 which was then reduced with NaBH4 at 
0 ºC to obtain the deoxygulose sugar 10 in 55% yield and excellent stereoselectivity. Compound 10 
was then activated as triflate which was treated with sodium azide; unfortunately, this reaction 
produced a complex mixture in which elimination products prevailed instead of the azide 
substituted D-fucose. Actually, difficulties in nucleophilic displacement of 3-OTf-gulose derivatives 
have been reported,8,9 and they have been solved by using a 4,6-O-benzylidene ring8 and/or a 2-O-
acyl protecting group.9 Both methods, which minimize elimination reactions, nevertheless were 
considered to be not very useful for our scope, due to the impossible installation of a 4,6-O-
benzylidene on a 6-deoxysugar and the necessity of avoiding the use of 2-O-acyl protecting group 
in the synthesis of a D-Fucp3NAc donor so to favour α-stereoselectivity in subsequent 
glycosylations. 
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 Reagents and conditions: (a) i. EtOH, Amberlist-15 (H+), reflux, ii. Ac2O, pyridine, rt,  iii. FeCl3, CH2Cl2, rt, 56% over 
three steps; (b) NaOMe, MeOH, rt, 87%; (c) i. trimethyl orthoacetate, CSA, DMF, 40°C, ii. NaH, AllBr, rt, iii. 80% 
AcOH, rt, 51% over three steps; (d) 2:1 DMSO/Ac2O, rt; (e) NaBH4, 9:1 THF/MeOH, 0°C, 55% over two steps from 3; 
(f) NH2OMe.HCl, 64% over two steps from 3. 
 
 
Scheme 3.1: Ineffective attempts in synthesis of D-Fucp3-NAc building block 
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Trying to use anyway the keto-intermediate 9, we decided to convert it into its O-methyloxime 
derivative to be successively reduced.10 Thus, compound 9 was treated with NH2OMe.HCl giving 
intermediate 12 on which, unfortunately, reduction conditions were not successful to obtain the 
desired 3-amino compound. 
In carbohydrate chemistry, formation of trichloromethyl ozaxolines has already been experimented 
on allylic trichloroacetimidate11 and bis(trichloroacetimidate) since 1983.12 Even though formation 
of a trichloromethyloxazoline by means of an intramolecular cyclization has been accomplished on 
open-chain compounds,13 its application on saccharidic compounds is not widely reported.14 Thus, 
we thought to use this tool to put an amino function with the right configuration at fucose-C3 by 
means of an intramolecular cyclization of a 2,3-epoxytrichloroacetimidate derivative.  
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Reagents and conditions: (a) i. trimethyl orthoacetate, CSA, DMF, 40°C, ii. Ac2O, pyridine, rt, iii. AcOH 80%, rt, 
58% over three steps; (b) Tf2O, 1:1 CH2Cl2/py, 0°C; (c) NaOMe, MeOH, rt; (d) Cl3CCN, DBU, CH2Cl2, 0°C; (e) 
silica gel (0.063-0.200mm), CHCl3, 45°C, in vacuo, 64% over four steps from 9; (f) BnBr, NaH, DMF, rt, 68%; (g) 
i. 1M HCl, THF, rt, ii. Ac2O, py, rt, 63% over two steps; (h) PdCl2, 1:1 CH2Cl2/MeOH, rt, 84% (α:β=1:1.5 as 
determined by 1H NMR analysis); (i) Cl3CCN, DBU, CH2Cl2, 0°C, 53%; (j) CF3C(NPh)CCl, NaH, molecular sieves 
4Å, CH2Cl2, 0°C, 67% (α:β=3:1 as determined by 1H NMR analysis). 
 
Scheme 3.2: Synthesis of D-Fucp3-NAc donor 
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According to a published procedure, the commercially available D-galactose was converted into 
allyl α-D-fucopyranoside 13,15 which then underwent an one-pot sequence of three reactions to 
obtain the alcohol 14 regio- and stereo selectively (Scheme 3.2). After activation of 14 by triflation, 
Zemplèn conditions afforded the 2,3-epoxyalcohol 16 which was subsequently converted to the 
epoxytrichloroacetimidate 17 by treatment with Cl3CCN and DBU. The crucial step of the strategy 
was the intramolecular cyclization of 17 which was simply performed by adsorption on silica gel at 
45 °C in vacuo, bypassing Lewis acids catalysis which is generally required in the 
mechanism.13,14,16 Purification of the product, gave the oxazoline derivative 18 in 64% yield (after 
four steps from 14). To satisfy the structural requirements of the target and to favour subsequent α-
glycosylations, 18 was then protected with a benzyl group (non-participating protecting group) at 
C2 and with an acetyl group at C4, after acid hydrolysis of the fused oxazolinic ring; 4-O-acyl 
protecting group is, actually, supposed to be supportive in α-glycosylations by invoking a long 
range participation effect.17 Anomeric deallylation of 20 afforded the hemiacetal 21 which was 
converted into two different glycosyl donors afterwards. Schmidt and co-workers18 already reported 
the effectiveness of trichloroacetimidate (TCAI) as kind of glycosyl donor to achieve high α-
selectivity in fucosylations. Thus, treatment of 21 with CH3CN and DBU gave the 
triclhoroacetimidate 22 in  moderate 53% yield. Since few years similar trihaloacetimidate-type 
donors, N-phenyl trifluoroacetimidates (TFAI), have been exploited in successful glycosylations.19 
Thus, we decide to activate hemiacetal 21 as TFAI-donor by treatment of 21 with CF3C(NPh)Cl and 
NaH20 obtaining 23 with a superior yield (67%).  
 
Both glycosyl donors 22 and 23 were tested in their reactivity towards some L-and D-rhamnosyl 
acceptors in order to open a route to synthesize α-D-Fucp3NAc containing repeating units of O-
chain from phytopathogenic bacteria. Trying to synthesize structures as similar as possible to the 
natural ones, we chose rhamnosyl acceptor 2421, 2622, 2823and 2924 (Scheme 3.3) as the resulting 
disaccharides might be suitable building blocks for the synthesis of different D-Fucp3NAc 
containing oligosaccharides related to phytopatogenic O-chains. As showed in Table 3.1 donor 22 
was not effective in glycosylation conditions when coupled with acceptors 24 and 26: actually, no 
coupling product formation was observed activating 22 in mild conditions (BF3.OEt2) even using 
stoichiometric amounts of activator in DCM at reflux; on the other hand, a catalytic amount 
(0.01eq.) of the stronger activator TMSOTf afforded only traces of disaccharide and the 
decomposition of the donor in few minutes even working at very low temperature (-50 °C). 
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Entry Acceptor Donor Solvent Activator Yielda (α/β) Product
1 24 22 (2.0 eq) CH2Cl2 TMSOTf traces 25 
2 26 22 (2.0 eq) CH2Cl2 TMSOTf traces 27 
3 24 22 (2.0 eq) CH2Cl2 BF3.OEt2 no product //// 
4 24 23 (2.0 eq) CH2Cl2 TMSOTf 65% (62:38)b 25 
5 26 23 (2.0 eq) CH2Cl2 TMSOTf 61% (68:32)b 27 
6 26 23 (1.5 eq) Dioxane/DME/toluene 4:1:1 TMSOTf 55% (88:12)b 27 
7 28 23 (1.5 eq) Dioxane/DME/toluene 4:1:1 TMSOTf no product //// 
8 29 23 (1.8 eq) CH2Cl2 TMSOTf 70% (82:18)c 30 
9 29 23 (1.5 eq) Dioxane/DME/toluene 4:1:1 TMSOTf  63% (89:11)c 30 
a Isolated yield. b Measured by 1H NMR. c Measured after separation of the two anomers.  
 
Table 3.1: Glycosylations with D-Fucp3N trihaloacetimidate donors  
 
These results prompted us to focus our efforts on the donor 23. In contrast with previous 
glycosylation tests, activation of 23 with 0.1 eq. of TMSOTf afforded the desired disaccharides in 
good yields and without significant glycosyl donor decomposition; however, α-selectivity was not 
gratifyingly. It is known that electron-donating solvents have a beneficial effect on α-selectivity in 
glycosylation reactions even if they might affect the yields.25 Nevertheless, recently Adinolfi and 
co-workers exploited the effectiveness of an ether-based ternary mixture (dioxane/DME/toluene 
4:1:1) as solvent in glycosylations involving armed N-phenyl trifluoroacetimidate donors affording 
stereoselectively 1,2-cis-adducts with good yields.19c,26 We decided, therefore, to make use of this 
ternary mixture in coupling of 23 with 26: α-selectivity was noticeably improved despite the 
negligible decreasing of the yield. However, activation of 23 in coupling with the 2-acyl protected 
acceptor 28 by using TMSOTf and the ternary mixture as solvent, did not afford any disaccharide 
product. On the other hand, satisfying results in stereoselectivity and yield were obtained by 
coupling donor 23 with the ether-type protected acceptor 29. Definitely, the above results point out 
that 23 is an efficiently reactive glycosyl donor only towards armed acceptors and α-selectivity of 
glycosylation can be well controlled by using an α–directing ether-based ternary mixture as solvent 
for the reaction. 
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Scheme 3.3 Glycosyl acceptors and products of Table 3.1 (reaction conditions of the glycosylations 
are described therein) 
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3.2 Synthesis of the repeating unit of the O-Chain from Pseudomonas syringae 
pv. holci IMV 83002 
 
The repeating unit of the major O-antigen component from Pseudomonas syringae pv. holci, a 
generic phtytopathogenic bacterium,27 comprises a branched α-D-Fucp3NAc-containing 
pentasaccharide rhamnanic chain: 
 
→3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→2)-α-L-Rhap-(1→2)-α-L-Rhap-(1→ 
                                                                                                                            3 
                                                                                                                            ↓ 
                                                                                                                            1 
                                                                                                                 α-D-Fucp3NAc 
 
This repeating unit is very similar to the one of the major O-antigen component from Pseudomonas 
syringae pv. ribicola NVPPB 1010: these two oligosaccharide chains differ each other in the type of 
side branch, which is a D-Glcp-NAc unit in P. syringae pv. ribicola related structure.28 The 
synthesis of this last structure employed a [4+1] coupling highlighting that this strategy requires a 
large excess of amino sugar donor with a very poorly reactive benzoylated-protected 
tetrasaccharidic acceptor.21 Based on this work and on optimized glycosylation conditions found for 
coupling the D-Fucp3NAc-donor 23 with several rhamnosyl acceptors (see paragraph 3.1), we 
achieved easily the synthesis of the pentasaccharide showed above. Thus, as donor 23 was not 
easily synthesized we discarded the coupling between 23 and the linear rhamnosyl tetrasaccharide21 
and turned our attention to the alternative [3+2] approach (Scheme 3.4) . 
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         Scheme 3.4: Retrosynthetic analysis of target 31 
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As suggested from the target structure, the synthesis requires a 3-OH rhamnosyl acceptor bearing a 
temporary orthogonal protecting group at C2. Compound 30 was chosen for this purpose and as 
potential disaccharidic acceptor: 30 was treated with PdCl2 affording 34 in 93% yield (Scheme 3.5). 
Even though 2-OH function on acceptor 34 might be considered poorly reactive because of its steric 
hindrance, the mild BF3.OEt2 was strong enough to perform the coupling between 34 and the 
trisaccharide donor 3321 which was already stored in our laboratories. Moreover, no side product 
formation due to potential competitive nucleophilic attack by NHAc29 was observed. 
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Reagents and conditions: (a) PdCl2, 1:1 CH2Cl2/MeOH, rt, 93%; (b) BF3.OEt2, AW-300 4Å 
molecular sieves, CH2Cl2, -20°C, 51%; (c) i. Pd/C, 9:1 MeOH/HCOOH, ultrasound bath, rt, ii. 1M 
NaOMe, MeOH, rt, 78% over two steps. 
 
   Scheme 3.5: Affording the disaccharide acceptor 34 and target 31. 
 
α-Configuration of the new glycosidic linkage was confirmed by the value of the heteronuclear 
1JC,H coupling constant (173 Hz). The synthesis was completed by deprotection steps involving a 
debenzylation by transfer hydrogenation under Perlin conditions30 and subsequent de-O-acylation 
under Zemplèn conditions; the target, as methyl glycoside, was obtained in 78% yield over the two 
last steps. It is noteworthy that this have been the first reported synthesis of an Fucp3NAc 
containing oligosaccharide and is also useful to perform the oligomerization of the repeating unit. 
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3.3 Synthesis of the β-D-Rhamnosylated trisaccharide repeating unit of the O-
Chain from Xanthomonas campestris pv. campestris 800431 
 
Xanthomonas campestris pv. campestris (Xcc) strain 8004 is a pathogen of cruciferous crops that is 
the causative agent of black rot, a disease of worldwide importance.32 A very recent study has 
demonstrated the effectiveness of both Lipid-A and core extracted from this bacterium to be active 
in HR suppression triggering, moreover with two independent mechanisms.33 The O-chain from Xcc 
8004 shows a trisaccharide repeating unit consisting of a D-rhamnose disaccharide backbone with a 
3-acetamido-3,6-dideoxy-D-galactopyranose (D-Fucp3NAc) unit as branch:34  
 
→3)-β-D-Rhap-(1→3)-α-D-Rhap-(1→ 
                                                                2 
                                                                ↑ 
                                                                   1 
                                                    α-D-Fucp3NAc 
 
Also from a synthetic point of view, this is one of the most interesting and challenging structure 
among phytopathogenic bacteria because of the presence of a β-rhamnosidic linkage, the “steric 
crowd” on the 1,2-cis-diglycosylated D-rhamnose unit and finally the non-commercial availability 
of both D-rhamnose and D-Fucp3NAc. 1,2-cis-diglycosylated moiety present on the β-D-rhamnose 
unit clearly suggested a synthetic approach, in which the β-D-rhamnosidic linkage is firstly built up 
to give a rhamnose disaccharide with an orthogonal protecting-group pattern, that allows the 
selective deprotection on O-2B position and the subsequent α-coupling with a suitable D-
Fucp3NAc donor. Retrosynthetic analysis is showed in the following Scheme 3.6: 
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Among the several protocols developed to build β-rhamnosyl linkages we preferred to explore the 
possibility to apply a “non-benzylidene requiring” method of β-D-mannosylation to the D-rhamnose 
series: we decide to use a benzylsulfonyl group, already exploited by Schmidt (see chapter 2), as β-
directing and temporary protecting group; beside, a benzylsulfonyl group can be very easily 
installed on a hydroxyl function and selectively cleaved in presence of ether-based protecting 
groups.35 Thus, in order to prepare a suitable 2-O-benzylsulfonylated D-rhamnosyl donor, the 
known methyl 4-O-benzyl-α-D-rhamnopyranoside 3922 was regioselectively allylated at position O-
3 with the stannylidene method giving 40 in 82% yield (Scheme 3.7) and this alcohol was then 
subjected to benzylsulfonylation with BnSO2Cl in pyridine without any intermediate 
chromatography; subsequent acetolysis and cleavage of the anomeric acetate gave the hemi-acetal 
41 in 57% yield after three steps. 
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Reagents and conditions: (a) i. Bu2SnO, 10:1 benzene/methanol, 60°C, 90 min; ii. TBAB, AllBr, toluene, 
65°C, 60 min, 82% over two steps; (b) i. BnSO2Cl, py, rt, 45 min; ii. 73:26:1 Ac2O/AcOH/H2SO4, rt, 3 
hours; iii. hydrazine acetate, DMF, rt, 2 hours, 57% over three steps (α/β=3:1); (c) Cl3CCN, DBU, CH2Cl2, 
rt, 2 hours, 35%; (d) (PhO)2POCl, DMAP, CH2Cl2, -30°C to –10°C, overnight; (e) CF3C(NPh)Cl, NaH, 
CH2Cl2, 0°C, 4 hours, 69% (α/β=1:1); (f) see Table 3.2, entry 3; (g) see Table 3.2, entries 4 and 5; (h) 
NaNH2, DMF, rt, 4 days, 62%. 
 
 
Schema 3.7: Synthesis of different suitable rhamnosyl donors used in formation of disaccaride 
acceptor 46  
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Conversion of the hemi-acetal into trichloroacetimidate 42 surprisingly proceeded with low yield 
(35%). This result was explained with the high instability of compound 42, which was degraded 
during the chromatographic purification, even when it was performed on a neutral alumina support. 
Despite this low stability, the coupling of 42 with the D-rhamnose acceptor 38, which was 
synthesized in one step from 39 according to the known phase-transfer procedure,22,36 was 
attempted, but the total consumption of the donor was observed giving no disaccharide product 
(Table 3.2). In order to have a glycosyl donor, that was effective in glycosylate 38 and not too 
fastly degradable, alternative glycosylation procedures were investigated. Gin dehydrative 
coupling37 between hemi-acetal 41 and acceptor 38 was firstly tested, but it did not proceed at all: 
no product was detected by TLC analysis, even when the reaction was conducted for 2 days. 
Actually, ESI-MS analysis revealed the presence of a small peak related to disaccharide formation, 
which was quantified in less than 10% yield by NMR analysis. Since glycosyl phosphates are 
known to be β-directing glycosyl donor,38 hemi-acetal 41 was converted into the diphenyl-
phosphate donor 43 by treatment with diphenyl chlorophosphate in CH2Cl2 at –10°C in presence of 
DMAP.39 Analogously to 42, 43 demonstrated to be highly unstable by TLC analysis and 
chromatography on neutral alumina support, which did not allow the recover of any glycosyl 
phosphate. Thus, crude 43 (α/β=2.5:1) was directly subjected to glycosylation reaction without any 
chromatographic purification: upon coupling 43 and 44 with stoichiometric TMSOTf in CH2Cl2 at -
78°C, the desired disaccharide 45 was obtained in 58% yield. The stereoselectivity of the coupling 
was quite low: the β-disaccharide 45β was recovered in 31% yield, whereas the α- one in 27% 
yield. The configuration of the new glycosidic bond in 45α and 45β was ascertained by comparing 
the chemical shifts values of H-3B and H-5B, which are upfield shifted in 45β (H-3: 3.34 ppm; H-5: 
3.24 ppm) with respect to 45α (H-3, H-5: 3.84 ppm). In order to enhance the yield of the coupling, 
a N-phenyl-trifluoroacetimidate was chosen as alternative leaving group on the anomeric 
position,19a,b since it leads to glycosyl donors that are more stable and sometimes also more effective 
in glycosylation reactions than trichloroacetimidate ones.40,2 Hemi-acetal 41 was therefore treated 
with CF3C(NPh)CCl and NaH20 to give 44, after chromatography on neutral alumina, in a rather 
better yield (69%; α/β=1:1) than 42. Coupling of 44 with 38 in CH2Cl2 at –25°C using catalytic 
TMSOTf gave 45 in excellent yield and acceptable ratio of anomeric glycosides (99%; α/β=2:3; 
59% of isolated 45β). A slight modification in the solvent mixture (addition of hexane in order to 
enhance the SN2 character of the glycosyl acceptor attack on the supposed intermediate glycosyl 
triflate/oxacarbenium ion)41 afforded 45 in slightly lower yield (Table 3.2, entry 5) and worst β vs 
α selectivity. 
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Entry Donor Acceptor Solvent Activator Temperature  Yielda (α/β)b
1 41 38 CH2Cl2/toluene 3:1Tf2O/Ph2SO/DTBMP -78°C to rt traces 
2 42 38 CH2Cl2 TMSOTf -50°C to rt no product 
3 43 38 CH2Cl2 TMSOTf -78°C to -15°C 58% (1:1.1) 
4 44 38 CH2Cl2 TMSOTf -60°C to -25°C 99% (2:3) 
5 44 38 CH2Cl2/hexane 1:1 TMSOTf -50°C 95% (1.1:1) 
a Isolated yield. b Measured after isolation of the two anomers   
 
 Table 3.2: Glycosylation reactions of acceptor 38to give disaccharide 45 
 
Cleavage of the benzylsulfonyl protecting group on 45β with sodium amide in DMF afforded the 
disaccharide acceptor 46 (62%). 
The installation of the D-Fucp3NAc unit was firstly attempted with the known N-phenyl-
trifluoroacetimidate 23, the sole efficient D-Fucp3NAc donor reported to date (see paragraph 3.1): 
the glycosylation with TMSOTf in an α-stereodirecting ternary solvent mixture (4:1:1 
dioxane/DME/toluene)26 afforded the trisaccharide 47 in only 17% yield (Table 3.3, entry 1). 
 
Entry Donor Acceptor Solvent Activator Temperature Yield Product
1 23 46 
dioxane/DME/toluene
4:1:1 TMSOTf 0°C to rt 17% 47 
2 51 46 CH2Cl2/Et2O 1:1 NIS/TfOH -20°C traces 47 
3 52α 46 CH2Cl2/Et2O 1:1 NIS/TfOH -20°C 15% 37 
4 52β 46 CH2Cl2/Et2O 1:1 NIS/TfOH -20°C 40% (55%)a 37 
aYield calculated on reacted acceptor     
 
Table 3.3: Glycosylation reactions of disaccharide acceptor 46 
 
Not surprisingly, coupling between 23 and 46 proceeded with low yield: since 23 has been already 
demonstrated to glycosylate selectively armed acceptors (see paragraph 3.1),  low yield in this case 
can be ascribed to the nature of the acceptor which might be considered “sterically disarmed”. 
A different D-Fucp3NAc donor was therefore required: since thiofucosides have been already 
reported to act as efficient donors in glycosylations in which glycosyl trihaloacetimidates failed,42 
the synthesis of a D-Fucp3NAc thioglycoside was attempted (Scheme 3.8). Thus, compound 4843 
was subjected to a one-pot sequence of three reactions (orthoesterification, acetylation and 
orthoester regioselective opening; 82% over three steps) to afford the alcohol 49. Unfortunately, the 
treatment of the triflate derivative of 49 with sodium in methanol gave a complex mixture, in which 
only traces of the desired 2,3-epoxide 50 were identified; the latter was required for the subsequent 
 44
insertion of the 3-amino functionality via the intramolecular cyclization of an α-
epoxytrichloroacetimidate (see paragraph 3.1).  
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Reagents and conditions: (a) i. CSA, 2:7 DMF/MeC(OMe)3, 100 mbar, rt, 20 min; ii. Ac2O, py, rt, 
overnight; iii. 80% AcOH, rt, 10 min, 82% over three steps; (b) Tf2O, 1:1 py/CH2Cl2, 0°C, 45 min; (c) 
Na, 1:1 MeOH/CH2Cl2, rt; (d) see Table 3.3, entry 1; (e) i. Ac2O, py, rt, overnight; ii. EtSH, BF3.OEt2, rt, 
overnight, 79% over two steps (α/β=1:1); (f) AcCl, DIPEA, CH2Cl2, rt, overnight, 91%; (g) see Table 
3.3, entries 3 and 4; (h) i. PdCl2, 1:1 CH2Cl2/MeOH, rt, overnight; ii. 0.4 M NaOMe, 1:1 CH2Cl2/MeOH, 
rt, 3 hours; iii. H2, Pd/C, MeOH, rt, 4 days then HCOOH, ultrasound bath, rt, 3 hours, 84% over three 
steps. 
 
   Scheme 3.8 Synthesis of fucosyl donors 52 and trisaccharide target 36 
 
 
For this reason, it was decided to install a thioalkyl group directly on a D-Fucp3NAc building-
block, whose position 3 is namely already aminated. Thus, hemiacetal 21 was acetylated and then 
treated with EtSH/BF3.OEt2 in CH2Cl2 to give the thioglycoside 51 (79%; α/β=1:1 as an inseparable 
mixture). The NIS/TfOH mediated coupling of this donor and acceptor 46 in 1:1 CH2Cl2/Et2O 
afforded only traces of the desired α-trisaccharide 47 (Table 3.3); this result can be ascribed to the 
inhibitory effect of the NHAc group on the glycosyl donor, as it has already been reported.44,29 
Thus, in order to enhance the yield, compound 51 was converted into a more efficient D-Fucp3NAc 
donor: it was treated with AcCl/DIPEA in CH2Cl2 to give the N,N-diacetylated thioglycoside 52 in 
a ca. 1:1 α/β mixture, which was then easily separated by standard silica gel chromatography (52α: 
44%; 52β: 47%). The α-anomer gave the α-trisaccharide 37 in 15% yield, whereas compound 52β 
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afforded the same coupling product in higher yield (40%) together with a 27% recovery of 
unreacted acceptor 46 (55% yield based on reacted 46) and 10% of compound 47, whose formation 
is probably due to an acidic cleavage of the diamide function to NHAc group. The α-configuration 
of the newly formed glycosydic bond was ascertained by the 3JH1-H2 value (3.4 Hz). In comparison 
with the NHAc group, the presence of a N,N’-diacetyl protecting group in 37 does not increase the 
number of the required deprotection steps, since conventional transesterification with NaOMe on a 
NAc2 group retains one N-acetyl functionality, that occurs in the natural repeating unit of the O-
antigen from Xcc. Thus, after a first de-O-allylation step with PdCl2 in 1:1 MeOH/CH2Cl2, Zemplèn 
deacetylation and subsequent hydrogenolysis afforded the target-compound 36 (84%). Interestingly, 
hydrogenolysis with Pd/C in MeOH under H2 atmosphere allowed the cleavage only of two benzyl 
groups, even after a prolonged period of several days; the complete debenzylation was however 
accomplished by transfer hydrogenation under Perlin conditions.30  
It is noteworthy that the proposed synthetic approach yields the orthogonally protected trisaccharide 
building-block 37, whose allyl protecting group could be regioselectively cleaved to give a 
trisaccharide acceptor. This one would allow its further elongation to higher oligosaccharide 
fragments of the O-antigen from Xcc, suitable, as 36, for phytopathological structure-activity 
studies. 
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3.4 Synthesis of the repeating unit of the O-Chain from Pseudomonas syringae 
pv. syringae (cerasi) 43545 
 
The O-Chain from Pseudomonas syringae pv. cerasi 435, a generic phytopatogenic bacteria,46 
consists of an α-linked D-rhamnose branched tetrasaccharide repeating unit, which is shown 
below:47  
 
                                                               α-D-Rhap 
                                                                1 
                                                                ↓ 
                                                                 3 
→3)-α-D-Rhap-(1→3)-α-D-Rhap-(1→2)-α-D-Rhap-(1→ 
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                                         Figure 3.1: Repeating unit of the O-Chain from  
                                         Pseudomonas syringae pv. cerasi 435 
 
The structure suggests a strategy which makes use of a D-rhamnose building-block which would be 
suitably functionalized during the synthesis in order to convert it into both a glycosyl-donor and a 
glycosyl-acceptor. On purpose, we chose a D-rhamnose unit bearing a selectively removable 3-O-
protecting group, such as methyl 3-O-allyl-4-O-benzoyl-α-D-rhamnopyranoside 55 (Scheme 3.9). 
Again, the “ambitious” aim to have an oligomerizable tetrasaccharide structure imposes the 
condition to employ an orthogonal protecting group pattern; more precisely, we need to differentiate 
residues B and D of the target relating to their 3-O-position. The following scheme shows 
retrosynthetic analysis of the target as α-methyl- glycoside: 
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Scheme 3.9: Retrosynthetic analysis of tetrasaccharide 53 
 
 
Benzoylation and ketal cleavage performed on the known methyl 2,3-O-isopropylidene-α-D-
rhamnopyranoside 2648 afforded the diol 56 which was selectively allylated at 3-O position by the 
well-tested stannylene-mediated method (Scheme 3.10).49 To synthesize the glycosyl acceptor, 
intermediate 55 was then converted into a 3-OH-rhamnosyl unit bearing a selectively removable 
protecting group at 2-O position. Levulinoyl protecting group was chosen as it is reported to be not 
prone to acyl migration23 when it is adjacent to alcohol functions; on the contrary, in a first attempt 
a chloroacetyl group showed to be inconvenient for the same purpose because of its migration from 
2-O to 3-O position after palladium-catalyzed deallylation. Thus, acceptor 54 was obtained from 
compound 55 by treatment with LevOH in the presence of N,N’-diisopropylcarbodiimide (DIPC) 
and 4-dimethylaminopyridine (DMAP) and subsequent deallylation with PdCl2.  
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Reagents and conditions: (a) i: BzCl, pyridine, 0°C, 60 min; ii: 4:1 TFA/H2O, rt, 20 min; 77%; (b) i: Bu2SnO, 
10:1 benzene/MeOH 0°C, 90 min; ii: Bu4NBr, AllBr, toluene, 65°C, 2 hours; 88%; (c) LevOH, DIPC, DMAP, 
CH2Cl2, rt, 60 min, 79%; (d) PdCl2, 3:2 MeOH/CH2Cl2, rt, overnight, 78%; (e) i: 100:40:1 Ac2O/AcOH/H2SO4, rt, 
30 min; ii: hydrazine acetate, DMF, rt, 40 min; 59% (α/β=3.5/1); (f) i: BzCl, pyridine, rt, 30 min; ii: 100:40:1 
Ac2O/AcOH/H2SO4, rt, 60 min; iii: hydrazine acetate, DMF, rt, 45 min; 58% (α/β=5:1); (g) Cl3CCN, DBU, 
CH2Cl2, 0°C, 60 min; 72% for 59, 55% for 63. 
 
Scheme 3.10: Synthesis of glycosyl donors 37 and 41 
 
 
To achieve a suitable glycosyl donor, 2-O-acyl-protected hemiacetal 58, obtained from 55 by a one-
pot sequence of two reactions, was converted into the trichloroacetimidate 59 by treatment with 
Cl3CCN and DBU. The first coupling of the synthesis concerned donor 59 and acceptor 54 and was 
performed by BF3.OEt2-mediated activation at -50 °C; it afforded disaccharide 60(residue A and B 
of the target) in 86% yield (Scheme 3.11). Conversion of 60 into a glycosyl acceptor for the next 
coupling needed first the displacement of the allyl protecting group with a permanent one because 
of the requirement of oligomerizability explained above. Thus, compound 60 was treated with 
PdCl2, acetylated and then deprived of Lev-group to afford alcohol 61 in a very satisfying 87% 
yield over three steps. However, deallylation of 60 produced a 3-O-acetylated side-product which 
would have been a problem in a later step of the synthesis, more precisely in the formation of a 
trisaccharide acceptor. For this reason, we prefered to use donor 63 instead than 59 to lengthen the 
chain, as benzoyl groups are reported to be less prone than acetates to acyl migration;50 63 was 
synthesized similarly to 59 but benzoylation of 55 was required before acetolysis and cleavage of 
the anomeric acetate. Probably, the presence of a benzoyl group decreases the reactivity of a 
glycosyl-donor more than an acetyl one as a stronger promoter, such as TMSOTf, was necessary to 
build the glycosidic linkage between 61 and 63. Successively, trisaccharide 64 was converted into 
acceptor 65 which was then coupled with donor 63 in 70% yield. 
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The synthesis was finally ultimated by deprotecting tetrasaccharide 66 with a de-O-allylation first 
and a Zemplén deacylation afterwards. 
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Reagents and conditions: (a) BF3.OEt2, 4Å AW-300 MS, CH2Cl2, -50°C, 150 min; 86%; (b) i: PdCl2, 2:1 
MeOH/CH2Cl2, rt, 4 hours; ii: Ac2O, pyridine, rt, overnight; iii: hydrazine acetate, 4:1 CH2Cl2/MeOH; 87%; 
(c) TMSOTf, 4Å AW-300 MS, CH2Cl2, -50°C, 3 hours; 71%; (d) PdCl2, 3:2 MeOH/CH2Cl2, rt, 4 hours; 92%; 
(e) TMSOTf, 4Å AW-300 MS, CH2Cl2, -50°C, 90 min; 70%; (f) i: PdCl2, 1:1 MeOH/CH2Cl2, rt, overnight; ii: 
3.4M NaOMe, 1:1 MeOH/CH2Cl2, rt, overnight; 72%. 
 
Scheme 3.11: Couplings in synthesis of target 53 
 
 
All configurations of glycosidic bonds were assigned by measuring heteronuclear 1JC,H coupling 
constant value in bi-dimensional NMR experiments. Besides, 1H NMR spectrum of synthetic 
tetrasaccharide 53 was fairly completely coincident (Δppm = ±0.06) with the spectrum of the 
natural O-chain.47 More appreciable differences in 13C chemical shifts concern, obviously, positions 
involved in glycosylations within the natural oligosaccharide; more precisely, in synthetic structure 
C3D and C1A signals are highfield shifted (8.0 ppm and 1.3 ppm respectively) and C2A signal is 
downfield shifted in comparison with the values of the natural O-chain, due both to the absence of 
other linked subunit and the presence of a methoxyl as “storing” protecting group on the C1A 
position. The proposed synthetic approach allows the selectively deprotection of the tetrasaccharide 
so to convert it into a suitable building block for its oligomerization.  
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3.5 Experimental part 
 
General methods. ⎯ 1H (400 MHz; 200 MHz) and 13C NMR (100 MHz; 50 MHz) spectra were 
respectively recorded on a Bruker DRX-400 or on a Varian XL-200 NMR, in CDCl3 (internal 
standard, for 1H: CHCl3 at δ 7.26; for 13C: CDCl3 at δ 77.0) or in D2O (internal standard, for 1H and 
13C: (CH3)2CO at δ 2.22 and at δ 31.5 respectively). Assignment of proton and carbon chemical 
shifts were based on 1D and 2D NMR experiments such as COSY, TOCSY, NOESY, HSQC and 
HMQC-COSY. IR spectra were recorded on a JASCO-FT/IR-430 spectrometer Positive ESI-MS 
spectra were recorded on a Finnigan LCQ-DECA ion trap mass spectrometer. Optical rotations 
were measured on a JASCO P-1010 polarimeter. Elementar analysis were performed on a Carlo 
Erba 1108 instrument. Purification of compound 37 was performed by HPLC with an Agilent 1100 
series instrument (Phenomenex Proteo 90A C-18 column, 250x10 mm; 2:2:1 MeOH, CH3CN, H2O 
as eluent). Analytical thin layer chromatographies (TLC) were performed on aluminium plates 
precoated with Merck Silica Gel 60 F254 as the adsorbent. The plates were developed with 5% 
H2SO4 ethanolic solution and then heating to 130°C. Column chromatographies were performed on 
Kieselgel 60 (63-200 mesh). Gel filtration chromatographies were permorfed on a Sephadex G-10 
column (1.0 x 20 cm) with H2O as eluant. Solvents used were purchased from Fluka and not further 
purified before use. 
 
 
Allyl 3-deoxy-4,3-(2-trichloromethyl-1-oxa-3-azaprop-2-eno)-α-D-fucopyranoside (18): A solution 
of 14(1.34 g, 4.61 mmol) in 1:1 CH2Cl2/pyridine (10 mL) was cooled at 0°C and then Tf2O (1.6 
mL, 9.7 mmol) was slowly added. The solution was stirred at 0°C for 40’, after that the solution 
was diluted with CH2Cl2 (300 mL) and washed with 1M HCl (300 mL), 1M NaHCO3 (300 mL) and 
water (300 mL). The organic layer was collected, dried and concentrated to afford an oily residue, 
that was dissolved in 2:1 MeOH/CH2Cl2 (21 mL) and treated with a 0.6 M solution of NaOMe in 
MeOH (12 mL) at rt. After 2 hours, the solution was diluted with CH2Cl2 (350 mL) and washed 
with water (350 mL). The organic layer was collected, dried and concentrated to afford an oily 
residue, that was then dissolved in CH2Cl2 (13 mL). The solution was cooled at 0°C and then 
treated with Cl3CCN (4.5 mL, 44.8 mmol) and DBU (360 μL, 0.72 mmol). After 60’ under stirring 
at 0°C, the solution was concentrated. Silica gel (0.063-0.200 mm) (5.6 g) was then added to the 
residue, the mixture was suspended in CHCl3 (20 mL) and immediately concentrated in vacuo at 
45°C. After 10’ the solvent was completely evaporated and the solid residue was chromatographed 
(8:1 petroleum ether/EtOAc) to give 18 (965 mg, 64%) as a yellowish oil. [α]D= +31.7 (c=0.7, 
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CH2Cl2). 1H NMR (CDCl3, 200 MHz) δ 5.90 (m, 1H, OCH2CH=CH2), 5.28 (dd, 1H, Jvic= 17.2 Hz, 
Jgem=1.6 Hz, OCH2CH=CH2 trans), 5.21 (dd, 1H, Jvic= 10.4 Hz, Jgem=1.6 Hz, OCH2CH=CH2 cis), 
4.85 (dd, 1H, J4,3=9.8 Hz, J4,5=1.6 Hz, H4), 4.76 (d, 1H, J1,2=4.4 Hz, H1), 4.72 (dd, 1H, J3,4=9.8 Hz, 
J3,2=3.8 Hz, H3), 4.40-4.28 (m, 3H, H2, H5, OCH2CH=CH2), 4.13 (m, 1H, OCH2CH=CH2), 3.08 (bs, 
1H, OH), 1.29 (d, 3H, J6,5=6.6 Hz, H6); 13C NMR (CDCl3, 50 MHz) δ 164.2 (C=N), 133.8 
(OCH2CH=CH2), 117.5 (OCH2CH=CH2), 94.6 (C1), 83.5 (C4), 68.3, 66.9, 65.7, 64.8 (C2, C3, C5, 
OCH2CH=CH2), 15.9 (C6). ESI-MS for C11H14Cl3NO4 (m/z): Mr (calcd) 329.00, Mr (found) 351.88 
(M+Na)+. 
 
Allyl 2-O-benzyl-3-deoxy-4,3-(2-trichloromethyl-1-oxa-3-azaprop-2-eno)-α-D-fucopyranoside (19): 
A solution of 18 (903 mg, 2.74 mmol) in DMF (20 mL) was treated with BnBr (3.4 mL, 28.6 
mmol) and NaH (60% oil suspension; 353 mg, 14.7 mmol). The solution was stirred at rt for 90 
min, then diluted with CH2Cl2 (300 mL) and washed with water (300 mL). The organic layer was 
collected, dried and concentrated to give a residue, that, after chromatography (11:1 petroleum 
ether/EtOAc), afforded pure 19 (840 mg, 68%) as a yellowish oil. [α]D= +70.2 (c=1.0, CH2Cl2). IR 
(thin film, NaCl) 3035, 2944, 1677, 1266 cm-1. 1H NMR (CDCl3, 200 MHz) δ 7.36 (m, 5H, H-Ar), 
5.91 (m, 1H, OCH2CH=CH2), 5.32 (dd, 1H, Jvic= 17.2 Hz, Jgem=1.6 Hz, OCH2CH=CHH trans), 
5.20 (dd, 1H, Jvic= 10.4 Hz, Jgem=1.6 Hz, OCH2CH=CHH cis), 4.85 (d, 1H, Jgem=12.0 Hz, 
OCHHPh), 4.76-4.69 (m, 3H, H1, H4, OCHHPh), 4.55 (dd, 1H, J3,4=9.0 Hz, J3,2=5.4 Hz, H3), 4.30 
(m, 2H, H5, OCHHCH=CH2), 4.05 (m, 1H, OCHHCH=CH2), 3.77 (dd, 1H, J2,3=5.4 Hz, J2,1=4.0 
Hz, H2), 1.33 (d, 3H, J6,5=6.6 Hz, H6); 13C NMR (CDCl3, 50 MHz) δ 164.1 (C=N), 138.0 (Cipso), 
134.0 (OCH2CH=CH2), 128.5 (C-Ar), 117.2 (OCH2CH=CH2), 96.1 (C1), 84.7 (C4), 74.0, 73.8, 68.7, 
66.8, 64.2 (C2, C3, C5, OCH2CH=CH2, OCH2Ph), 16.1 (C6). ESI-MS for C18H20Cl3NO4 (m/z): Mr 
(calcd) 419.05, Mr (found) 442.28 (M+Na)+. Anal. calcd.: C 51.39, H 4.79, N 3.33. Found: C 51.55, 
H 4.70, N 3.32. 
 
Allyl 4-O-acetyl-3-acetamido-2-O-benzyl-α-D-fucopyranoside (20): 
To a solution of 19 (689 mg, 1.64 mmol) in THF (10 mL), 1M HCl was added (1.57 mL). The 
mixture was vigorously stirred at rt for 30 min, after that 1M NaHCO3 (200 mL) was added. 
Stirring was continued for additional 10 min, then EtOAc (200 mL) was added. The organic layer 
was collected, dried and concentrated to afford an oily residue that was subsequently dissolved in 
pyridine (3 mL). The solution was treated with acetic anhydride (3 mL) and stirred at rt overnight. 
The solution was then concentrated and the residue dissolved in CH2Cl2 (100 mL) and extracted 
with 1M HCl (100 mL) and water (100 mL). The organic layer was collected, dried and 
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concentrated to afford a residue, that, after chromatography (3:2 petroleum ether/EtOAc), gave pure 
20 (403 mg, 63%) as a white foam. [α]D= +126.8 (c=1.0, CH2Cl2). IR (thin film, NaCl) 3055, 2951, 
1735, 1664, 1259 cm-1. 1H NMR (CDCl3, 200 MHz) δ 7.36 (m, 5H, H-Ar), 5.897 (m, 1H, 
OCH2CH=CH2), 5.35-5.14 (m, 4H, H4, NH, OCH2CH=CH2), 4.95 (d, 1H, J1,2=2.7 Hz, H1), 4.65 (d, 
1H, Jgem=12.0 Hz, OCHHPh), 4.53 (m, 1H, H3), 4.47 (d, 1H, Jgem=12.0 Hz, OCHHPh), 4.13 (m, 
2H, H5, OCH2CH=CH2), 3.97 (m, 2H, OCH2CH=CH2), 3.67 (dd, 1H, J2,3=11.4 Hz, J2,1=2.7 Hz, 
H2), 2.06 (s, 3H, OAc), 1.79 (s, 3H, NAc), 1.03 (d, 3H, J6,5=6.6 Hz, H6); 13C NMR (CDCl3, 50 
MHz) δ 170.0 (2 COCH3), 138.0 (Cipso), 133.7 (OCH2CH=CH2), 128.5 (C-Ar), 117.8 
(OCH2CH=CH2), 95.4 (C1), 73.1, 72.7, 71.6, 68.4, 64.8 (C2, C4, C5, OCH2CH=CH2, OCH2Ph), 48.2 
(C3), 23.0, 20.6 (2 COCH3), 16.1 (C6). ESI-MS for C20H27NO6 (m/z): Mr (calcd) 377.18, Mr (found) 
400.37 (M+Na)+. Anal. calcd.: C 63.64, H 7.21, N 3.71. Found: C 63.80, H 7.00, N 3.65. 
 
4-O-Acetyl-3-acetamido-2-O-benzyl-D-fucopyranose (21): 
A suspension of 20 (357 mg, 0.92 mmol) and PdCl2 (27 mg, 0.15 mmol) in 1:1 CH2Cl2/MeOH (10 
mL) was vigorously stirred at rt for 5 h. The mixture was filtered over a Celite pad, then diluted 
with CH2Cl2 (150 mL) and washed with 5M NaCl (150 mL). The organic layer was collected, dried 
and concentrated. The resulting residue was chromatographed (1:1 petroleum ether/EtOAc) to 
afford 21 (270 mg, 84%; α:β=1:1.5) as a yellowish oil. IR (thin film, NaCl) 3517, 3009, 1743, 
1666, 1255 cm-1. 1H NMR (CDCl3, 200 MHz) δ 5.40 (d, 1H, J1,2=3.6 Hz, H-1α), 5.27 (d, 1H, 
J4,3=2.8 Hz, H-4α), 5.21 (d, 1H, J4,3=2.8 Hz, H-4β), 5.01-4.83 (m, 4H, H-1β, NHα, NHβ, OCHHPh), 
4.76 (d, 1H, Jgem=12.0 Hz, OCHHPh), 4.68 (d, 1H, Jgem=12.0 Hz, OCHHPh), 4.53 (m, 2H, H-3α, 
OCHHPh), 4.38 (q, 1H, J5,6=6.6 Hz, H-5α), 4.17 (m, 1H, H-3β), 3.84 (q, 1H, J5,6=6.6 Hz, H-5β), 
3.63 (dd, 1H, J2,3=10.2 Hz, J2,1=3.6 Hz, H-2α), 3.33 (dd, 1H, J2,3=10.2 Hz, J2,1=7.2 Hz, H-2β), 2.08 
(s, 3H, OAc), 2.04 (s, 3H, OAc), 1.84 (s, 3H, NAc), 1.79 (s, 3H, NAc), 1.13 (d, 3H, J6,5=6.6 Hz, H-
5β), 1.07 (d, 3H, J6,5=6.6 Hz, H-5α); 13C NMR (CDCl3, 50 MHz) δ 170.0 (4 COCH3), 138.1 (Cipso), 
137.4 (Cipso), 128.4 (C-Ar), 98.0 (C-1α), 90.5 (C-1β), 76.0, 73.7, 72.8, 72.1, 71.9, 70.2, 65.0, 60.4 
(C-2α, C-2β, C-4α, C-4β, C-5α, C-5β, 2 OCH2Ph), 52.0, 47.8 (C-3α, C-3β), 23.2 (2 COCH3), 21.0, 
20.7 (2 COCH3), 16.5, 16.3 (C-6α, C-6β). ESI-MS for C17H23NO6 (m/z): Mr (calcd) 337.15, Mr 
(found) 360.22 (M+Na)+. Anal. calcd.: C 60.52, H 6.87, N 4.15. Found: C 60.89, H 6.80, N 4.00. 
 
4-O-Acetyl-3-acetamido-2-O-benzyl-α-D-fucopyranosyl  trichloroacetimidate (22):  
Compound 21 (77 mg, 0.22 mmol) was dissolved in CH2Cl2 (3.0 mL) under an argon atmosphere 
and to the 0°C cooled solution Cl3CCN (115 μL, 1.21 mmol) and DBU (3.3 μL, 6.6 μmol) were 
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added. The solution was stirred at 0°C for 4 h and then concentrated. The resulting residue was 
chromatographed (1:1 petroleum ether/EtOAc) over neutral alumina gel to afford 22 (57 mg, 53%) 
as a white foam. [α]D= +99.2 (c=0.8, CH2Cl2). IR (thin film, NaCl) 3022, 2979, 1739, 1671 cm-1. 
1H NMR (CDCl3, 200 MHz) δ 8.60 (s, 1H, NHCCl3), 7.36 (m, 5H, H-Ar), 6.60 (d, 1H, J1,2=3.4 Hz, 
H1), 5.41 (d, 1H, J4,3=2.4 Hz, H4), 5.02 (d, 1H, JH,NH=6.6 Hz, NH), 4.75 (d, 1H, Jgem=12.0 Hz, 
OCHHPh), 4.55 (m, 1H, H3), 4.46 (d, 1H, Jgem=12.0 Hz, OCHHPh), 4.33 (q, 1H, J5,6=6.6 Hz, H5), 
3.81 (dd, 1H, J2,3=11.4 Hz, J2,1=3.4 Hz), 2.08 (s, 3H, OAc), 1.84 (s, 3H, NAc), 1.09 (d, 3H, J6,5=6.6 
Hz, H6); 13C NMR (CDCl3, 50 MHz) δ 170.1, 169.9 (2 COCH3), 161.4 (Cl3CC=NH), 137.4 (Cipso), 
128.3 (C-Ar), 93.5 (C-1), 72.0, 71.9, 71.8, 67.8 (C2, C4, C5, OCH2Ph), 48.7 (C3), 23.1, 20.6 (2 
COCH3), 16.3 (C6). ESI-MS for C19H23Cl3N2O6 (m/z): Mr (calcd) 480.06, Mr (found) 513.30 
(M+Na)+. Anal. calcd.: C 47.37, H 4.81, N 5.81. Found: C 47.60, H 4.89, N 5.75. 
 
4-O-Acetyl-3-acetamido-2-O-benzyl-D-fucopyranosyl N-phenyl-trifluoroacetimidate (23):  
A mixture of 21 (251 mg, 0.72 mmol) and freshly powdered 4Å molecular sieves was suspended 
under argon in CH2Cl2 (5 mL) and cooled to 0°C under stirring. CF3C(NPh)Cl (53 μL, 0.42 mmol) 
and NaH (60% oil suspension; 17 mg, 0.42 mmol) were added and stirred was continued at 0°C for 
3 h, after that the mixture was filtered over Celite and the filtrate concentrated. Neutral alumina 
(Brockman grade 1) column chromatography (3:2 petroleum ether/EtOAc) on the residue, afforded 
23 (277 mg, 74%; α:β=3:1) as a colourless oil. IR (thin film, NaCl) 3040, 1738, 1670, 1656, 1260 
cm-1. 1H NMR (CDCl3, 200 MHz) (α-anomer) δ 7.42-6.73 (H-Ar), 6.60 (m, 1H, H-1), 5.38 (d, 1H, 
J4,3=2.4 Hz, H-4), 4.83 (m, 2H, NH, OCHHPh), 4.50 (m, 2H, H3, OCHHPh), 4.28 (q, 1H, J5,6=6.6 
Hz, H-5), 3.75 (dd, 1H, J2,3=10.2 Hz, J2,1=3.4 Hz, H-2), 2.07 (s, 3H, OAc), 1.84 (s, 3H, NAc), 1.11 
(dd, 3H, J6,5=6.6 Hz, H-6); 13C NMR (CDCl3, 50 MHz) (α-anomer) δ 170.1, 169.9 (2 COCH3), 
143.5, 137.4 (2 Cipso), 129.3-119.4 (C-Ar), 92.5 (C-1), 72.3, 71.9, 71.8, 67.9 (C2, C4, C5, OCH2Ph), 
48.5 (C3), 23.2, 20.6 (2 COCH3), 16.4 (C6). ESI-MS for C25H27F3N2O6 (m/z): Mr (calcd) 508.18, Mr 
(found) 531.38 (M+Na)+. Anal. calcd.: C 59.05, H 5,35; N. 5.51. Found: C 59.10, H 5.45, N 5.43. 
 
General procedure for D-Fucp3NAc couplings in CH2Cl2: 
A mixture of donor 23 (37 mg, 0.074 mmol) and rhamnosyl acceptor (0.037 mmol) was 
coevaporated three times with toluene, the residue was then mixed with freshly powdered AW-300 
4Å molecular sieves and suspended under argon in CH2Cl2 (1.0 mL). The mixture was cooled and 
stirred at 0°C, TMSOTf (1.2 μL, 7.4 μmol) was added and the temperature was allowed to 
gradually rise to rt. After completion of the reaction (TLC analysis), the mixture was neutralized by 
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adding pyridine. The mixture was then filtered over Celite and concentrated to give a residue, that 
was purified by column chromatography. 
General procedure for D-Fucp3NAc couplings in dioxane/toluene/DME 4:1:1 v/v/v: 
A mixture of donor 23 (37 mg, 0.074 mmol) and rhamnosyl acceptor (0.049 mmol) was 
coevaporated three times with toluene, the residue was then mixed with freshly powdered AW-300 
4Å molecular sieves and suspended under argon in 4:1 dioxane/toluene (1.5 mL). The mixture was 
cooled and stirred at 0°C, a 0.025 M DME solution of TMSOTf (0.3 mL , 7.4 μmol) was added and 
the temperature was allowed to gradually raise to rt. After completion of the reaction (TLC 
analysis), the mixture was neutralised by adding pyridine. The mixture was then filtered over Celite 
and concentrated to give a residue, that was purified by column chromatography. 
 
Benzyl (4-O-acetyl-3-acetamido-2-O-benzyl-D-fucopyranosyl)-(1→3)-3-O-allyl-4-O-benzoyl-α-L-
rhamnopyranoside (25):  
See the general procedure for D-Fucp3NAc couplings in CH2Cl2 and in dioxane/toluene/DME 4:1:1 
v/v/v. IR (thin film, NaCl) 3025, 2980, 2933, 1744, 1666 cm-1.  1H NMR (CDCl3, 400 MHz) δ 8.11-
7.26 (m, 30H, H-Ar), 5.73 (m, 2H, 2 OCH2CH=CH2), 5.50 (t, 1H, J4,3=J4,5=10.0 Hz, H-4Aβ), 5.41 
(d, 1H, J4,3=1.8 Hz, H-4Bα), 5.35 (t, 1H, J4,3=J4,5=10.0 Hz, H-4Aα), 5.20-5.10 (m, 5H, H-1Aβ, H-4Bβ,  
OCHHPh, 2 OCH2CH=CHH trans), 5.08-4.97 (m, 4H, H-1Bα, NHα, 2 OCH2CH=CHH cis), 4.91 
(bs, 1H, H-1Aα), 4.77 (m, 4H, NHβ, 3 OCHHPh),  4.65 (d, 1H, J1,2=7.4 Hz, H-1Bβ), 4.61-4.50 (m, 
6H, H-3Bα, H-5Bα, 4 OCHHPh ), 4.12-4.03 (m, 5H, H-2Aα,  H-2Aβ,  H-3Bβ, 2 OCHHCH=CH2), 4.01-
3.94 (m, 6H, H-3Aα, H-3Aβ,  H-5Aα,  H-5Aβ, 2 OCHHCH=CH2), 3.78 (dd, 1H, J2,3=10.3 Hz, J2,1=3.4 
Hz, H-2Bα), 3.69 (q, 1H, J5,6=6.4 Hz, H-5Bβ), 3.34 (dd, 1H, J2,3=10.7 Hz, J2,1=7.4 Hz, H-2Bβ), 2.078 
(s, 3H, OAc), 2.05 (s, 3H, OAc), 1.84 (s, 3H, NAc), 1.79 (s, 3H, NAc), 1.29 (m, 6H, H-6Aα, H-
6Aβ), 1.01 (d, 3H, J6,5=6.4 Hz, H-6Bα), 0.98 (m, 6H, J6,5=6.4 Hz, H-6Bβ); 13C NMR (CDCl3, 100 
MHz) δ 170.1, 169.9 (4 COCH3), 165.5, 165.4 (COPh), 134.4-128.1 (2 OCH2CH=CH2, C-Ar), 
116.7, 116.6 (2 OCH2CH=CH2), 105.8 (C-1Bβ), 98.7, 96.6, 96.4 (C-1Aα, C-1Aβ, C-1Bα), 76.9, 76.0, 
75.8, 74.4, 74.2, 73.6, 73.5, 73.4, 72.6, 71.5, 71.3, 71.2, 70.9, 70.5, 69.1, 69.0, 68.9, 67.3, 66.7, 65.1 
(C-2Aα, C-2Aβ, C-2Bα, C-2Bβ, C-3Aα, C-3Aβ, C-4Aα, C-4Aβ, C-4Bα, C-4Bβ, C-5Aα, C-5Aβ, C-5Bα, C-
5Bβ, 2 OCH2CH=CH2, 4 OCH2Ph,), 23.0, 22.9, 20.6, 20.4 (4 COCH3), 17.6, 17.5, 16.3, 16.1 (C-
6Aα, C-6Aβ, C-6Bα, C-6Bβ). ESI-MS for C40H47NO11 (m/z): Mr (calcd) 717.31, Mr (found) 740.51 
(M+Na)+. Anal. calcd.: C 66.93, H 6.60, N 1.95. Found: C 67.10, H 6.47, N 1.99. 
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Methyl (4-O-acetyl-3-acetamido-2-O-benzyl-D-fucopyranosyl)-(1→3)-2,3-O-isopropylidene-α-L-
rhamnopyranoside (27):  
See the general procedure for D-Fucp3NAc couplings in CH2Cl2 and in dioxane/toluene/DME 4:1:1 
v/v/v. IR (thin film, NaCl) 3042, 1748, 1680, 1229 cm-1. 1H NMR (CDCl3, 400 MHz) δ 7.41-
7.26 (m, 10H, H-Arα,β), δ 5.73 (d, 1H, J1,2=3.5 Hz, H-1Bα), 5.33 (d, 1H, J4,3=2.2 Hz, H-4Bα), 5.14 
(d, 1H, J4,3=2.2 Hz, H-4Bβ), 4.86 (m, 5H, H-1Aα, H-1Bβ, NHα, 2 OCHHPh), 4.67-4.54 (m, 4H, H-
1Bβ, H-5Bβ, NHβ, OCHHPh), 4.44 (d, 1H, Jgem=12.0 Hz, OCHHPh), 4.40 (m, 1H, H-3Bα), 4.31 (t, 
1H, J4,3= J4,5=7.1 Hz, H-3Aβ), 4.24 (t, 1H, J4,3= J4,5=7.1 Hz, H-3Aα), 4.20-4.07 (m, 4H, H-2Aα, H-
2Aβ, H-3Bβ, H-5Bα), 3.72 (m, 2H, H-5Aα, H-5Aβ), 3.65 (dd, 1H, J2,3=11.4 Hz, J2,1=3.5 Hz, H-
2Bα), 3.56 (dd, 1H, J4,5=9.9 Hz, J4,3=7.1 Hz, H-4Aα), 3.51 (dd, 1H, J4,5=9.9 Hz, J4,3=7.1 Hz, H-
4Aβ), 3.36 (m, 7H, H-2Bβ OMeα, OMeβ), 2.08 (2s, 6H, 2 OAc), 1.85 (s, 3H, NAc), 1.76 (s, 3H, 
NAc), 1.57 (s, 6H, 2 CH3), 1.36 (s, 6H, 2 CH3), 1.34 (d,  3H, J6,5=6.2 Hz, H-6Aα), 1.24 (d, 3H, 
J6,5=6.6 Hz, H-6Bβ), 1.15 (d, 3H, J6,5=6.2 Hz, H-6Aβ), 1.09 (d, 3H, J6,5=6.6 Hz, H-6Bα); 13C NMR 
(CDCl3, 100 MHz) δ 167.8 (COCH3), 137.6 (Cipso), 126.5-125.7 (C-Ar), 104.2 (C-1Bβ), 97.9 C-1Aα, 
C-1Aβ), 94.5 (C-1Bα), 82.2, 78.4, 78.2, 76.4, 76.0, 75.8, 75.2, 73.8, 72.3, 72.1, 71.2, 70.5, 67.3, 65.0, 
63.7 (C-2Aα, C-2Aβ, C-2Bα, C-2Bβ, C-3Aα, C-3Aβ, C-4Aα, C-4Aβ, C-4Bα, C-4Bβ, C-5Aα, C-5Aβ, C-
5Bα, C-5Bβ,  OCHHPh ), 54.5 (OMe), 51.8 (C-3Bβ), 47.9 (C-3Bα), 27.8 (CH3), 26.1 (CH3), 22.9, 22.8, 
20.6, 20.5 (4 COCH3), 17.8, 17.5, 16.3, 15.9 (C-6Aα, C-6Aβ, C-6Bα, C-6Bβ). ESI-MS for C27H39NO10 
(m/z): Mr (calcd) 537.26, Mr (found) 538.20 (M+H)+. Anal. calcd.: C 60.32, H 7.31, N 2.61. Found: 
C 60.40, H 7.19, N 2.51. 
 
Methyl (4-O-acetyl-3-acetamido-2-O-benzyl-α-D-fucopyranosyl)-(1→3)-2-O-allyl-4-O-benzyl-α-L-
rhamnopyranoside (30):  
See the general procedure for D-Fucp3NAc couplings in CH2Cl2 and in dioxane/toluene/DME 4:1:1 
v/v/v. (α-anomer) [α]D= +20.4 (c=0.6, CH2Cl2). IR (thin film, NaCl) 3019, 2956, 1747, 1665, 1253 
cm-1. 1H NMR (CDCl3, 400 MHz) δ 7.42-7.27 (m, 10H, H-Ar), 5.87 (m, 1H, OCH2CH=CH2), 5.24 
(dd, 1H, Jvic= 17.3 Hz, Jgem=1.7 Hz, OCH2CH=CHH trans), 5.21 (d, 1H, J1,2=3.4 Hz, H-1B), 5.14 
(dd, 1H, Jvic= 10.2 Hz, Jgem=1.7 Hz, OCH2CH=CHH cis), 5.07 (d, 1H, J4,3=3.0 Hz, H-4B), 4.86 (d, 
1H, Jgem=10.5 Hz, OCHHPh), 4.81-4.60 (m, 5H, H-1A, H-3B, NH, 2 OCHHPh), 4.43 (d, 1H, 
Jgem=12.0 Hz, OCHHPh), 4.27-4.09 (m, 3H, H-5B, OCH2CH=CH2), 4.05 (dd, 1H, J3,4=8.7 Hz, 
J3,2=2.7 Hz, H-3A), 3.79 (bs, 1H, H-2A), 3.71 (m, 2H, H-2B, H-5A), 3.61 (t, 1H, J4,3= J4,5=9.3 Hz, H-
4A), 3.33 (m, 3H, OMe), 2.04 (s, 3H, OAc), 1.79 (s, 3H, NAc), 1.37 (d, 3H, J6,5=6.0 Hz, H-6A), 0.78 
(d, 3H, J6,5=6.6 Hz, H-6B); 13C NMR (CDCl3, 100 MHz) δ 169.9 (COCH3), 138.1, 138.0 (2 Cipso), 
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134.9 (OCH2CH=CH2), 129.6-127.7 (C-Ar), 117.2 (OCH2CH=CH2), 98.9 (C-1A), 93.6 (C-1B), 79.8, 
75.5, 74.4, 72.9, 72.8, 72.2, 71.6, 68.1, 68.0, 65.1 (C-2A, C-2B, C-3A, C-4A, C-4B, C-5A, C-5B, 
OCH2Ph, OCH2CH=CH2), 54.7 (OMe), 48.1 (C-3B), 23.1, 20.6 (2 COCH3), 18.1, 15.9 (C-6A, C-6B). 
ESI-MS for C34H45NO10 (m/z): Mr (calcd) 627.72, Mr (found) 650.50 (M+Na)+. Anal. calcd.: C 
65.05, H 7.23, N 2.23. Found: C 65.20, H 7.19, N 2.32 
 
Methyl (4-O-acetyl-3-acetamido-2-O-benzyl-α-D-fucopyranosyl)-(1→3)-4-O-benzyl-α-L-
rhamnopyranoside (34):  
A mixture of compound 30-α (56 mg, 0.089 mmol) and PdCl2 (7.8 mg, 44 μmol) was suspended in 
1:1 CH2Cl2/MeOH (2.0 mL) under vigorous stirring. After 4h the mixture was filtered on a Celite 
pad, then diluted with CH2Cl2 (25 mL) and washed with 5M NaCl (30 mL). The organic layer was 
collected, dried and concentrated to give an oily residue that, after column chromatography (1:2 
petroleum ether/EtOAc) afforded 34 (49 mg, 93%) as an oil. [α]D= +32.3 (c=1.0, CH2Cl2). IR (thin 
film, NaCl) 3509, 3030, 1741, 1669, 1258 cm-1. 1H NMR (CDCl3, 400 MHz) δ 7.49-7.29 (m, 10H, 
H-Ar), 5.07 (d, 1H, J4,3=3.0 Hz, H-4B), 5.04 (bs, 1H, H-1A), 4.80-4.71 (m, 4H, H-1B, 3 OCHHPh), 
4.53 (m, 1H, H-3B), 4.44 (d, 1H, Jgem=12.0 Hz, OCHHPh), 4.06 (q, 1H, J5,6=6.6 Hz, H-5B), 3.99 (m, 
2H, H-2A, H-3A), 3.75 (dq, 1H, J5,4=9.3 Hz, J5,6=6.0 Hz, H-5A), 3.63 (dd, 1H, J2,3=11.4 Hz, J2,1=3.3 
Hz, H-2B), 3.52 (t, 1H, J4,3=J4,5=9.3 Hz, H-4A), 3.36 (s, 3H, OMe), 2.05 (s, 3H, OAc), 1.79 (s, 3H, 
NAc), 1.38 (d, 3H, J6,5=6.0 Hz, H-6A), 0.73 (d, 3H, J6,5=6.6 Hz, H-6B); 13C NMR (CDCl3, 100 
MHz) δ 169.9 (COCH3), 138.1, 137.1 (2 Cipso), 128.7-127.5 (C-Ar), 99.9 (C-1A), 93.3 (C-1B), 79.3, 
77.1, 75.5, 73.1, 73.0, 72.7, 67.6, 67.2 (C-2A, C-2B, C-3A, C-4A, C-4B, C-5A, C-5B, 2 OCH2Ph), 54.6 
(OMe), 48.1 (C-3B), 23.1, 20.5 (2 COCH3), 17.9 (C-6A), 15.8 (C-6B). ESI-MS for C31H41NO10 (m/z): 
Mr (calcd) 587.27, Mr (found) 610.00 (M+Na)+. Anal. calcd.: C 63.36, H 7.03, N 2.38. Found: C 
63.55, H 6.96, N 2.34.       
 
Methyl (2,4-di-O-benzoyl-3-O-chloroacetyl-α-L-rhamnopyranosyl)-(1→3)-(2,4-di-O-benzoyl-α-L-
rhamnopyranosyl)-(1→2)-(3,4-di-O-benzoyl-α-L-rhamnopyranosyl)-(1→2)-[4-O-acetyl-3-
acetylamino-2-O-benzyl-α-D-fucopyranosyl-(1→3)]-4-O-benzyl-α-L-rhamnopyranoside (35):  
A mixture of 34 (20 mg, 34.1 μmol) and 33(66 mg, 50.8 μmol) was coevaporated three times with 
toluene, the residue was then mixed with freshly powdered AW-300 4Å molecular sieves, 
suspended under argon in CH2Cl2 (2.0 mL) and stirred at –20°C. BF3.OEt2 (3.2 μL, 25.4 μmol) was 
then added. After 24 hours, an additional aliquot of 33 (44 mg, 33.9 μmol) and BF3.OEt2 (2.1 μL, 
16.9 μmol) was added. After an additional day the reaction was quenched with a drop of Et3N. 
After filtration over a Celite pad, the mixture was concentrated to give a residue, that, after column 
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chromatography (1:1 petroleum ether/EtOAc), afforded 35 (30 mg, 51%) as a white foam. [α]D= 
+113.3 (c=1.0, CH2Cl2). IR (thin film, NaCl) 3052, 3028, 1739, 1656, 1249 cm-1. 1H NMR (CDCl3, 
400 MHz) δ 8.18-7.10 (m, 40H), 5.83 (dd, 1H, J3,4=9.6 Hz, J3,2=2.8 Hz, H-3B), 5.72 (d, 1H, J2,3=3.0 
Hz, H-2C), 5.59 (t, 1H, J4,3=J4,5=10.0 Hz, H-4B), 5.56 (t, 1H, J4,3=J4,5=9.6 Hz, H-4C), 5.44 (dd, 1H, 
J3,4=9.8 Hz, J3,2=2.8 Hz, H-3D), 5.34 (m, 2H, H-1B, H-4D), 5.18 (m, 3H, H-1D, H-1E, H-2D), 5.11 (d, 
1H, J4,3=2.8 Hz, H-4E), 5.06 (bs, 1H, H-1C), 4.90 (d, 1H, Jgem=10.8 Hz, OCHHPh), 4.87 (d, 1H, 
Jgem=12.0 Hz, OCHHPh), 4.84 (bs, 1H, H-1A), 4.76 (d, 1H, Jgem=10.8 Hz, OCHHPh), 4.63 (m, 2H, 
H-3C, NH), 4.50 (m, 1H, H-3E), 4.42 (d, 1H, Jgem=12.0 Hz, OCHHPh), 4.34 (bs, 1H, H-2B), 4.30-
4.20 (m, 4H, H-5B, H-5C, H-5D, H-5E), 4.13 (dd, 1H, J3,4=9.6 Hz, J3,2=2.8 Hz, H-3A), 4.08 (bs, 1H, 
H-2A), 3.79-3.64 (m, 5H, H-2E, H-4A, H-5A, CH2Cl), 3.37 (s, 3H, OMe), 1.96 (s, 3H, OAc), 1.54 (s, 
3H, NAc), 1.42 (d, 3H, J6,5=6.0 Hz, H-6A), 1.33 (m, 6H, H-6B, H-6C), 1.18 (d, 3H, J6,5=6.2 Hz, H-
6D), 0.77 (d, 3H, J6,5=6.6 Hz, H-6E); 13C NMR (CDCl3, 100 MHz) δ 166.9 (COCH2Cl), 165.4-164.5 
(COCH3, COPh), 138.2, 137.1 (2 Cipso), 133.4-128.0 (C-Ar), 100.5 (C-1B), 99.8 (C-1C, 1JC,H=173 
Hz), 99.6 (C-1A), 98.9 (C-1E), 94.2 (C-1E), 79.8 (C-4A), 78.7 (C-2B), 76.6 (C-2A), 75.7 (C-3A), 75.5 
(OCH2Ph), 74.4 (C-3C), 73.5 (C-4C), 72.7 (C-4E), 72.2 (C-2E), 72.0 (C-4B), 71.8 (C-2C), 71.5 (C-4D, 
OCH2Ph), 70.4 (C-3B), 70.3 (C-3D), 68.2 (C-5A), 67.8-67.2 (C-5B, C-5C, C-5D, C-5E), 55.0 (OMe), 
48.1 (C-3E), 40.2 (COCH2Cl), 22.9, 20.4 (2 COCH3), 18.1 (C-6A), 17.7 (C-6B, C-6C), 17.3 (C-6D), 
15.8 (C-6E). ESI-MS for C93H96ClNO29 (m/z): Mr (calcd) 1725.58, Mr (found) 1748.05 (M+Na)+. 
Anal. calcd.: C 64.67, H 5.60, N 0.81. Found: C 64.57, H 5.80, N 0.75.       
 
Methyl α-L-rhamnopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-L-rhamnopyranosyl-(1→2)-
[3-acetamido-α-D-fucopyranosyl-(1→3)]-α-L-rhamnopyranoside (31): 
Compound 35 (13.0 mg, 7.54 μmol) was dissolved in 9:1 MeOH/HCOOH (2.0 mL) under argon. 
Pd/C (8 mg) was added and the mixture was kept in an ultrasound bath for 1 hour, after that it was 
filtered on a Celite pad and concentrated. The residue was dissolved in MeOH (2.0 mL) and 
NaOMe 1M in MeOH (250 μL) was added. After 48 hours the solution was neutralized with 
Amberlist-15 H+, filtered and concentrated. The residue was purified by gel filtration to obtain 31 
(4.7 mg, 78%) as a white wax. [α]D= +11 (c=0.3, D2O). 1H NMR (D2O, 400 MHz) δ 5.12 (d, 1H, 
J1,2=1.6 Hz, H-1B), 5.04 (d, 1H, J1,2=1.6 Hz, H-1D), 5.02 (d, 1H, J1,2=4.0 Hz, H-1E), 4.93 (d, 1H, 
J1,2=1.6 Hz, H-1C), 4.83 (d, 1H, J1,2=1.6 Hz, H-1A), 4.33 (q, 1H, J5,6=6.5 Hz, H-5E), 4.25 (dd, 1H, 
J3,2=11.1 Hz, J3,4=2.9 Hz, H-3E), 4.12 (m, 2H, H-2A, H-2C), 4.07 (dd, 1H, J2,3=3.6 Hz, J2,1=1.6 Hz, 
H-2D), 4.04 (dd, 1H, J2,3=3.6 Hz, J2,1=1.6 Hz, H-2B), 3.92-3.73 (m, 10H, H-2E, H-3A, H-3B, H-3C, 
H-3D, H-4E, H-5A, H-5B, H-5C, H-5D), 3.63 (t, 1H, J4,3=J4,5=9.6 Hz, H-4A), 3.52 (t, 1H, J4,3=J4,5=9.5 
Hz, H-4C), 3.49 (t, 1H, J4,3=J4,5=9.8 Hz, H-4B), 3.46 (t, 1H, J4,3=J4,5=9.8 Hz, H-4D), 3.42 (s, 3H, 
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OMe), 2.05 (s, 3H, Ac), 1.35 (d, 3H, J6,5=6.2 Hz, H-6A), 1.29 (2d, 6H, J6,5=6.2 Hz, H-6B, H-6D), 
1.26 (d, 3H, J6,5=6.2 Hz, H-6C), 1.18 (d, 3H, J6,5=6.6 Hz, H-6E); 13C NMR (D2O, 100 MHz) 
δ 165.5 (COCH3), 102.4 (C-1D), 101.8 (C-1C), 100.5 (C-1B), 99.4 (C-1A), 94.5 (C-1E), 78.5 (C-2B), 
78.0 (C-3C), 75.0 (C-2A), 74.0 (C-3A), 72.1 (C-4B), 72.0 (C-4D), 71.3 (C-4C), 70.4 (C-4A), 70.3 (C-
4E), 70.1 (C-2D), 70.0 (C-3D), 69.9 (C-2C), 69.8 (C-3B), 69.2 (C-5B), 69.0 (C-5C), 68.9 (C-5D), 68.3 
(C-5A), 66.8 (C-5E), 65.5 (C-2E), 54.9 (OMe), 51.1 (C-3E), 22.0 (COCH3), 16.7-16.6 (C-6A, C-6B, 
C-6C, C-6D), 15.1 (C-6E). ESI-MS for C33H57NO21 (m/z): Mr (calcd) 803.34, Mr (found) 826.53 
(M+Na)+. Anal. calcd.: C 49.31, H 7.15, N 1.74. Found: C 49.49, H 7.10, N 1.85.   
 
Methyl 3-O-allyl-4-O-benzyl-α-D-rhamnopyranoside (40):  
Diol 3922 (1.337 g, 4.99 mmol) was dissolved in 10:1 benzene/methanol (34 mL) and Bu2SnO 
(1.565 g, 6.29 mmol) was then added. After stirring at 60°C for 90 min, the solvent was evaporated. 
Bu4NBr (1.609 g, 4.99 mmol) was added to the residue under argon. The mixture was suspended in 
toluene (22 mL), AllBr (4.63 mL, 54.8 mmol) was then added and stirring was conducted at 65°C 
for 60 min, after that the solvent was evaporated. A column chromatography (6:1 petroleum ether-
ethyl acetate) on the residue afforded 40 (1.258 g, 82%) as a yellowish oil. [α]D= +54.0 (c=0.9, 
CH2Cl2). 1H NMR (CDCl3, 200 MHz) δ 7.33 (m, 5H), 5.93 (m, 1H), 5.32 (dd, 1H, Jvic=17.0 Hz, 
Jgem=1.6 Hz), 5.20 (dd, 1H, Jvic=10.4 Hz, Jgem=1.6 Hz), 4.87 (d, 1H, Jgem=10.8  Hz), 4.69 (bs, 1H), 
4.62 (d, 1H, Jgem=10.8  Hz), 4.16 (m, 2H), 3.99 (bd, 1H, J2,3=3.0 Hz), 3.68 (m, 2H), 3.40 (t, 1H, 
J4,3= J4,5=9.6 Hz), 3.34 (s, 3H), 2.48 (s, 1H), 1.31 (d, 3H, J6,5=6.2 Hz); 13C NMR (CDCl3, 50 MHz) 
δ 138.4, 134.5, 128.3-127.7, 117.3, 100.0, 79.8, 79.6, 75.3, 70.9, 68.6, 67.0, 54.7, 17.9. ESI-MS for 
C17H24O5 (m/z): Mr (calcd) 308.16, Mr (found) 331.39 (M+Na)+. Anal. calcd.: C 66.21, H 7.84. 
Found: C 66.50, H 7.87 
 
3-O-Allyl-2-O-benzensulfonyl-4-O-benzyl-D-rhamnopyranose (41):  
Compound 40 (0.577 g, 1.87 mmol) was dissolved in pyridine (12 mL) and then BnSO2Cl (0.899 g, 
4.71 mmol) was added. The solution was stirred for 45 min at rt, after that water (10 mL) was 
added. The mixture was diluted with CH2Cl2 and washed with water. The organic layer was 
collected, dried and concentrated to give a brown oil, that was dissolved in Ac2O (10 mL), cooled to 
0°C and a 25:20:0.5 v/v/v mixture of Ac2O/AcOH/H2SO4 (15 mL) was added. The solution was 
allowed to gradually warm to rt and after 3 hours it was diluted with CH2Cl2 and washed with 
water, 1M NaHCO3 and water again. The organic layer was collected, dried and concentrated to 
give a residue, that was dissolved in DMF (5 mL). The solution was treated with hydrazine acetate 
(0.488 g, 5.10 mmol) and then stirred for 2 hours at rt, after that it was diluted with CH2Cl2, washed 
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with 5N NaCl, dried and concentrated. The residue was subjected to column chromatography (4:1 
to 2:1 petroleum ether/ethyl acetate) to give 41 (0.478 g, 57%; α/β=6:1) as a yellowish oil. 1H NMR 
(CDCl3, 200 MHz) (α-anomer) δ 7.50-7.27 (m, 10H), 5.96 (m, 1H), 5.36 (dd, 1H, Jvic=17.2 Hz, 
Jgem=1.6 Hz), 5.23 (dd, 1H, Jvic=10.5 Hz, Jgem=1.6 Hz), 5.14 (d, 1H, J1,2=1.6 Hz), 4.99 (dd, 1H, 
J2,3=2.8 Hz, J1,2=1.6 Hz), 4.92 (d, 1H, Jgem=11.2  Hz), 4.64 (d, 1H, Jgem=11.2  Hz), 4.54 (AB d, 1H, 
Jgem=14.6  Hz), 4.45 (AB d, 1H, Jgem=14.6  Hz), 4.23 (m, 2H), 3.91 (m, 2H), 3.37 (t, 1H, J4,3= 
J4,5=9.6 Hz), 1.28 (d, 3H, J6,5=6.2 Hz); 13C NMR (CDCl3, 50 MHz) (α-anomer) δ 138.2, 134.2, 
130.8-127.8, 117.7, 92.3, 79.8, 78.0, 75.6, 75.4, 71.5, 67.7, 57.4, 17.9. ESI-MS for C23H28O7S (m/z): 
Mr (calcd) 448.16, Mr (found) 471.41 (M+Na)+. Anal. calcd.: C 61.59, H 6.29. Found: C 61.70, H 
6.26. 
 
3-O-Allyl-2-O-benzensulfonyl-4-O-benzyl-D-rhamnopyranosyl trichloroacetimidate (42):  
Hemi-acetal 41 (0.459 g, 1.02 mmol) was dissolved under argon in CH2Cl2 (11 mL) and Cl3CCN 
(0.565 mL, 5.60 mmol) and DBU (30 μL, 0.20 mmol) were sequentially added and the solution was 
stirred at rt for 2 hours, after that it was concentrated to give a residue, which, after neutral alumina 
(Brockman grade 1) column chromatography (10:1 petroleum ether/ethyl acetate) afforded 42 
(0.214 g, 35%) as a colourless oil.  [α]D= +6.1 (c=1.0, CH2Cl2). 1H NMR (CDCl3, 200 MHz) δ 8.65 
(s, 1H), 7.44-7.20 (m, 10H), 6.14 (bs, 1H), 5.92 (m, 1H), 5.31 (dd, 1H, Jvic=17.2 Hz, Jgem=1.6 Hz), 
5.19 (dd, 1H, Jvic=10.5 Hz, Jgem=1.6 Hz), 5.05 (bd, 1H, J2,3=2.8 Hz), 4.89 (d, 1H, Jgem=11.1  Hz), 
4.61 (d, 1H, Jgem=11.1  Hz), 4.52 (d, 1H, Jgem=14.7  Hz), 4.47 (m, 3H), 4.35-4.10 (m, 5H), 3.87 (m, 
2H), 3.44 (m, 3H), 1.29 (d, 3H, J6,5=6.2 Hz), 1.23 (d, 1H, J6,5=6.2 Hz); 13C NMR (CDCl3, 50 MHz) 
159.7, 137.7, 133.9, 130.7-127.5, 118.4, 95.0, 78.8, 76.5, 75.6, 75.4, 71.5, 70.9, 57.6, 17.7. Anal. 
calcd.: C 50.64, H 4.76, N 2.36. Found: C 50.58, H 4.73, N 2.37. 
 
3-O-Allyl-2-O-benzensulfonyl-4-O-benzyl-D-rhamnopyranosyl  N-phenyl-trifluoroacetimidate (44):  
A mixture of 41 (0.544 g, 1.21 mmol) and freshly activated 4Å molecular sieves was suspended 
under argon in CH2Cl2 (25 mL) and cooled to 0°C. CF3C(NPh)Cl (195 μL, 1.58 mmol) and NaH 
(60% oil suspension; 86 mg, 2.14 mmol) were sequentially added. The mixture was stirred at 0°C 
for 4 hours after that it was filtered over a Celite pad and concentrated. Neutral alumina (Brockman 
grade 1) column chromatography (13:1 petroleum ether/ethyl acetate) on the residue afforded 44 
(0.514 g, 69%; α:β=1:1) as a yellowish oil. 1H NMR (CDCl3, 200 MHz) δ 7.45-6.79 (m, 15H), 
6.08-5.90 (m, 3H), 5.79 (bm, 1H), 5.35 (2 dd, 2H, Jvic=17.4 Hz, Jgem=1.6 Hz), 5.21 (m, 3H), 5.11 
(dd, 1H), 4.95 (d, 1H, Jgem=10.8  Hz), 4.91 (d, 1H, Jgem=10.8  Hz), 4.67 (d, 1H, Jgem=10.8  Hz), 4.62 
(d, 1H, Jgem=10.8  Hz), 4.57 (d, 1H, Jgem=14.4  Hz), 4.47 (m, 3H), 4.35-4.10 (m, 5H), 3.87 (m, 2H), 
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3.44 (m, 3H), 1.29 (d, 3H, J6,5=6.2 Hz), 1.23 (d, 1H, J6,5=6.2 Hz); 13C NMR (CDCl3, 50 MHz) 
δ 135.9, 130.9, 130.7, 128.7-123.7, 119.3, 119.2, 94.0, 93.4, 78.8, 78.7, 77.5, 75.6, 75.5, 75.1, 72.9, 
71.7, 71.1, 70.6, 57.6, 17.7. ESI-MS for C31H32F3NO7S (m/z): Mr (calcd) 619.19, Mr (found) 619.65 
(M+Na)+. Anal. calcd.: C 60.09, H 5,21; N 2.26. Found: C 60.16, H 5.22, N 2.25. 
 
Methyl (3-O-allyl-2-O-benzensulfonyl-4-O-benzyl-β-D-rhamnopyranosyl)-(1→3)-2,4-di-O-benzyl-
α-D-rhamnopyranoside (45):  
A mixture of acceptor 38 (0.182 g, 0.51 mmol) and donor 44 (0.362 g, 0.58 mmol) was 
coevaporated three times with toluene (5 mL). The residue was mixed with freshly activated AW-
300 4Å molecular sieves and suspended under argon in CH2Cl2 (20 mL). The mixture was cooled to 
–60°C and a 80 μM solution of TMSOTf in CH2Cl2 (75 μL, 6.0 μmol) was added. The temperature 
was allowed to gradually rise to –25°C. After 4 hours the mixture was neutralized by adding Et3N, 
then filtered over Celite and concentrated to give a residue, that after column chromatography (9:1 
to 6:1 petroleum ether/ethyl acetate) afforded, as first eluted compound, 45α (0.165 g, 41%) as a 
yellowish oil. [α]D= -6.8 (c=1.0, CH2Cl2). 1H NMR (CDCl3, 200 MHz) δ 7.40-7.24 (m, 20H), 5.91 
(m, 1H), 5.27 (dd, 1H, Jvic=17.4 Hz, Jgem=1.6 Hz), 5.14 (dd, 1H, Jvic=10.6 Hz, Jgem=1.6 Hz), 5.07 
(bd, 1H, J2,3=2.7 Hz), 4.91 (d, 1H, Jgem=11.1 Hz), 4.80 (d, 1H, Jgem=10.8  Hz), 4.66 (d, 1H, J1,2=1.5 
Hz), 4.64 (bs, 1H), 4.62 (d, 1H, Jgem=11.1  Hz), 4.57 (d, 1H, Jgem=10.8  Hz), 4.42 (d, 1H, Jgem=14.1  
Hz), 4.35 (d, 1H, Jgem=14.1  Hz), 4.17 (m, 1H), 4.02 (m, 2H, H-3A), 3.84 (m, 2H), 3.70 (bd, 1H, 
J2,3=2.7 Hz), 3.63 (dq, 1H, J5,4=9.4 Hz, J5,6=6.2 Hz), 3.57 (t, 1H, J4,5=J4,3=9.4 Hz), 3.36 (t, 1H, 
J4,5=J4,3=9.8 Hz), 3.30 (s, 3H), 1.26 (m, 6H); 13C NMR (CDCl3, 50 MHz) δ 138.4, 138.0, 134.3, 
130.9, 128.7-127.8, 117.7, 99.1, 98.3, 80.5, 79.7, 78.4, 77.4, 77.3, 75.3, 75.2, 72.7, 71.3, 68.6, 67.9, 
57.5, 54.7, 17.9. ESI-MS for C44H52O11S (m/z): Mr (calcd) 788.32, Mr (found) 810.91 (M+Na)+. 
Anal. calcd.: C 66.98, H 6.64. Found: C 66.88, H 6.62. 
As second eluted compound 45β (0.237 g, 59%) was recovered as a yellowish oil. [α]D= -22.1 
(c=0.8, CH2Cl2). 1H NMR (CDCl3, 200 MHz) δ 7.40-7.25 (m, 20H), 5.99 (m, 1H), 5.39 (dd, 1H, 
Jvic=17.4 Hz, Jgem=1.8 Hz), 5.23 (dd, 1H, Jvic=10.5 Hz, Jgem=1.8 Hz), 5.04 (d, 1H, J2,3=2.1 Hz), 4.97 
(d, 1H, Jgem=10.8  Hz), 4.92 (d, 1H, Jgem=10.8  Hz), 4.79 (d, 1H, Jgem=12.0  Hz), 4.75 (bs, 1H), 4.65 
(d, 1H, Jgem=12.0  Hz), 4.61 (d, 1H, Jgem=10.8  Hz), 4.52 (d, 3H), 4.44 (bs, 1H), 4.34 (dd, 1H, 
Jgem=14.4 Hz, Jvic=6.6 Hz), 4.11 (m, 2H, H-3A), 3.75 (t, 1H, J2,1=J2,3=5.8 Hz), 3.63 (dq, 1H, J5,4=9.6 
Hz, J5,6=6.2 Hz), 3.55 (t, 1H, J4,5=J4,3=9.6 Hz), 3.34 (m, 5H), 3.24 (dq, 1H, J5,4=9.6 Hz, J5,6=6.2 
Hz), 1.28 (d, 6H, J6,5=6.2 Hz); 13C NMR (CDCl3, 50 MHz) δ 138.8, 138.3, 134.3, 131.0, 130.9, 
128.6-127.4, 117.7, 99.1, 96.8, 80.0, 79.9, 79.7, 78.1, 75.9, 75.7, 74.0, 72.8, 72.1, 71.2, 67.7, 57.9, 
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54.9, 18.2, 17.9. ESI-MS for C44H52O11S (m/z): Mr (calcd) 788.32, Mr (found) 810.91 (M+Na)+. 
Anal. calcd.: C 66.98, H 6.64. Found: C 67.11, H 6.58. 
 
Methyl (3-O-allyl-4-O-benzyl-β-D-rhamnopyranosyl)-(1→3)-2,4-di-O-benzyl-α-D-
rhamnopyranoside (46):  
A mixture of 45 (0.229 g, 0.29 mmol) and NaNH2 (127 mg, 3.26 mmol) were suspended in DMF (5 
mL) and stirred at rt. After 24 and 48 hours additional aliquots of NaNH2 (127 mg, 3.26 mmol) 
were added. After 4 days methanol (30 mL) and then, dropwise, AcOH (3 mL) were added. The 
mixture was concentrated to give a residue, that was dissolved in CH2Cl2, washed with 1M 
NaHCO3 and 5M NaCl, dried and concentrated. Column chromatography (6:1 petroleum 
ether/EtOAc) on the residue afforded 46 (0.114 g, 62%) as a yellowish oil. [α]D= -11.1 (c=1.0, 
CH2Cl2). 1H NMR (CDCl3, 200 MHz) δ 7.39-7.26 (m, 15H), 5.98 (m, 1H), 5.34 (dd, 1H, Jvic=17.2 
Hz, Jgem=1.6 Hz), 5.21 (dd, 1H, Jvic=10.4 Hz, Jgem=1.6 Hz), 4.95 (d, 1H, Jgem=10.8 Hz), 4.90 (d, 1H, 
Jgem=10.8  Hz), 4.77 (d, 1H, Jgem=12.4  Hz), 4.72 (d, 1H, J1,2=1.9 Hz), 4.61-4.56 (m, 3H), 4.28 (bs, 
1H), 4.21 (m, 2H), 4.11 (m, 1H), 3.88 (d, 1H, J2,3=3.0 Hz), 3.73-3.64 (m, 2H), 3.56 (t, 1H, 
J4,3=J4,5=8.9 Hz), 3.45 (t, 1H, J4,3=J4,5=9.3 Hz), 3.33 (s, 3H), 3.28 (dd, 1H, J3,4=9.3 Hz, J3,2=3.0 Hz), 
3.19 (dq, J5,4=9.3 Hz, J5,6=6.2 Hz), 1.35 (d, 3H, J6,5=6.2 Hz), 1.27 (d, 3H, J6,5=6.2 Hz); 13C NMR 
(CDCl3, 50 MHz) δ 138.5, 138.0, 134.8, 134.7, 128.3-127.5, 117.2, 98.6, 97.1, 81.4, 79.7, 75.5, 
75.0, 74.7, 72.5, 71.6, 70.5, 68.8, 67.5, 54.7, 18.1, 17.9. ESI-MS for C37H46O9 (m/z): Mr (calcd) 
634.31, Mr (found) 657.47 (M+Na)+. Anal. calcd.: C 70.01, H 7.30. Found: C 69.90, H 7.30. 
 
Ethyl 2,4-di-O-acetyl-1-thio-β-D-fucopyranoside (49)  
Triol 48 (0.775 g, 3.72 mmol) was dissolved in 2:7 v/v DMF/MeC(OMe)3 (9.0 mL), CSA (80 mg, 
0.34 mmol) was then added and the solution was evacuated at 100 mbar for 20 min, after that 
pyridine (7.0 mL) and Ac2O (7.0 mL) were sequentially added. The solution was stirred overnight 
at rt, then coevaporated four times with toluene (10 mL each). The residue was dissolved in 80% 
AcOH and the solution was stirred at rt for 10 min, after that it was coevaporated two times with 
toluene (5 mL each). The residue was subjected to column chromatography (5:2 petroleum 
ether/ethyl acetate) to give 49 (0.893 g, 82%) as a white solid. [α]D= -2.4 (c=1.0, CH2Cl2).  1H 
NMR (CDCl3, 200 MHz) δ 5.17 (dd, 1H, J4,3=3.2 Hz, J4,5=0.8 Hz), 4.97 (t, 1H, J2,3= J2,1=9.6 Hz), 
4.37 (d, 1H, J1,2=10.0 Hz), 3.79 (dd, 1H, J3,2=9.6 Hz, J3,4=3.2 Hz), 3.71 (dq, J5,6=6.4 Hz, J5,4=0.8 
Hz), 2.67 (dq, 2H, Jvic=7.2 Hz, Jgem=3.2 Hz), 2.14, 2.07 (2s, 6H), 1.23 (t, 3H, Jvic=7.2 Hz), 1.16 (d, 
3H, J6,5=6.4 Hz); 13C NMR (CDCl3, 50 MHz) δ 171.3, 171.0, 83.1, 73.4, 73.1, 72.4, 71.0, 24.1, 
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20.9, 20.8, 16.6, 14.7. ESI-MS for C12H20O6S (m/z): Mr (calcd) 292.10, Mr (found) 292.21 (M+Na)+. 
Anal. calcd.: C 49.30, H 6.90. Found: C 49.35, H 6.85. 
 
Ethyl 3-acetamido-4-O-acetyl-2-O-benzyl-1-thio-D-fucopyranoside (51): 
Hemiacetal 2138 (100 mg, 297 μmol) was dissolved in pyridine (1.5 mL) and Ac2O (2.0 mL) was 
added. The solution was stirred overnight at rt, then coevaporated two times with toluene (10 mL). 
The residue was dissolved in CH2Cl2, washed with 1M HCl and 0.2M NaHCO3, dried and 
concentrated to give a residue, which was then dissolved in CH2Cl2 (2.0 mL) and treated with EtSH 
(25 μL, 0.34 mmol) and BF3.OEt2 (76 μL, 0.60 mmol). After stirring overnight at rt the mixture was 
diluted with CH2Cl2 (40 mL), washed with 1M KOH (50 mL) and water (50 mL), dried and 
concentrated. The residue was subjected to column chromatography (1:1 petroleum ether/ethyl 
acetate) to afford 51 (90 mg, 79%; α/β=1:1) as a white foam. 1H NMR (CDCl3, 200 MHz) 
δ 7.36 (m, 10H), 5.57 (d, 1H, J1,2=5.0 Hz), 5.33 (d, 1H, J4,3=2.2 Hz), 5.20 (d, 1H, J4,3=2.4 
Hz), 5.02-4.87 (m, 2H), 4.86 (d, 1H, Jgem=11.4  Hz), 4.78 (d, 1H, Jgem=12.0  Hz), 4.57 (m, 2H), 4.46 
(q, 1H, J5,6=6.0 Hz), 4.38 (d, 1H, Jgem=12.0  Hz), 4.33-4.16 (m, 2H), 3.87 (dd, 1H, J2,3=11.2 Hz, 
J2,1=5.0 Hz), 3.76 (q, 1H, J5,6=6.6 Hz), 3.397 (t, 1H, J2,3=J2,1=9.8 Hz), 2.79, 2.58 (2q, 4H, Jvic=6.8 
Hz), 2.09, 2.08 (2s, 6H), 1.82, 1.73 (2s, 6H), 1.33 (t, 6H, Jvic=6.8 Hz), 1.13 (d, 3H, J6,5=6.0 Hz), 
1.07 (d, 3H, J6,5=6.6 Hz); 13C NMR (CDCl3, 50 MHz) δ 170.1-169.9, 137.6, 137.4, 128.4-128.0, 
85.8, 82.8, 75.4, 74.1, 73.6, 72.6, 72.2, 72.1, 71.2, 64.9, 53.3, 49.8, 25.2, 23.6, 23.0, 20.6, 16.7, 
16.1, 14.9, 14.8. ESI-MS for C19H27NO5S (m/z): Mr (calcd) 381.16, Mr (found) 404.36 (M+Na)+. 
Anal. calcd.: C 59.82, H 7.13, N 3.67. Found: C 59.89, H 7.19, N 3.68. 
 
Ethyl 3,3-Diacetamido-4-O-acetyl-2-O-benzyl-1-thio-D-fucopyranoside (52):  
Compound 51 (71 mg, 186 μmol) was dissolved under argon in CH2Cl2 (2.0 mL). This solution was 
treated with DIPEA (148 μL, 0.86 mmol) and then, dropwise, with AcCl (183 μL, 2.58 mmol). The 
solution was stirred overnight at rt, then diluted with CH2Cl2, washed with 1M NaHCO3, dried and 
concentrated. The residue was subjected to column chromatography (5:1 to 3:1 petroleum 
ether/ethyl acetate) to give, as first eluted compound, 52α (35 mg, 44%) as a white foam. [α]D= 
+20.3 (c=2.0, CH2Cl2). 1H NMR (CDCl3, 200 MHz) δ 7.30 (m, 5H), 5.55 (d, 1H, J1,2=4.0 Hz), 5.11 
(d, 1H), 4.68 (m, 2H), 4.58 (d, 1H, Jgem=10.6  Hz), 4.47 (q, 1H, J5,6=6.6 Hz), 4.26 (d, 1H, Jgem=10.6  
Hz), 2.51 (q, 2H, Jvic=7.2 Hz), 2.21 (s, 6H), 2.12 (s, 3H), 1.27 (t, 3H, Jvic=7.2 Hz), 1.15 (d, 3H, 
J6,5=6.6 Hz); 13C NMR (CDCl3, 50 MHz) δ 173.9, 171.3, 137.1, 128.3-127.9, 83.6, 71.6, 71.3, 70.8, 
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65.7, 57.9, 27.0, 23.7, 21.0, 16.1, 14.9. ESI-MS for C21H29NO6S (m/z): Mr (calcd) 423.17, Mr 
(found) 446.41 (M+Na)+. Anal. calcd.: C 59.55, H 6.90, N 3.31. Found: C 59.56, H 6.87, N 3.29. 
As second eluted compound was recovered 52β (37 mg, 47%) as a white foam. [α]D= -45.3 (c=0.9, 
CH2Cl2). 1H NMR (CDCl3, 200 MHz) δ 7.30 (m, 5H), 5.12 (bs, 1H), 4.99 (d, 1H, Jgem=11.0  Hz), 
4.50 (m, 3H), 4.33 (d, 1H, Jgem=11.0  Hz), 3.82 (q, 1H, J5,6=6.0 Hz), 2.79 (dq, 2H, Jvic=7.6 Hz, 
Jgem=2.0 Hz), 2.23 (s, 6H), 2.10 (s, 3H), 1.33 (t, 3H, Jvic=7.6 Hz), 1.19 (d, 3H, J6,5=6.0 Hz); 13C 
NMR (CDCl3, 50 MHz) δ 174.2, 171.5, 138.1, 128.3-127.4, 87.2, 74.4, 73.7, 73.5, 72.0, 62.5, 27.2, 
25.0, 20.9, 16.6, 14.9. ESI-MS for C21H29NO6S (m/z): Mr (calcd) 423.17, Mr (found) 446.39 
(M+Na)+. Anal. calcd.: C 59.55, H 6.90, N 3.31. Found: C 59.59, H 6.86, N 3.28. 
 
Methyl (3,3-diacetamido-4-O-acetyl-2-O-benzyl-α-D-fucopyranosyl)-(1→2)-(3-O-allyl-4-O-benzyl-
β-D-rhamnopyranosyl)-(1→3)-2,4-di-O-benzyl-α-D-rhamnopyranoside (37): 
A mixture of acceptor 46 (19.7 mg, 31.0 μmol) and donor 52β (28 mg, 66 μmol) was coevaporated 
three times with toluene (1 mL). The residue was mixed with freshly activated AW-300 4Å 
molecular sieves and suspended under argon in 1:1 v/v CH2Cl2/Et2O (800 μL). NIS (16 mg, 71 
μmol) was then added under argon, the mixture was cooled to –20°C and a 0.60 mM solution of 
TfOH in CH2Cl2 (20 μL, 12 μmol) was added. After 90 min stirring at –20°C, the mixture was 
filtered over Celite, diluted with CH2Cl2, washed with 10% Na2S2O3 and 1M NaHCO3, dried and 
concentrated. The residue was then subjected firstly to column chromatography (6:1 petroleum 
ether/ethyl acetate) and then to HPLC (Phenomenex Proteo 90A C-18 column, 250x10 mm; eluent: 
MeOH/CH3CN/H2O 2:2:1) to afford a first eluted fraction, containing 46 (5.4 mg, 27%), and a 
second fraction, which contained 37 (12.3 mg, 40%) as a white foam. [α]D= +5 (c=0.3, CH2Cl2). 1H 
NMR (CDCl3, 400 MHz) δ 7.39-7.10 (m, 20H), 5.92 (m, 1H), 5.76 (d, 1H, J1,2=3.4 Hz), 5.29 (d, 
1H, Jgem=18.0 Hz), 5.21 (d, 1H, Jgem=10.4 Hz), 5.13 (bs, 1H), 5.04 (m, 2H), 4.85 (q, 1H, J5,6=6.4 
Hz), 4.75 (d, 1H, Jgem=12.0  Hz), 4.71 (m, 2H), 4.64 (d, 1H, Jgem=12.0  Hz), 4.52 (m, 2H), 4.39 (m, 
2H), 4.28 (d, 1H, Jgem=11.1  Hz), 4.24-4.07 (m, 4H), 3.67 (m, 2H), 3.49 (t, 1H, J4,3=J4,5=9.5 Hz), 
3.44 (t, 1H, J4,3=J4,5=9.3 Hz), 3.32 (s, 3H), 3.24 (m, 2H), 2.11 (s, 3H), 2.01 (s, 6H), 1.35 (d, 3H, 
J6,5=6.0 Hz), 1.28 (d, 3H, J6,5=6.2 Hz), 1.16 (d, 3H, J6,5=6.4 Hz); 13C NMR (CDCl3, 100 MHz) 
174.3, 171.5, 138.8, 138.5, 138.3, 138.0, 134.5, 130.8-126.9, 117.6, 98.9, 98.4, 95.8, 83.2, 80.6, 
80.5, 75.1, 75.0, 73.3, 72.5, 72.4, 72.2, 72.1, 72.0, 71.9, 71.5, 70.2, 68.2, 65.7, 56.7, 54.7, 23.8, 
21.0, 18.5, 17.9, 16.2. ESI-MS for C56H69NO15 (m/z): Mr (calcd) 995.47, Mr (found) 1018.50 
(M+Na)+. Anal. calcd.: C. 67,52; H. 6,98; N. 1,41; Found: C 67.44, H 7.02, N 1.40. 
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Methyl 3-acetamido-α-D-fucopyranosyl-(1→2)-β-D-rhamnopyranosyl-(1→3)-α-D-
rhamnopyranoside (36):  
To a solution of 37 (8.6 mg, 8.6 μmol) in 1:1 CH2Cl2/MeOH (400 μL) PdCl2 (0.6 mg, 3.4 μmol) 
was added and the mixture was vigorously stirred at rt overnight, after that it was filtered over a 
Celite pad, diluted with CH2Cl2, washed with 5N NaCl, dried and concentrated. The residue was 
then dissolved in 1:1 CH2Cl2/MeOH (800 μL) and treated with a 0.4 M methanolic solution of 
NaOMe (30 μL). After 3 hours stirring at rt the solution was neutralized with Amberlist-15 (H+), 
filtered and concentrated. The residue was dissolved in MeOH (1.5 mL) and then added to a 
suspension of 10% Pd/C (catalyst amount) in MeOH (0.5 mL). After stirring at rt for 4 days under a 
hydrogen atmosphere, HCOOH (100 μL) was added and the mixture was kept in an ultrasound bath 
for 3 hours, after that it was filtered on Celite and concentrated to give 36 (3.7 mg, 84% yield). 
[α]D= +26 (c=0.2, H2O). 1H NMR (D2O, 600 MHz) δ 5.18 (d, 1H, J1,2=3.6 Hz, H-1C), 4.81 (s, 1H, 
H-1B), 4.74 (s, 1H, H-1A), 4.54 (q, 1H, J5,6=6.4 Hz, H-5C), 4.27 (dd, 1H, J3,2=9.5 Hz, J3,4=3.2 Hz, 
H-3C), 4.14 (bs, 1H, H-2A), 4.12 (d, 1H, J2,3=3.0 Hz, H-2B), 3.92 (dd, 1H, J3,4=9.8 Hz, J3,2=3.0 Hz, 
H-3A), 3.87 (dd, 1H, J2,3=9.5 Hz, J2,1=3.6 Hz, H-2C), 3.72 (m, 3H, H-3B, H-4C, H-5A), 3.53 (t, 1H, 
J4,3=J4,5=9.5 Hz, H-4A), 3.50 (t, 1H, J4,3=J4,5=9.3 Hz, H-4B), 3.41 (m, 4H, H-5B, OMe), 2.06 (s, 3H, 
NHAc), 1.33 (d, 3H, J6,5=6.2 Hz, H-6A), 1.31 (d, 3H, J6,5=6.2 Hz, H-6B), 1.18 (d, 3H, J6,5=6.4 Hz, 
H-6C); 13C NMR (CDCl3, 150 MHz) 174.4 (NHCOCH3), 100.5 (C-1A), 100.1 (C-1C), 96.6 (C-1B), 
78.7 (C-2B), 77.0 (C-3A), 73.5 (C-3B), 72.5 (C-4B), 72.4 (C-5B), 70.5 (C-4A), 70.3 (C-4C), 68.5 (C-
5A), 67.1 (C-2A, C-5C), 66.6 (C-2C), 54.7 (OMe), 51.2 (C-3C), 22.0 (NHCOCH3), 16.7, 16.6 (C-6A, 
C-6B), 15.3 (C-6C). ESI-MS for C21H37NO13 (m/z): Mr (calcd) 511.23, Mr (found) 533.71 (M+Na)+. 
Anal. calcd.: C. 49.31; H. 7.29; N. 2.74; Found: C 48.79, H 7.47, N 2.67. 
 
Methyl 4-O-benzoyl-α-D-rhamnopyranoside (56): To a 0°C cooled solution of 26 (0.869 g, 4.02 
mmol) in pyridine (5.8 mL), BzCl (1.3 mL, 10.9 mmol) was added and the mixture was stirred at 
0°C for an hour, after that CH2Cl2 (20 mL) was added. The mixture was  washed with 0.5 M HCl. 
The organic phase was collected, dried and concentrated to afford a brown residue, that was 
subsequently suspended in 4:1 TFA/H2O (9 mL) and stirred at rt. After 20’ the mixture was 
concentrated to give a residue, that, after silica gel chromatography (2:1 petroleum ether/ethyl 
acetate), afforded 56 (0.878 g, 77%) as a white foam. [α]D +114.5 (c 1.0, CH2Cl2); 1H NMR (200 
MHz, CDCl3): δ 8.10-7.41 (m, 5H, H-Ar), 5.04 (t, J4,3=J4,5=9.8 Hz, 1H, H-4), 4.77 (bs, 1H, H-1), 
4.14-3.91 (m, 3H, H-2, H-3, H-5), 3.42 (s, 3H, OMe), 1.30 (d, J6,5=6.2 Hz, 3H, H-6). 13C NMR (50 
MHz, CDCl3): δ 167.5 (C=O), 133.5 (Cipso), 129.8-128.5 (C-Ar), 100.4 (C-1), 70.8, 70.6, 70.4 (C2, 
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C3, C4), 65.5 (C5), 55.1 (OMe), 17.7 (C6). ESI-MS for C14H18O6 (m/z): Mr (calcd) 282.11, Mr 
(found) 305.25 (M+Na)+. Anal. calcd: C. 59.57; H. 6.43. Found: C. 59.25; H. 6.53. 
 
Methyl 3-O-allyl-4-O-benzoyl-α-D-rhamnopyranoside (55): A mixture of 56 (0.878 g, 3.14 mmol) 
and Bu2SnO (0.978 g, 3.91 mmol) was suspended in 10:1 benzene/methanol (23 mL) and then 
heated and stirred at 60°C. After 90’ solvent was removed. The residue was mixed under argon 
atmosphere with Bu4NBr (0.995 g, 3.21 mmol) and the solid mixture suspended in toluene (12 mL). 
Allyl bromide (2.91 mL, 34.1 mmol) was added and the mixture was stirred at 65°C. After 2 hours 
the residue was concentrated. Silica gel chromatography (7:1 petroleum ether/ethyl acetate) of the 
residue afforded 55 (2.76 mmol, 88%) as a yellowish oil. [α]D +42.0 (c 1.0, CH2Cl2); 1H NMR (200 
MHz, CDCl3): δ 8.10-7.40 (m, 5H, H-Ar), 5.72 (m, 1H, OCH2CH=CH2), 5.28 (t, J4,3=J4,5=9.8 Hz, 
1H, H-4), 5.16 (bd, Jvic=17.4 Hz, 1H, OCH2CH=CH2 trans), 5.07 (bd, Jvic=10.2 Hz, 1H, 
OCH2CH=CH2 cis), 4.78 (bs, 1H, H-1), 4.16-3.89 (m, 4H, H-2, H-5, OCH2CH=CH2), 3.81 (dd, 
J3,4=9.8 Hz, J3,2=3.4 Hz, 1H, H-3), 3.41 (s, 3H, OMe), 1.25 (d, J6,5=6.4 Hz, 3H, H-6). 13C NMR (50 
MHz, CDCl3): δ 165.7 (C=O), 134.1 (OCH2CH=CH2), 133.1 (Cipso), 129.7-128.4 (C-Ar), 117.7 
(OCH2CH=CH2), 100.2 (C-1), 76.6 (C-3), 73.1, 71.0, 68.7, 66.1 (C-2, C-4, C-5, OCH2CH=CH2), 
55.0 (OMe), 17.5 (C-6). ESI-MS for C17H22O6 (m/z): Mr (calcd) 322.14, Mr (found) 345.39 
(M+Na)+. Anal. calcd: C. 63.34; H. 6.88. Found: C. 63.45; H. 6.99. 
Methyl 3-O-allyl-4-O-benzoyl-2-O-levulinoyl-α-D-rhamnopyranoside (57): To a solution of 55 
(0.499 g, 1.55 mmol) in CH2Cl2 (11 mL), levulinic acid (1.0 mL, 8.64 mmol), DMAP (0.120 g, 0.98 
mmol) and then DIPC (1.6 mL, 10.2 mmol) were added. The mixture was stirred at rt for 60’, after 
that it was filtered over a Celite pad, washed with water, dried and concentrated to afford a brown 
residue. Silica gel chromatography (6:1 petroleum ether/ethyl acetate) of the residue afforded 57 
(0.516 g, 79%) as a yellowish oil. [α]D -3.3 (c 0.7, CH2Cl2); 1H NMR (200 MHz, CDCl3): δ 8.08-
7.40 (m, 5H, H-Ar), 5.65 (m, 1H, OCH2CH=CH2), 5.30 (dd, J2,3=3.2 Hz, J2,1=1.6 Hz, 1H, H-2), 
5.22 (t, J4,3=J4,5=10.0 Hz, 1H, H-4), 5.13 (bd, Jvic=17.4 Hz, 1H, OCH2CH=CH2 trans), 5.02 (bd, 
Jvic=10.4 Hz, 1H, OCH2CH=CH2 cis), 4.67 (bs, 1H, H-1), 4.12-3.81 (m, 4H, H-3, H-5, 
OCH2CH=CH2), 3.39 (s, 3H, OMe), 2.82-2.62 (m, 4H, CH2CH2), 2.20 (s, 3H, CH3CO), 1.25 (d, 
J6,5=6.2 Hz, 3H, H-6). 13C NMR (50 MHz, CDCl3): δ 206.3 (CH3C=O), 171.9 (C=O Lev), 165.6 
(C=O Bz), 134.3 (OCH2CH=CH2), 133.1 (Cipso), 130.0-128.4 (C-Ar), 117.2 (OCH2CH=CH2), 98.7 
(C-1), 74.4, 73.1, 70.5, 69.0, 66.4 (C-2, C-3, C-4, C-5, OCH2CH=CH2), 55.1 (OMe), 38.0, 29.8, 
28.2 (CH2CH2, CH3C=O), 17.6 (C-6). ESI-MS for C22H28O8 (m/z): Mr (calcd) 420.18, Mr (found) 
443.40 (M+Na)+. Anal. calcd: C. 62.85; H. 6.71. Found: C. 62.95; H. 6.78. 
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Methyl 4-O-benzoyl-2-O-levulinoyl-α-D-rhamnopyranoside (54): Compound 57 (0.487 g, 1.16 
mmol) was dissolved in 3:2 MeOH/CH2Cl2 (20 mL) and PdCl2 (82 mg, 0.46 mmol) was added. The 
mixture was stirred at rt overnight, after that it was filtered over a Celite pad, washed with 5N NaCl, 
dried and concentrated. Silica gel chromatography (4:1 petroleum ether/ethyl acetate) afforded 54 
(0.346 g, 78%) as a white foam. [α]D +30.8 (c 0.9, CH2Cl2); 1H NMR (200 MHz, CDCl3): δ 8.12-
7.41 (m, 5H, H-Ar), 5.19 (dd, J2,3=3.2 Hz, J2,1=1.6 Hz, 1H, H-2), 5.09 (t, J4,3=J4,5=10.0 Hz, 1H, H-
4), 4.69 (bs, 1H, H-1), 4.23-3.88 (m, 2H, H-3, H-5), 3.40 (s, 3H, OMe), 2.86-2.65 (m, 4H, 
CH2CH2), 2.22 (s, 3H, CH3CO), 1.27 (d, J6,5=6.2 Hz, 3H, H-6).. 13C NMR (50 MHz, CDCl3): 
δ 207.0 (CH3C=O), 172.2 (C=O Lev), 166.7 (C=O Bz), 133.3 (Cipso), 129.8-128.4 (C-Ar), 98.4 (C-
1), 75.3, 72.7, 68.7, 66.1 (C-2, C-3, C-4, C-5), 55.2 (OMe), 38.3, 29.8, 28.3 (CH2CH2, CH3C=O), 
17.6 (C-6). ESI-MS for C19H24O8 (m/z): Mr (calcd) 380.15, Mr (found) 403.37 (M+Na)+. Anal. 
calcd: C. 59.99; H. 6.36. Found: C. 60.18; H. 6.29. 
 
2-O-acetyl-3-O-allyl-4-O-benzoyl-D-rhamnopyranose (58): Compound 55 (1.337 g, 4.15 mmol) 
was dissolved in Ac2O (10 mL). To this solution 25:20:0.5 v/v/v Ac2O/AcOH/H2SO4 (18 mL) was 
added. The solution was stirred for 30’at rt, then water (5.0 mL) was dropwise added and stirring 
was continued for additional 10’, after that the solution was diluted with CH2Cl2 (400 mL). After 
successive washings with water, 1M NaHCO3 and then with water  again, the organic layer was 
collected, dried and concentrated. The residue was dissolved in DMF (15 mL) and then hydrazine 
acetate (0.295 g, 3.11 mmol) was added. After 40’ stirring at rt, the solution was diluted with 
CH2Cl2 (400 mL) and washed with 5N NaCl, dried and concentrated to give a residue, that  after 
silica gel chromatography (5:1 petroleum ether/ethyl acetate), afforded 58 (0.858 g, 59%; 
α/β=3.5/1) as a yellowish oil. 1H NMR (200 MHz, CDCl3; α-anomer): δ 8.09-7.43 (m, 5H, H-Ar), 
5.68 (m, 1H, OCH2CH=CH2), 5.36 (dd, J2,3=3.3 Hz, J2,1=1.8 Hz, 1H, H-2), 5.28 (t, J4,3=J4,5=9.9 Hz, 
1H, H-4), 5.22 (bs, 1H, H-1), 5.16 (dd, Jvic=17.4 Hz, Jgem=1.5 Hz, 1H, OCH2CH=CH2 trans), 5.05 
(dd, Jvic=10.2 Hz, Jgem=1.5 Hz, 1H, OCH2CH=CH2 cis), 4.21 (dq, J5,4=9.9 Hz, J5,6=6.2 Hz, 1H, H-
5), 4.17-3.94 (m, 3H, H-3, OCH2CH=CH2), 2.24 (s, 3H, CH3CO), 1.25 (d, J6,5=6.2 Hz, 3H, H-6). 
13C NMR (50 MHz, CDCl3; α-anomer): δ 170.3 (C=O Ac), 166.5 (C=O Bz), 134.1 
(OCH2CH=CH2), 133.2 (Cipso), 129.8-128.5 (C-Ar), 117.3 (OCH2CH=CH2), 93.0 (C-1), 74.4, 73.2, 
70.4, 70.2, 66.9 (C-2, C-3, C-4, C-5, OCH2CH=CH2), 20.4 (CH3C=O Ac), 17.7 (C-6).. ESI-MS for 
C18H22O7 (m/z): Mr (calcd) 350.14, Mr (found) 373.27 (M+Na)+. Anal. calcd: C. 61.71; H. 6.33. 
Found: C. 61.88; H. 6.20. 
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2-O-acetyl-3-O-allyl-4-O-benzoyl-α-D-rhamnopyranosyl trichloroacetimidate (59): To a 0°C 
cooled solution of 58 (0.429 g, 1.23 mmol) in CH2Cl2 (10 mL), Cl3CCN (0.610 mL, 6.08 mmol) 
and DBU (0.105 mL, 0.703 mmol) were added under argon atmosphere. After 60’ stirring at 0°C, 
the solution was concentrated at 20°C. Silica gel chromatography (14:1 petroleum ether/ethyl 
acetate) of the residue afforded 59 (0.435 g, 72%) as a yellowish oil. [α]D +14.4 (c 1.0, CH2Cl2); 1H 
NMR (200 MHz, CDCl3): δ 8.73 (s, 1H, NH), 8.10-7.44 (m, 5H, H-Ar), 6.25 (d, J1,2=2.0 Hz, H-1), 
5.68 (m, 1H, OCH2CH=CH2), 5.51 (dd, J2,3=3.2 Hz, J2,1=2.0 Hz, 1H, H-2), 5.37 (t, J4,3=J4,5=10.0 
Hz, 1H, H-4), 5.16 (dd, Jvic=17.4 Hz, Jgem=1.6 Hz, 1H, OCH2CH=CH2 trans), 5.08 (dd, Jvic=10.2 
Hz, Jgem=1.6 Hz, 1H, OCH2CH=CH2 cis), 4.23-3.90 (m, 4H, H-3, H-5, OCH2CH=CH2), 2.21 (s, 
3H, CH3C=O Ac), 1.30 (d, J6,5=6.2 Hz, 3H, H-6). 13C NMR (50 MHz, CDCl3): δ 170.1 (C=O Ac), 
165.6 (C=O Bz), 159.9 (C=NH), 134.0 (OCH2CH=CH2), 133.3 (Cipso), 129.8-128.5 (C-Ar), 118.0 
(OCH2CH=CH2), 95.1 (C-1), 77.2 (C-3), 72.2, 70.9, 69.7, 67.4 (C-2, C-4, C-5, OCH2CH=CH2), 
20.9 (CH3C=O), 17.6 (C-6). ESI-MS for C20H22Cl3NO7 (m/z): Mr (calcd) 493.05, Mr (found) 516.41 
(M+Na)+. Anal. calcd: C. 48.55; H. 4.48; N. 2.83. Found: C. 49.00; H. 4.44; N.2.78. 
 
Methyl (2-O-acetyl-3-O-allyl-4-O-benzoyl-α-D-rhamnopyranosyl)-(1→3)-4-O-benzoyl-2-O-
levulinoyl-α-D-rhamnopyranoside (60): A suspension of acceptor 54 (0.243 g, 0.64 mmol), imidate 
59 (0.413 g, 0.84 mmol) and freshly powdered 4Ǻ HW-300 molecular sieves in CH2Cl2 (15 mL) 
was stirred at -50°C under argon atmosphere. BF3.OEt2 (32 μL, 0.25 mmol) was added and the 
mixture was kept at -50°C for 150 min, after that it was filtered on a Celite pad and washed with 
1M NaHCO3 and water. The organic layer was collected, dried and concentrated. Silica gel 
chromatography (3:1 petroleum ether/ethyl acetate) of the residue afforded 60 (0.389 g, 86%) as a 
white foam. [α]D -21.4 (c 1.0, CH2Cl2); 1H NMR (200 MHz, CDCl3): δ 8.10-7.41 (m, 10H, H-Ar), 
5.52 (m, 1H, OCH2CH=CH2), 5.34 (t, J4,3=J4,5=9.8 Hz, 1H, H-4A), 5.27 (dd, J2,3=3.2 Hz, J2,1=1.6 
Hz, 1H, H-2A), 5.13 (t, J4,3=J4,5=10.0 Hz, 1H, H-4B), 5.02-4.85 (m, 3H, H-2B, OCH2CH=CH2), 4.69 
(bs, 1H, H-1A), 4.67 (bs, 1H, H-1B), 4.26 (dd, J3,4=10.2 Hz, J3,2=3.2 Hz, 1H, H-3A), 3.96 (m, 2H, H-
5A, H-5B), 3.84-3.63 (3H, H-3B, OCH2CH=CH2), 3.41 (OMe), 2.77 (m, 4H, CH2CH2), 2.21 (s, 3H, 
CH3C=O Lev), 1.92 (s, 3H, CH3C=O Ac), 1.29 (d, J6,5=6.2 Hz, 3H, H-6A), 1.19 (d, J6,5=6.2 Hz, 3H, 
H-6B). 13C NMR (50 MHz, CDCl3): δ 206.6 (CH3C=O), 171.8 (C=O Lev), 169.6 (C=O Ac), 165.7 
(C=O Bz), 134.1 (OCH2CH=CH2), 133.4, 133.0 (2 Cipso), 129.8-128.3 (C-Ar), 117.0 
(OCH2CH=CH2), 99.8 (C-1B, 1JC,H=173 Hz), 98.3 (C-1A), 75.3, 74.0, 73.2, 72.9, 71.6, 70.5, 68.8, 
67.5, 66.5 (C-2A, C-2B, C-3A, C-3B, C-4A, C-4B, C-5A, C-5B, OCH2CH=CH2), 55.2 (OMe), 37.8, 
29.8, 28.1 (CH2CH2, CH3C=O Lev), 20.7 (CH3C=O Ac), 17.5, 17.4 (C-6A, C-6B). ESI-MS for 
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C37H44O14 (m/z): Mr (calcd) 712.27, Mr (found) 735.49 (M+Na)+. Anal. calcd: C. 62.35; H. 6.22. 
Found: C. 62.50; H. 6.34. 
 
Methyl (2,3-di-O-acetyl-4-O-benzoyl-α-D-rhamnopyranosyl)-(1→3)-4-O-benzoyl-α-D-
rhamnopyranoside (61): To a solution of 60 (0.350 g, 0.49 mmol) in 2:1 MeOH/CH2Cl2 (8.6 mL), 
PdCl2 (18 mg, 0.10 mmol) was added and the mixture was stirred vigorously at rt for 4 hours. The 
mixture was then filtered over a Celite pad, diluted with CH2Cl2 (100 mL) and washed with 5N 
NaCl. The organic layer was collected, dried and concentrated to afford a brownish residue, that 
was dissolved in pyridine (4.0 mL) and then Ac2O (4.0 mL) was added to the mixture. The solution 
was stirred at rt overnight, then it was concentrated, diluted with CH2Cl2 (100 mL) and washed with 
1M HCl (100 mL) and 1M NaHCO3 (100 mL). The organic layer was collected, dried and 
concentrated. The residue was dissolved in 4:1 CH2Cl2/MeOH (8.0 mL) and then hydrazine acetate 
(65 mg, 0.68 mmol) was added. The solution was stirred 4 hours at rt, then it was concentrated to 
give a residue, that, after silica gel chromatography (4:1 petroleum ether/ethyl acetate) afforded 61 
(0.278 g, 87%) as a white foam. [α]D +0.9 (c 1.0, CH2Cl2); 1H NMR (200 MHz, CDCl3): δ 8.09-
7.40 (m, 10H, H-Ar), 5.47-5.35 (m, 2H, H-4A, H-3B), 5.23 (t, J4,3=J4,5=9.6 Hz, 1H, H-4B), 5.02 (dd, 
J2,3=3.6 Hz, J2,1=1.6 Hz, 1H, H-2B), 4.94 (d, J1,2=1.6 Hz, 1H, H-1B), 4.76 (bs, 1H, H-1A), 4.23-4.05 
(m, 3H, H-2A, H-3A, H-5B), 3.93 (dq, J5,4=9.8 Hz, J5,6=6.2 Hz, 1H, H-5A), 3.43 (s, 3H, OMe), 1.90 
(s, 3H, CH3C=O), 1.79 (s, 3H, CH3C=O), 1.26 (m, 6H, H-6A, H-6B). 13C NMR (50 MHz, CDCl3): 
δ 169.5, 169.2 (2 C=O Ac), 165.6, 165.4 (2 C=O Bz), 133.4, 133.2 (2 Cipso), 129.8-128.3 (C-Ar), 
100.3, 99.1 (C-1A, C-1B), 77.2 (C-3A), 73.0, 71.4, 70.8, 69.7, 68.4, 67.4, 66.3 (C-2A, C-2B, C-3B, C-
4A, C-4B, C-5A, C-5B), 55.1 (OMe), 20.5, 20.4 (2 CH3C=O Ac), 17.5, 17.4 (C-6A, C-6B). ESI-MS 
for C31H36O13 (m/z): Mr (calcd) 616.22, Mr (found) 639.31 (M+Na)+. Anal. calcd: C. 60.38; H. 5.88. 
Found: C. 60.55; H. 6.00. 
 
3-O-allyl-2,4-di-O-benzoyl-D-rhamnopyranose (62): Compound 55 (0.982 g, 3.05 mmol) was 
dissolved in pyridine (5.0 mL) and then BzCl (0.710 mL, 6.14 mmol) was added. The mixture was 
stirred for 30’, water (20 mL) was then added. After 10’ additional stirring it was diluted with 
CH2Cl2 (100 mL) and washed with 0.5M HCl. The organic layer was collected, dried and 
concentrated to give a residue that was suspended in Ac2O (7.5 mL). 25:20:0.5 v/v/v 
Ac2O/AcOH/H2SO4 (12.5 mL) was added and the solution was stirred for 60’ at rt. Water (5.0 mL) 
was then dropwise added and after 5’ additional stirring the mixture was diluted with CH2Cl2 (300 
mL) and washed with 5N NaCl, 1M NaHCO3 and water. The organic layer was collected, dried and 
concentrated to give a yellowish oil, that was dissolved in DMF (15 mL). Hydrazine acetate (0.331 
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g, 3.46 mmol) was added and the mixture was stirred for 45’ at rt, after that it was diluted with 
CH2Cl2 (400 mL) and washed with 5N NaCl, dried and concentrated. Silica gel chromatography 
(5:1 petroleum ether/ethyl acetate) of the residue afforded 62 (0.733 g, 58%; α/β=5:1) as a 
colourless oil. 1H NMR (200 MHz, CDCl3; α-anomer): δ 8.14-7.42 (m, 10H, H-Ar), 5.66 (m, 1H, 
OCH2CH=CH2), 5.58 (dd, J2,3=3.3 Hz, J2,1=1.8 Hz, 1H, H-2), 5.43 (t, J4,3=J4,5=9.8 Hz, 1H, H-4), 
5.38 (bs, 1H, H-1), 5.15 (dd, Jvic=17.2 Hz, Jgem=1.6 Hz, 1H, OCH2CH=CH2 trans), 5.03 (dd, 
Jvic=10.4 Hz, Jgem=1.6 Hz, 1H, OCH2CH=CH2 cis), 4.27 (dq, J5,4=9.8 Hz, J5,6=6.2 Hz, 1H, H-5), 
4.17-3.91 (m, 3H, H-3, OCH2CH=CH2), 1.30 (d, J6,5=6.2 Hz, 3H, H-6). 13C NMR (50 MHz, CDCl3; 
α-anomer): δ 165.9, 165.7 (2 C=O), 134.3 (OCH2CH=CH2), 133.3, 133.1 (2 Cipso), 130.0-128.4 (C-
Ar), 117.4 (OCH2CH=CH2), 92.5 (C-1), 73.9, 73.3, 70.7, 70.0, 66.8 (C-2, C-3, C-4, C-5, 
OCH2CH=CH2), 17.8 (C-6). ESI-MS for C23H24O7 (m/z): Mr (calcd) 412.15, Mr (found) 435.38 
(M+Na)+. Anal. calcd: C. 66.98; H. 5.87. Found: C. 66.74; H. 5.99. 
 
3-O-allyl-2,4-di-O-benzoyl-α-D-rhamnopyranosyl trichloroacetimidate (63): To a 0°C cooled 
solution of 62 (0.728 g, 1.77 mmol) in CH2Cl2 (13 mL), Cl3CCN (0.890 mL, 8.88 mmol) and DBU 
(0.152 mL, 1.02 mmol) were added under argon atmosphere. After 60’ stirring at rt, the solution 
was concentrated at 20°C. Silica gel chromatography (12:1 petroleum ether/ethyl acetate) of the 
residue afforded 63 (0.539 g, 55%) as a white foam. [α]D -50.3 (c 1.0, CH2Cl2); 1H NMR (200 
MHz, CDCl3): δ 8.77 (s, 1H, NH), 8.12-7.39 (m, 10H, H-Ar), 6.38 (d, J1,2=2.0 Hz, H-1), 5.72 (dd, 
J2,3=3.4 Hz, J2,1=2.0 Hz, 1H, H-2), 5.67 (m, 1H, OCH2CH=CH2), 5.49 (t, J4,3=J4,5=10.0 Hz, 1H, H-
4), 5.13 (dd, Jvic=17.4 Hz, Jgem=1.6 Hz, 1H, OCH2CH=CH2 trans), 5.04 (dd, Jvic=10.2 Hz, Jgem=1.6 
Hz, 1H, OCH2CH=CH2 cis), 4.27-3.92 (m, 4H, H-3, H-5, OCH2CH=CH2), 1.33 (d, J6,5=6.0 Hz, 3H, 
H-6). 13C NMR (50 MHz, CDCl3): δ 165.6, 165.4 (2 C=O Bz), 159.8 (C=NH), 134.0 
(OCH2CH=CH2), 133.4, 133.2 (2 Cipso), 129.9-128.4 (C-Ar), 117.9 (OCH2CH=CH2), 95.1 (C-1), 
73.9, 72.4, 70.9, 69.7, 68.0 (C-2, C-3, C-4, C-5, OCH2CH=CH2), 17.7 (C-6). ESI-MS for 
C25H24Cl3NO7 (m/z): Mr (calcd) 555.06, Mr (found) 578.17 (M+Na)+. Anal. calcd: C. 53.93; H. 4.34; 
N. 2.52. Found: C. 54.10; H. 4.24; N.2.73. 
 
Methyl (3-O-allyl-2,4-di-O-benzoyl-α-D-rhamnopyranosyl)-(1→2)-[2,3-di-O-acetyl-4-O-benzoyl-
α-D-rhamnopyranosyl-(1→3)]-4-O-benzoyl-α-D-rhamnopyranoside (64): A suspension of acceptor 
61 (0.271 g, 0.44 mmol), imidate 63 (0.342 g, 0.62 mmol) and freshly powdered 4Ǻ AW-300 
molecular sieves in CH2Cl2 (16 mL) was stirred at -50°C under argon atmosphere. TMSOTf (1.1 
μL, 6.1 μmol) was added and the mixture was kept at -50°C. After 60’ other TMSOTf (9.0 μL, 50 
μmol) was added and stirring was continued for additional 2 hours, after that the reaction was 
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quenched by adding a drop of Et3N. The mixture was then filtered on a Celite pad and concentrated. 
Silica gel chromatography (6:1 petroleum ether/ethyl acetate) of the residue afforded 64 (0.315 g, 
71%) as a white foam. [α]D -59.0 (c 1.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 8.15-7.29 (m, 
20H, H-Ar), 5.76 (m, 1H, OCH2CH=CH2), 5.63 (dd, J2,3=3.0 Hz, J2,1=1.6 Hz, 1H, H-2B), 5.50 (m, 
2H, H-4A, H-3C), 5.42 (t, J4,3=J4,5=9.8 Hz, 1H, H-4B), 5.30 (dd, Jvic=17.2 Hz, Jgem=1.4 Hz, 1H, 
OCH2CH=CH2 trans), 5.26 (t, J4,3=J4,5=9.9 Hz, 1H, H-4C), 5.22 (d, J1,2=1.6 Hz, 1H, H-1B), 5.15 
(dd, Jvic=10.2 Hz, Jgem=1.4 Hz, 1H, OCH2CH=CH2 cis), 5.05 (dd, J2,3=3.2 Hz, J2,1=1.6 Hz, 1H, H-
2C), 4.97 (d, J1,2=1.6 Hz, 1H, H-1C), 4.88 (d, J1,2=1.5 Hz, 1H, H-1A), 4.28-4.11 (m, 6H, H-3A, H-3C, 
H-5A, H-5C, OCH2CH=CH2), 4.06 (dd, J2,3=3.0 Hz, J2,1=1.6 Hz, 1H, H-2A), 3.93 (dq, J5,4=9.8 Hz, 
J5,6=6.2 Hz, 1H, H-5B), 3.42 (s, 3H, OMe), 1.94 (s, 3H, CH3C=O), 1.71 (s, 3H, CH3C=O), 1.34 (d, 
J6,5=6.2 Hz, 3H, H-6B), 1.31 (d, J6,5=6.2 Hz, 3H, H-6C), 1.27 (d, J6,5=6.2 Hz, 3H, H-6A). 13C NMR 
(100 MHz, CDCl3): δ 169.3, 169.0 (2 C=O Ac), 165.9-165.4 (4 C=O Bz), 134.1 (OCH2CH=CH2), 
133.1-133.0 (4 Cipso), 129.9-128.4 (C-Ar), 118.2 (OCH2CH=CH2), 100.0, 99.9, 99.7 (C-1A, C-1B, C-
1C, 1JC,H=173 Hz, 1JC,H=173 Hz, 1JC,H=174 Hz), 79.6 (C-2A), 77.2 (C-3A), 73.9, 73.3, 73.2, 71.5, 
71.0, 70.1, 70.0, 68.5, 67.7, 67.6, 66.7 (C-2B, C-2C, C-3A, C-3B, C-3C, C-4A, C-4B, C-4C, C-5A, C-5B, 
C-5C, OCH2CH=CH2), 55.2 (OMe), 20.7, 20.4 (2 CH3C=O), 17.8-17.7 (C-6A, C-6B, C-6C). ESI-MS 
for C54H58O19 (m/z): Mr (calcd) 1010.36, Mr (found) 1033.70 (M+Na)+. Anal. calcd: C. 64.15; H. 
5.78. Found: C. 64.00; H. 5.72. 
 
Methyl (2,4-di-O-benzoyl-α-D-rhamnopyranosyl)-(1→2)-[2,3-di-O-acetyl-4-O-benzoyl-α-D-
rhamnopyranosyl-(1→3)]-4-O-benzoyl-α-D-rhamnopyranoside (65): A solution of 64 (0.297 g, 
0.29 mmol) in 3:2 MeOH/CH2Cl2 (10 mL) was treated with PdCl2 (16 mg, 90 μmol). After 7 hours  
stirring at rt, the mixture was filtered on a Celite pad, diluted with CH2Cl2 (100 mL) and extracted 
with 5M NaCl. The organic layer was collected, dried and concentrated. The residue was subjected 
to silica gel chromatography (5:1 petroleum ether/ethyl acetate) to afford 65 (0.260 g, 92%) as a 
white foam. [α]D -48.0 (c 1.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 8.16-7.37 (H-Ar), 5.54 (m, 
2H, H-2B, H-3C), 5.42 (m, 2H, H-4A, H-4B), 5.27 (t, J4,3=J4,5=9.8 Hz, 1H, H-4C), 5.21 (d, J1,2=1.9 
Hz, 1H, H-1B), 5.08 (dd, J2,3=3.2 Hz, J2,1=1.8 Hz, 1H, H-2C), 5.00 (d, J1,2=1.8 Hz, 1H, H-1C), 4.86 
(d, J1,2=1.6 Hz, 1H, H-1A), 4.58 (dd, J3,4=9.8 Hz, J3,2=3.4 Hz, 1H, H-3B), 4.33-4.25 (m, 3H, H-3A, 
H-5B, H-5C), 4.06 (dd, J2,3=3.2 Hz, J2,1=1.6 Hz, 1H, H-2A), 3.92 (dq, J5,4=9.6 Hz, J5,6=6.0 Hz, 1H, 
H-5A), 3.43 (s, 3H, OMe), 1.89 (s, 3H, CH3C=O), 1.70 (s, 3H, CH3C=O), 1.35-1.24 (m, 9H, H-6A, 
H-6B, H-6C). 13C NMR (100 MHz, CDCl3): δ 169.5, 169.0 (2 C=O Ac), 166.4, 165.6, 165.5, 165.2 
(4 C=O Bz), 133.1-133.0 (4 Cipso), 129.7-128.2 (C-Ar), 99.4-99.2 (C-1A, C-1B, C-1C), 79.2 (C-2A), 
75.6 (C-3A), 74.4, 73.6, 73.2, 71.2, 69.7, 68.5, 67.9, 67.6, 67.5, 66.4 (C-2B, C-2C, C-3A, C-3B, C-3C, 
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C-4A, C-4B, C-4C, C-5A, C-5B, C-5C), 54.9 (OMe), 20.4, 20.3 (2 CH3C=O), 17.6-17.5 (C-6A, C-6B, 
C-6C). ESI-MS for C51H54O19 (m/z): Mr (calcd) 970.33, Mr (found) 971.02 (M+H)+. Anal. calcd: C. 
63.09; H. 5.61. Found: C. 63.09; H. 5.58. 
 
Methyl (3-O-allyl-2,4-di-O-benzoyl-α-D-rhamnopyranosyl)-(1→3)-(2,4-di-O-benzoyl-α-D-
rhamnopyranosyl)-(1→2)-[2,3-di-O-acetyl-4-O-benzoyl-α-D-rhamnopyranosyl-(1→3)]-4-O-
benzoyl-α-D-rhamnopyranoside (66): A suspension of acceptor 65 (0.212 g, 0.22 mmol), imidate 63 
(0.165 g, 0.30 mmol) and freshly powdered 4Ǻ AW-300 molecular sieves in CH2Cl2 (10 mL) was 
stirred at -50°C under argon atmosphere. TMSOTf (0.54 μL, 3.0 μmol) was added and the mixture 
was kept at -50°C. After 90’ the reaction was quenched by adding a drop of Et3N. The mixture was 
then filtered on a Celite pad and concentrated. Silica gel chromatography (7:1 petroleum ether/ethyl 
acetate) of the residue afforded 66 (0.210 g, 70%) as a white foam. [α]D -82.0 (c 1.0, CH2Cl2);. 1H 
NMR (400 MHz, CDCl3): δ 8.06-7.34 (H-Ar), 5.67 (dd, J2,3=3.2 Hz, J2,1=1.6 Hz, 1H, H-2C), 5.64 (t, 
J2,3=9.8 Hz, 1H, H-4C), 5.44 (m, 2H, H-3B, H-4A), 5.33 (d, J2,1=1.6 Hz, 1H, H-1C), 5.30-5.23 (m, 
5H, H-1C, H-1D, H-2D, H-4B, H-4D), 5.08 (dd, J2,3=3.2 Hz, J2,1=1.6 Hz, 1H, H-2B), 4.96 (d, J2,1=1.6 
Hz, 1H, H-1B), 4.87 (m, 2H, H-1A, OCH2CH=CH2 trans), 4.77 (dd, Jvic=10.2 Hz, Jgem=1.4 Hz, 1H, 
OCH2CH=CH2 cis), 4.59 (dd, J3,4=9.8 Hz, J3,2=3.2 Hz, 1H, H-3C), 4.29 (dd, J3,4=9.8 Hz, J3,2=3.3 
Hz, 1H, H-3A), 4.23 (m, 2H, H-5B, H-5C), 4.08 (m, 2H, H-2A, H-5D), 3.93 (m, 1H, H-5A), 3.83 (dd, 
J3,4=9.8 Hz, J3,2=3.4 Hz, 1H, H-3D), 3.75 (m, 1H, OCH2CH=CH2), 3.62 (m, 1H, OCH2CH=CH2), 
3.43 (s, 3H, OMe), 1.34 (m, 6H, H-6A, H-6C) 1.26 (d, J6,5=6.2 Hz, 3H, H-6B), 1.15 (d, J6,5=6.2 Hz, 
3H, H-6D). 13C NMR (100 MHz, CDCl3): δ 169.2, 168.6 (2 C=O Ac), 166.0, 165.8, 165.3, 165.2, 
165.0, 164.9 (6 C=O Bz), 134.0 (OCH2CH=CH2), 133.4-132.8 (6 Cipso), 129.8-128.1 (C-Ar), 117.2 
(OCH2CH=CH2), 100.0, 99.7, 99.6, 99.2 (C-1A, C-1B, C-1C, C-1D, 1JC,H=173 Hz, 1JC,H=173 Hz, 
1JC,H=173 Hz, 1JC,H=174 Hz), 79.0 (C-2A), 76.4, 74.9, 73.8, 73.3, 72.9, 72.4, 71.5, 70.2, 70.0, 69.2, 
68.4, 67.7, 67.6, 67.3, 66.9 (C-2B, C-2C, C-2D, C-3A, C-3B, C-3C, C-3D, C-4A, C-4B, C-4C, C-4D, C-
5A, C-5B, C-5C, C-5D, OCH2CH=CH2), 55.2 (OMe), 20.6, 20.2 (2 CH3C=O), 17.8-17.5 (C-6A, C-6B, 
C-6C, C-6C). ESI-MS for C74H76O25 (m/z): Mr (calcd) 1364.47, Mr (found) 1387.43 (M+Na)+. Anal. 
calcd: C. 65.09; H. 5.61. Found: C. 66.01; H. 5.48. 
 
Methyl α-D-rhamnopyranosyl-(1→3)-α-D-rhamnopyranosyl)-(1→2)-[α-D-rhamnopyranosyl-
(1→3)]-α-D-rhamnopyranoside (53): A solution of 66 (30 mg, 22 μmol) in 1:1 MeOH/CH2Cl2 (1.5 
mL) was treated with PdCl2 (4.0 mg, 22 μmol). After stirring overnight at rt, the mixture was 
filtered on a Celite pad, diluted with CH2Cl2 (25 mL) and extracted with 5M NaCl (25 mL). The 
organic layer was collected, dried and concentrated. The residue was dissolved in 1:1 
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MeOH/CH2Cl2 (1.0 mL) and treated with a 3.4 M methanolic solution of NaOMe (0.1 mL). The 
solution was stirred overnight at rt, then Amberlist-15 (H+) was added to adjust the pH value to 6. 
The mixture was filtered and concentrated to give a residue, that was purified by gel filtration on a 
G-10 (Sephadex) column using water as eluant, to obtain 53 (9.8 mg, 72%) as a white foamy solid. 
[α]D +38.3 (c 0.5, CH2Cl2); 1H NMR (400 MHz, D2O): δ 5.06 (bs, 2H, H-1B, H-1D), 4.96 (d, 1H, 
J1,2=1.7 Hz, 1H, H-1C), 4.78 (d, 1H, J1,2=1.6 Hz, 1H, H-1A), 4.06 (dd, 1H, J2,3=3.2 Hz, J2,3=1.6 Hz 
1H, H-2B), 4.04 (m, 2H, H-2C, H-2D), 4.00 (dd, 1H, J2,3=3.2 Hz, J2,3=1.6 Hz 1H, H-2A), 3.89-3.85 
(m, 2H, H-3A, H-3C), 3.82-3.76 (m, 2H, H-3B, H-5C), 3.74-3.65 (m, 4H, H-3D, H-5A, H-5B, H-5D), 
3.59 (t, 1H, J4,3= J4,5=9.6 Hz, 1H, H-4A), 3.55 (t, 1H, J4,3= J4,5=9.6 Hz, 1H, H-4C), 3.47 (m, 2H, H-
4B, H-4D), 3.41 (s, 3H, OMe), 1.30 (m, 12H, H-6A, H-6B, H-6C, H-6D). 13C NMR (100 MHz, 
D2O):28 δ 103.4 (C-1B, C-1D), 103.0 (C-1C), 100.6 (C-1A), 79.5 (C-2A), 78.5 (C-3A, C-3C), 73.3 (C-
4A, C-4B), 73.2 (C-4D), 73.0 (C-4C), 71.5 (C-2B), 71.3 (C-2C), 71.2 (C-2D), 71.1 (C-3B, C-3D), 70.4 
(C-5A, C-5B, C-5C, C-5D), 56.0 (OMe), 18.4-18.3 (C-6A, C-6B, C-6C, C-6D). ESI-MS for C25H44O17 
(m/z): Mr (calcd) 616.26, Mr (found) 639.58 (M+Na)+. Anal. calcd: C. 48.70; H. 7.19. Found: C. 
48.81; H. 7.17. 
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4. SYNTHESIS OF A RHAMNOGALACTURONAN II FRAGMENT  
 
 
 
To gain deeper acknowledgments on synthesis of rhamnosyl linkages, I spent my last year Ph.D. 
working in the laboratories of Centre for Carbohydrate Chemistry (CCC) (University of East 
Anglia, Norwich, UK) directed by Prof. R.A. Field. Among several projects, Field and co-workers 
are motivating in gain an insight into structural and functional knowledge of pectic polysaccharides 
of the plant cell wall. In this chapter a description of plant cell wall and its component has been 
reported. Additionally, herein a revised synthesis of a tetrasaccharide fragment from a pectic 
polysaccharide of the plant cell wall is described. 
 
 
4.1 Plant cell wall 
When pathogens attack a plant it has several passive (size of the pore too small for viruses) and 
active (death of the cell under attack) means of defence, and almost all of them involve the cell 
wall; actually, by affecting cell wall properties, plants are more likely to be vulnerable to viruses 
and pathogens. The cell wall, an essential component of higher plants, is also known to be involved 
in cell stability, shape, and development, as well as in the protection of the cell against pathogens.1 
Cellulose, hemicellulose and pectins are part of its components forming a compact network (Figure 
4.1) which contributes to the various chemical and structural properties of the whole cell wall. 
 
 
                              
                             Figure 4.1: Model of a primary plant cell wall 
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Figure 4.2 Rhamnogalacturonan II structure 
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Cellulose is composed of (1→4)-β-D-glucans forming a sheet-like structure and gives the 
mechanical strength to the plant cell wall.2 Hemicelluloses are flexible heterogeneous 
polysaccharides binding to the (1→4)-β-D-glucans. In contrast to cellulose that is crystalline, strong 
and resistant to hydrolysis, hemicellulose has a random, amorphous structure with little strength. 
The combination of both cellulose and hemicellulose in a tight network accounts for the structural 
support provided by the wall during the growth.2 The term “pectin” is employed to cover a group of 
acidic heteropolysaccharides consisting of linear chains of D-galacturonic acids which are α-(1→4)-
linked. The precise role of pectins is still uncertain; however, the pectic network of the primary cell 
wall is clearly a target for specific developmental modifications such as cell wall swelling and 
softening during fruit ripening, and cell separation during leaf and fruit abscission, pod dehiscence 
and root cap cell differentiation.3 The pectins are divided into three major more or less complex 
polysaccharides containing galacturonic acids and neutral sugars within their structure. 
Homogalacturonan (HG), and rhamnogalacturonan I (RG-I) are two of the pectins which are 
defined as relatively simple structurally4,1b whereas rhamnogalacturonan II (RG-II), is considered to 
be a very complex highly branched polysaccharide (Figure 3c).1b,4,5 From a compositional and 
structural point of view, HG has a relatively simple primary structure of 1,4-linked α-D-GalpA 
which are partially esterified, while the RG-I backbone consists of a repeating sequence of 1,4-
linked α-D-GalpA-(1→2)-α-L-Rhap disaccharide residues. In contrast to HG and RG-I which are 
notable for their heterogeneity, RG-II has a highly conserved structure throughout the plant 
kingdom. Not all details of this structure have yet been elucidated.  
 
 
4.2. Rhamnogalacturonan  
Rhamnogalacturonan-II (RG-II) is considered to be the most complex of the pectins and, in contrast 
to HG and RG-I which are other  pectic polysaccharides, has a highly conserved structure 
throughout the plant kingdom. It is a low molecular mass (5-10kDa) pectic polysaccharide with a 
backbone composed of 1,4-linked α-D-GalpA residues to which four oligosaccharide side chains 
are attached (Figure 4.2). The order in which the side chains are attached to the backbone has still 
to be unambiguously determined, and so their assignment is arbitrary. Nevertheless, it has been 
shown that two of the backbone GalpA residues are substituted at C3 with two structurally different 
disaccharides, and two octasaccharides are attached to C2 of two other backbone GalpA residues. 
Monomeric RG-II yields, upon hydrolysis, more than 12 different monosaccharides, including the 
rarely observed aceric acid and apiose, the only two-branched sugars known to exist in plant 
polysaccharides, and 2-O-methylxylose and 2-O-methylfucose.6  
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The complexity and occurrence of RGII suggest that it might have functions other than being a 
simple structural component of the cell wall. 
 
 
4.2.1. Rhamnogalacturonan-II dimer 
Inside the pectin matrix, recent studies have established that RG-II exists predominantly as a dimer 
resulting from a 1:2-borate-diol ester linkage which involves two apiofuranosyl residues belonging 
to the side chain called side chain A of two different RG-II units (Figure 4.3).7 The specificity of 
this cross-linkage suggests that there are precise structural requirements (nature of monosaccharides 
within the structure of the polysaccharide, for instance)8 for dRG-II formation, and this may explain 
why the structure of RG-II is highly conserved in plants.9,7a  
 
 
Figure 4.3: RGII dimer cross-linked via borate diester between apiose residues of the side chain A 
 
This RG-II dimer accounts for more than 80% of RG-II in plants10 and contributes to the 
coordination bonding of pectic chains and Ca2+.11 Furthermore, 1:2-borate cross-linked RG-II has 
been isolated from wine9a and its presence was confirmed in other fruit-derived products including 
juices. As an example, the dRG-II concentration corresponds to about 150 mg/L in red wine and 50 
mg/L in white wine.12 This high concentration, despite the fact that RG-II accounts for less than 5% 
in the primary cell wall, is explained by its resistance to a wide variety of enzymes. Studies 
revealing the specificity of the 1,2-diolester cross linkage,9b,8b enabled a better understanding of 
plant morphogenesis; thus, it is well clear the importance of studying specificity in dimer formation 
and, obviously, structural arrangement of fragment A. This would require synthesis of large 
oligosaccharide fragments modelling side-chain A of RG-II by means of orthogonal strategy 
leading to higher and higher structure. 
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4.3 Revised synthesis of a tetrasaccharide from RGII side chain A 
One of the ongoing research project in the CCC at the University of East Anglia (UEA) is the 
synthesis of RGII. In a previous work the synthesis of the tetrasaccharide 67 α-D-GalA-(1→2)-[β-
D-GalA-(1→3]-[α-L-Fuc-(1→4)]-α-L-Rha-OMe (Figure 4.4), a fragment of RG II side chain A, 
has been reported.13  
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          Figure 4.4: Tetrasaccharide fragment from RGII side chain A 
 
The strategy used in this work involves iterative glycosylations of the orthogonally protected α-
methyl rhamnoside acceptor 69 followed by oxidations carried out on galactosyl moieties; the 
retrosynthetic analysis is shown in the following scheme (Scheme 4.1). 
 
. 
O
HO
HO
OH
HO2C
O
OMe
OO
Me
O
O
OH
HO
OH
Me
O OH
OHOH
HO2C
BzO
O
BzO
BzO
OBz
O
OMe
OO
Me
O
O
OBn
OBn
OBn
Me
OBn
O OBn
OBnOBn
O
OBn
OBn
OBn
Me SPh
BnO
O
BnO
BnO
OBn
SMe
BzO
O
BzO
BzO
OBz
SMe
O
OMe
HO
Me
PMBO
OAc
67 68
7269 70 71  
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Nevertheless a revised synthesis of this tetrasaccharide has been considered; it involves the 
incorporation of a per-benzylated galactosyl residue at C-3 rhamnoside. This variation would render 
the synthesis more straightforward bypassing the de-benzoylation reaction in the deprotecting step. 
Furthermore building of 1,2-trans-anomeric linkage using an armed donor would be a challenging 
goal. Moreover the new synthesis would involve the use of a β-rhamnosyl acceptor whose 
configuration is the one naturally occurring. However glycosylation attempts were carried out using 
first the α-configurated rhamnosyl acceptor which is more straightforward to synthesize. 
 
 
4.3.1 Synthesis of galactosyl donor 
Thioglycoside was synthesised using the traditional method by Lewis acid-mediated activation of 
per-acetylated glycosides in the presence of a thiol.14 The 1,2-trans-glycosides are the main 
products because of the anchimeric assistance from the acetyl group. Anyway this reaction has to be 
carried out carefully because anomerization can occur when performing the reaction for a long time. 
The per-O-acetylated galactose 73 starting material was converted into its thioglycoside counterpart 
74 as described above. According to the procedure reported in the previous work by Field and co-
workers13 the thioglycoside was deprotected by a Zemplén reaction to obtain the compound 75, then 
benzylated by BnBr and NaH 60% (Scheme 4.2).The benzylation was confirmed by the presence of 
CH2 peaks of benzyl groups in the 1H NMR spectrum. 
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                        Reagent and conditions: (a) NaOAc/Ac2O, reflux; (b) EtSH, BF3.OEt2, DCM, 0 oC to rt; 
                        (c) MeOH/MeOK; (d) BnBr, NaH 60%, DMF 
 
         Scheme 4.2: Synthesis of an armed perbenzylated galactosyl donor 
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4.3.2 Synthesis of β-rhamnosyl acceptor 
A first attempt to synthesize an O-Me-β-rhamnoside acceptor was performed using a 1,2-cis-
stannylene acetal-based procedure15 (Scheme 4.3), but the reaction gave us a mixture of compounds 
within there was not the desired compound. 
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Scheme 4.3: Failed attempt of synthesis of O-Me-β-rhamnoside via 
stannylene acetal-based procedure 
 
Thus, it was decided to achieve the β-configuration by conversion of an O-Me-α-rhamnoside 
building block using a more classic protocol by means of a multi-step synthesis. The synthetic 
strategy employed on this purpose is shown in the following Scheme 4.4. 
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Reagents and conditions: a) DMP, TsOH, DMF; b) 1:3 Ac2O, Py; c) 4:1 TFA/H2O, 45% over three steps; d) 
(Cl3CO) 2CO, DCM, Py, -70 oC ; e) Ac2O, H2SO4, 90% over two steps; f) 33% HBr/AcOH; g) Hg(CN)2, 
MeOH, CH3CN, 79% over two steps; h) MeOH/MeOK; i)  (i) MeC(OEt)3, CSA, CH3CN; (ii) PMBCl, NaH, 
CH3CN; (iii) 80% aq AcOH, 20% over three steps 
 
Scheme 4.4: Multi-step synthesis of O-Me-β-rhamnoside acceptor 
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Starting from O-Methyl α-L-rhamnopyranoside, Br-α-rhamnoside 84 was synthesized by means a 
sequence of protection/deprotection steps.16 The most crucial step in the chosen route was the 
conversion of bromide 84 to the O-Me-β-rhamnoside acceptor. Thus, with the compound 84 in 
hands, several attempts of β-methylation were performed using different conditions. The best result 
was obtained using Hg(CN)217 as promoter. The synthesis proceeded as described in the previous 
work using the one-pot method18,19 described in paragraph 3.1; protection step of 4-OH with a p-
methoxybenzyl protecting group was performed in between the formation of the orthoester and its 
ring-opening leading to compound 86 with a free equatorial hydroxyl group on C-3 and two 
differentially protected hydroxyl groups on 2-OH and 4-OH(PMB and Ac), thus, creating a 
difference in reactivity between the groups on the ring. However, this reaction gave us compound 
86 with a very poor yield (20%) and needed to be optimized. Since compound 86 was quite 
“precious” we decided to carry glycosylation tests on its α-analogue; thus the synthesis of 
compound 69 was performed according to the procedure from previous work.13 
 
 
4.3.3 Synthesis of α-rhamnosyl acceptor13 
Starting from the commercially available methyl rhamnoside 87, the α-glycosyl acceptor 69 was 
synthesised by means of the one-pot protocol previously described which yields 70% of protected 
rhamnosyl acceptor in this case (Scheme 4.5). 
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                                           Reagents and conditions: a) MeC(OEt)3, pTsOH, CH3CN; b) PMBCl,  
              NaH, CH3CN; c) 80% aq. AcOH, 70% over three steps 
                                Scheme 4.5: One-pot procedure on synthesis of O-Me-α-rhamnoside 
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4.3.4 Towards the synthesis of the tri-substituted rhamnoside 
In the previous work the coupling between rhamnosyl acceptor 69 and thiogalactosyl donor 72 was 
considered. Unfortunately poor yields and stereselectivities were observed using NIS/TfOH (or 
NIS/TMSOTf) as promoter in a range of different solvents. In this work new attempts of 
glycosylation are reported, in order to improve yield and β-stereoselectivity of the 1,2-trans linked 
disaccharide. In order to have a wide range of tests where to pick up the best result from, several 
attempts of 1,2-trans glycosylation were performed in the present work by using different alonium 
ion-based activation methods; furthermore the efficiency of propionitrile as participating solvent 
favouring the β-stereoselectivity, as reported by Schmidt and co-workers,20 was tested and it was 
compared with the most used CH3CN. Thus, the efficiency of NIS/TfOH as promoter in coupling 
76 and 69, was tested again slightly changing the molar ratio and the temperature.  
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Scheme 4.6: Coupling of galactosyl donor 76 and α-rhamnosyl acceptor 69 
 
Unfortunately, these variations were unsuccessfull affording the disaccharide 90, as anomeric 
mixture, with poor yield and stereoselectivity in both nitriles as solvents. The nature of the triflate 
promoter and its effect on the anomeric selectivity was kept considering. As reported by Lowary 
and co-workers,21 thioglycosyl donors are activated with NIS/AgOTf. In fact, coupling between 
donor 76 and acceptor 69 using the last mentioned promoter provided disaccharide 90 with better 
stereocontrol in both nitrilic solvents. NBS has been reported to be a convenient activating agent for 
thioglycosyl donor; besides, NBS is less expansive and more stable than NIS. Nicolaou and co-
workers22 and Sasaki and co-workers23 used N-bromosuccinamide (NBS) alone, or in combination 
with TfOH, to activate phenyl thioglycosides; Li and co-workers24 found that NBS together with a 
catalytic amount of Me3SiOTf was effective for the activation of both phenyl- and ethyl-
thioglycosides with satisfying β-stereocontrol. In our case, combination of NBS with Me3SiOTf 
first and AgOTf later, yields a brominated anomeric mixture of the desired disaccharide in both 
nitrilic solvents, with a β/α ratio about 3. The anomeric ratios were based on the integration of the -
OCH3 group or acetyl group of the rhamnosyl moiety at 3.2 or 2.0 ppm respectively. Trying to gain 
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better in stereoselectivity, we exploited the use of the combination I2/DDQ in coupling 76 and 69. 
Iodine itself is a mild and effective activator of thioglycosides. Whilst iodine alone is able to 
activate reactive glycosyl donors, less reactive donors are activated when iodine is used together 
with DDQ, a versatile single electron oxidising agent;25 on the other hand, DDQ alone is not 
effective in activation of thioglycosides demonstrating that the combination of two reagents is key. 
The mechanism of activation by I2/DDQ is not yet completely understood but the more credible 
hypothesis is that DDQ oxidises iodide, generated in the activation process, to iodine, so preventing 
glycosyl iodide and favouring α-glycosyl nitrilium ion formation. Unfortunately, this glycosylating 
condition was not effective in couplings 76 and 69. All the results of the coupling are shown in 
Table 4.1. 
 
ENTRY PROMOTER SOLVENT T (oC) YIELD (%) β/α ratio
1 NIS/TfOH 6.7:1 CH3CN/DCM 0 41 1.6 
2 NIS/TfOH Pr-CN -35 47 1.8 
3 NIS/AgOTf CH3CN -35 to -20 71 2.7 
4 NIS/AgOTf Pr-CN -50 to -20 58 2.9 
5 NBS/Me3SiOTf CH3CN -35 to -20 70 3.6 
6 NBS/Me3SiOTf Pr-CN -50 to -20 51 3.7 
7 NBS/AgOTf CH3CN -35 25 1.1 
8 I2/DDQ CH3CN -35 31 1.5 
 
         Table 4.1: Glycosylation conditions and results in coupling galactosyl donor 76 and  
         α-rhamnosyl acceptor 69 
 
The best compromise in yield and stereoselectivity was afforded activating donor 76 by 
NBS/Me3SiOTf (entry 5, Table 4.1). However, not surprisingly, MS analysis revealed the presence 
of a bromine atom on the coupling product, as it is reported by Li and co-workers.24 The value of 
mass peak, indicating just one atom of bromine, and the difference in reactivity between benzyl and 
p-methoxybenzyl protecting group suggest us to hypothesize the presence of bromine on the 
aromatic ring of the latter. To be sure this would not have affected the further steps of the synthesis, 
we attempted on disaccharide anomeric mixture a preventing test of removal the brominated 
protecting group in the same conditions used to remove a not brominated one. The good outcome of 
the test encouraged us to proceed as in the previous work. 
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Reagents and conditions: a) 2:3 DCM/MeOH, MeONa, rt, 94%; b) NIS, TMSOTf, 2:3 DCM/Et2O,  
-55 oC; c) 9:1 CH3CN/H2O, CAN, 90% 
 
    Scheme: Synthesis of trisaccharide 94 
 
Thus, the anomeric mixture of 91 was treated with MeONa affording the disaccharide alcohol 92 as 
a single anomer after chromatography (Scheme 4.7). Consecutively acceptor 92 was coupled with 
donor 76 in an α-stereoselectivity-favouring mixture of solvents; the formation of the trisaccharide 
was ascertained by MS spectrum. Compound 93 was treated with CAN in 9:1 CH3CN/H2O 
affording the 3-OH-rhamnoside-acceptor which was ready to be coupled with fucosyl donor 70 in 
the same condition used in the previous work published by Field and co-workers.13  
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4.4 Experimental part  
All solvents were used as purchased, except for CH2Cl2, which was freshly distilled from CaH2, and 
stored over 4 Å molecular sieves. Cation-exchange resin (Amberlite IR-120, H+ form Fluka) was 
pre-washed with water and dry MeOH before use. Thin layer chromatography (TLC) was 
performed on aluminium-backed, pre-coated silica gel plates (Silica Gel 60 F254, Merck) which 
were developed by immersion in a 5% ethanolic solution of H2SO4, followed by heating to 200ºC. 
Column chromatography was performed on silica gel (40 – 70 μm, BDH-Merck). Evaporation of 
solvents was performed under reduced pressure at 25 – 40ºC. Reagents and dry solvents were added 
via syringes through septa. 1H and 13C NMR spectra were recorded at 24ºC with a Varian Gemini 
2000 spectrometer at 300 and 75 MHz, respectively, or with a Varian Unity Plus spectrometer at 
400 and 100 MHz, respectively, using CDCl3 or D2O as solvents. Resonance assignments for 
compound 91-94 were not made for all signals but only for diagnostic peaks. Accurate mass 
electrospray ionisation (ESI) mass spectra were obtained on a Finnigan MAT 900 XLT mass 
spectrometer at the EPSRC Mass Spectrometry Service Centre, Swansea. 
 
 
Ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-galactopyranoside (76). Compound 7513,14 was dissolved in 
DMF (50 cc) and then NaH (60% dispersion in mineral oil, 2.530 g, 58.73 mmol) was added. The 
mixture was kept under stirring for 30 min and then BnBr (4.9 eq, 58.73 mmol) was added at 0 oC. 
The mixture was kept under stirring at room temperature over night. MeOH (45 cc) was then added 
and the mixture was allowed to stir for 10 min. The mixture was partitioned between EtOAc and 
H2O. The organic layers were dried by MgSO4, filtered and concentrated. 
Column chromatography (7:1 hexane-ethyl acetate) of the residue afforded 76 as a white oil 
(86.7%, yield calculated over the last two steps): 1H NMR (CDCl3, 400 MHz) δ 4.95 (d, 1H, Jgem = 
11.6 Hz , OCH2Ph), 4.87 (d, 1H, Jgem = 10.4 Hz, OCH2Ph), 4.79 (d, 1H, Jgem = 10 Hz, OCH2Ph), 
4.62 (d, 1H, Jgem = 12 Hz, OCH2Ph), 4.45 (m, 4H, H-1, OCH2Ph), 3.95 (d,1H, J = 2.8 Hz, H-4), 
3.83 (t, 1H,  J = 9.6 Hz, H-2), 3.59 (m, 4H, H-3, H-5, H-6, H-6’), 2.78 (dq, 2H, SCH2CH3 ), 1.30 (t, 
3H, J = 7.2 Hz, SCH2CH3 ). 
 
Methyl 2-O-acetyl-4-O-(4-methoxybenzyl)-β-L-rhamnopyranoside (86). A solution of compound 
7817 (8.30 mmol, 1.478 g) and triethylorthoacetate (106 mmol 12.8 eq) in CH3CN was stirred for 
few minutes at room temperature and a catalytic amount of CSA was added. The mixture was 
stirred until TLC (7:1 DCM/MeOH) showed disappearance of starting material (over night), and the 
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solution was neutralized with Et3N. NaH (60% dispersion in mineral oil, 1.302 g, 32.5 mmol) was 
added to the mixture and after 15 min of stirring 4-methoxybenzyl chloride (7.5 mL, 49.8 mmol,) 
was added carefully. After one night the reaction is quenched by adding MeOH (7.5 mL) and the 
mixture concentrated. The residue was dissolved in EtOAc and washed with H2O, dried by MgSO4, 
filtered and concentrated. Column chromatography (5:2 hexane-ethyl acetate) of the residue gave 
86 (16%, yield calculated over three steps).  
 
Methyl (2,3,4,6-tetra-O-benzyl-D-galactopyranosyl)-(1→3)-2-O-acetyl-4-O-paramethoxybenzyl-α-
D-rhamnopyranoside (90) . 
Protocol with NIS/TfOH: A solid mixture of compound 76 (1.46 eq, 0.22 mmol, 128 mg) and 
compound 6913 (0.15 mmol, 51 mg) was codistilled by toluene and dried. Molecular sieves (4 Å, 
0.13 g) were added and the mixture was suspended in dry solvent (2.5cc) and kept under stirring for 
30 min at room temperature under N2. The mixture was cooled at 0 oC (or -50 oC) and NIS (0.33 
mmol, 1.5 eq) and TfOH (0.033 mmol) were added under N2. The mixture was allowed to stir at the 
desired temperature for 1h.Then the mixture was neutralized with Et3N, dilueted with CH2Cl2, 
filtered through celite, washed with 10% aq Na2S2O3 solution and H2O. The organic layers were 
dried by MgSO4, filtered and concentrated. 
 
Protocol with NIS/AgOTf: A solid mixture of compound 76 (1.33 eq, 0.22 mmol, 128 mg ) and 
compound 6913 (0.16 mmol, 56 mg) were codistilled by toluene and dried. Molecular sieves (4 Å, 
0.15 g) were added and the mixture was suspended in dry solvent (2.5cc) and kept under stirring for 
30 min at room temperature under N2. The mixture was cooled at -40 oC and NIS (0.25 mmol, 1.25 
eq) and AgOTf (0.07 mmol) were added under N2. The mixture was allowed to stir in a range of 
temperature between -40 oC and -20 oC for 1h. Then the mixture was neutralized with Et3N, diluted 
with CH2Cl2, filtered through celite, washed with 10% aq Na2S2O3 solution and H2O.The organic 
layers were dried by MgSO4, filtered and concentrated.  
 
Protocol with NBS/Me3SiOTf: A solid mixture of compound 76 (1.33 eq, 0.22 mmol, 128 mg) and 
compound 69 (0.16 mmol, 56 mg) was codistilled by toluene and dried. Molecular sieves (4 Å, 0.15 
g) were added and the mixture was suspended in dry solvent (2.5cc) and kept under stirring for 30 
min at room temperature under N2. The mixture was cooled at -40 oC and NBS (0.4 mmol, 2 eq) 
and Me3SiOTf (0.04 mmol) were added under N2. The mixture was allowed to stir in a range of 
temperature between -40 oC and -20 oC for 1h. Then the mixture was neutralized with Et3N, diluted 
with CH2Cl2, filtered through celite, washed with aq NaHCO3, NaHSO3 and H2O.The organic layers 
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were dried by MgSO4, filtered and concentrated. The anomeric ratios β/α are based on the 
integration of OCH3 group or acetyl group of the rhamnosyl moiety at 3.2 or 2.0 ppm respectively.  
 
Protocol with NBS/AgOTf: A solid mixture of compound 76 (1.33 eq, 0.22 mmol, 128 mg) and 
compound 69 (0.16 mmol, 56 mg) were codistilled by toluene and dried molecular sieves (4 Å, 0.15 
g) were added and the mixture was suspended in dry solvent (2.5cc) and kept under stirring for 30 
min at room temperature under N2. The mixture was cooled at -40 oC and NBS (0.4 mmol, 2 eq) 
and AgOTf (0.07 mmol, 0.35 eq) were added under N2. The mixture was allowed to stir in a range 
of temperature between -40 oC and -20 oC for 1h. Then the mixture was neutralized with Et3N, 
diluted with CH2Cl2, filtered through celite, washed with aq NaHCO3, NaHSO3 and H2O.The 
organic layers were dried by MgSO4, filtered and concentrated. The anomeric ratios β/α are based 
on the integration of OCH3 group or acetyl group of the rhamnosyl moiety at 3.2 or 2.0 ppm 
respectively.  
 
Protocol with I2/DDQ: A solid mixture of compound 76 (1.25 eq, 0.22 mmol, 128 mg) and 
compound 69 (0.18 mmol, 60 mg) was dissolved in dry solvent (2.5cc), dried molecular sieves (4 Å, 
0.15 g) were added and the reaction mixture was stirred under nitrogen for 30 min. I2 (1.5 eq) and 
DDQ (1.5 eq) were added. When the reaction was complete, the mixture was cooled to 0 oC, 
neutralized with Et3N, filtered through celite and concentrated. 
 
 
Brominated compound 92: Anomeric mixture of brominated compound 91 (1.462 g, 1.579 mmol) 
was suspended in 2:3 DCM/MeOH (15 mL) and 1 M MeONa solution was added until basic pH. 
The mixture was kept under stirring at room temperature. After 4.5 h a bit more of 1 M MeONa 
solution was added. After 7 h the mixture was neutralized by DOWEX H+ until pH 7, filtered and 
concentrated. Column chromatography (6:1 toluene-EtOAc) afforded 92 (1.308 g, 94%). The 
disappearance of a signal at δ= 2.19 ppm in 1H NMR spectrum was diagnostic of the absence of 
acetyl group. ESI-MS found m/z 900.90 [M + NH4]+. 
 
Brominated trisaccharide 93: A solution of disaccharide 92 (1.0 g, 1.131 mmol) and ethyl 2,3,4,6-
tetra-O-benzyl-1-thio-β-D-galactopyranoside 76 (2 eq, 1.323 g, 2.262 mmol) in 30 mL of dry DCM-
Et2O (2:3) was stirred with molecular sieves 4 Å (1 g) for 2 h at room temperature. After addition of 
NIS (2.262 mmol, 500 mg) the mixture was cooled to -55 oC and TMSOTf (0.19 mmol 34.38 μl) 
was added. The mixture was stirred for 75’ at -55 oC, neutralized with Et3N , then allowed to warm 
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at room temperature and diluted with DCM. The organic solution was washed with 10% aqueous 
Na2S2O3 solution, water, aqueous NaHCO3 solution, and brine, then dried and concentrated. 
Column chromatography (7:1, toluene-EtOAc) afforded 93 (1.420 g 88%). ESI-MS found m/z 
1422.56 [M + NH4]+. 
Methyl 2-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-3-O-(2,3,4,6-tetra- O-benzyl-β-D-
galactopyranosyl)-α-L-rhamnopyranoside (94). A solution of trisaccharide 93 (0.25 g, 0.177 mmol) 
and (NH4)2Ce(NO3)6 (0.58 g, 1.066 mmol) in CH3CN-H2O (9:1 3 ml) was stirred at room 
temperature for 1 h, diluted with DCM, washed with water, aqueous NaHCO3 solution and brine, 
dried and concentrate. Column chromatography (5:1 toluene-EtOAc) afforded 94 (195 mg 90%). 
The disappearance of a signal at δ= 2.99 ppm in 1H NMR spectrum was diagnostic of the absence 
of p-methoxybenzyl group. ESI-MS found m/z 1241.47 [M + NH4]+. 
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5. CONCLUSIONS 
 
 
 
The most widespread molecules in living systems are, undoubtedly, carbohydrates which can exist 
also as glycoconjugates (glycolipids, glycoproteins, proteoglycans). Their role in cell-cell 
recognitions and interactions is one of the most studied aspects of carbohydrates. Among these 
molecules, lipopolysaccharides (LPS), which occur on the cell surface of Gram-negative bacteria, 
are key structures in cell-cell interactions and are directly involved in pathogenesis of Gram-
negative bacterial infections.1 It is interesting that bacterial human- and plant-pathogens share a 
common LPS architecture even though host cells have different recognition and defence system. 
Indeed, biological functions and molecular mechanisms have been quite widely investigated for 
human pathogenic bacteria but still very little is known about LPS-plant interactions. In this field, a 
recent work2 highlighted that synthetic oligorhamnans3 induce biological activity in Arabidopsis 
thaliana leaves which were treated with different phytopathogenic Gram-negative bacteria once 
inoculated with aqueous solution of synthetic oligosaccharides and the plant response depends on 
the length of the chain. Nevertheless, still more has to be done in description of molecular 
mechanisms involved in plant-LPSs interaction. Based on this results, in order to gain deeper in 
structure-activity relationship of bacterial O-chains, my Ph. D. project concerned the synthesis of 
model oligosaccharides related to phytopathogenic bacterial O-chains mimicking natural structures 
to employ, in future, in biological experiments. Structural studies4 on different strains of 
Pseudomonas syringae and Xanthomonas campestris species show that their O-chains consist of 
linear rhamnans bearing different branch monosaccharides. Thus, I focused my work on the 
synthesis of branched rhamnan structures, which would be ready, as building blocks, for successive 
glycosylations to higher oligosaccharides to be emploied in biological studies. The first synthesized 
building-block was the amino-sugar 3-acetamido-3,6-dideoxy-D-galactopyranose (D-Fucp3N),5 
which is always α-linked in bacterial O-chains. This synthesis, which is the first one reported in 
literature, was based on the conversion of a 2,3-epoxitrichloroacetimidate to 
trichloromethiloxazoline by means of an intramolecular cyclization, in order to insert a latent amino 
function with the right configuration at C3 of the sugar (Scheme 5.1). The glycosylation reaction 
involving D-Fucp3N donors was studied with several rhamnosyl acceptors and the best yields and 
stereoselectivities were obtained using a N-phenyl-trifluoroacetimidate glycosyl donor in a ternary 
ether-based mixture as solvent.6  
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       Scheme 5.1: Key step in synthesis of D-Fucp3NAc N-phenyl-trifluoroacetimidate. 
 
 
The optimization of glycosylation conditions opened the access to synthetic α-D-Fucp3NAc 
containing oligorhamnans and they were applied on the synthesis of O-chains repeating units from 
Pseudomonas syringae pv holci IMV 83006 and Xanthomonas campestris pv. campestris 8004,7 
which have never been reported before. The former structure is a D-Fucp3NAc-branched 
tetrasaccharide oligorhamnan:8 
 
                                                                                                 α-D-Fucp3NAc 
                                                                                                    1 
                                                                                                    ↓ 
                                                                                                    3 
→3)- α-L-Rhap-(1→3)- α-L-Rhap-(1→2)- α-L-Rhap-(1→2)- α-L-Rhap-(1→ 
 
 
The synthetic strategy make use of a (3+2) approach, coupling a trisaccharide donor and a 
disaccharide acceptor (Scheme 5.2):  
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                   Scheme 5.2: Retrosynthesis of the pentasaccharide repeating unit of the major O-        
chain component from Pseudomonas syringae pv. holci IMV 8300. 
 
 
The O-chain repeating unit from Xanthomonas campestris pv. campestris 8004 displays a D-
Fucp3NAc residue on a linear rhamnosyl disaccharide:9 
                             
                                   →3)-β-D-Rhap-(1→3)-α-D-Rhap-(1→ 
                                                     2 
                                                     ↑ 
                                                     1  
                                           α-D-Fucp3NAc 
 
 
Its synthesis has been less easy than the previous one: the presence of a β-linked rhamnose 
disaccharide and the non-commercially availability of its constituents rendered the synthesis quite 
challenging. The trisaccharide as methyl glycoside was obtained by exploiting a strategy whose key 
steps were the sequential β-rhamnosylation of a 2-O-benzylsulfonyl-N-phenyltrifluoroacetimidate 
donor, debenzylsulfonylation, and coupling with a D-Fucp3NAc thioglycoside donor (Scheme 5.3).  
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Scheme 5.3: Retrosynthesis of the β-D-rhamnosylated trisaccharide repeating unit of the O-
chain from Xanthomonas campestris pv. campestris 8004. 
 
 
NMR analysis performed on synthetic oligosaccharides confirmed the structure of natural O-chains 
by means of comparison of the chemical shift of the signals. 
Successively, the synthesis of a D-rhamnose branched tetrasaccharide has been accomplished;10 it is 
the O-chain repeating unit from the bacterium Pseudomonas syringae pv. cerasi 435:11 
 
                                                                                                        α-D-Rhap 
                                                                                                                1 
                                                                                                                ↓ 
                                                                                                                3                     
→3)- α-D-Rhap-(1→3)- α-D-Rhap-(1→2)- α-D-Rhap-(1→ 
 
 
The synthetic strategy used was based on the synthesis of just one rhamnosyl building block 
(methyl 3-O-allyl-4-O-benzoyl-α-D-rhamnopyranoside) converted alternatively into both a glycosyl 
acceptor and two different glycosyl trichloroacetimidate donors (Scheme 5.4).  
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Scheme 5.4: Retrosynthesis of branched tetrasaccharide repeating unit of the O-chain from 
Pseudomonas syringae pv. cerasi 435 
 
 
It is worthy to remember, once again, that all the synthetic approaches used, involve protecting 
group pattern which could allow the oligomerization of the structures to obtain even higher 
oligosaccharides suitable for phytopathological structure-activity studies. 
In order to increase my acknowledgments on rhamnose chemistry, I worked eight months in the 
laboratories of Centre for Carbohydrate Chemistry (CCC) (University of East Anglia, Norwich, 
UK), directed by Prof. R. A. Field, where one of the ongoing project is the synthesis of 
rhamnogalacturonan II (RGII), a pectic polysaccharide of the plant cell wall.12 My contribute to this 
work has dealt with the optimization of the synthesis of a tetrasaccharide fragment of RGII:  
 
α-D-GalA-(1→2)-[β-D-GalA-(1→3]-[α-L-Fuc-(1→4]-α-L-Rha-OMe 
 
The previous work13 involved consecutively couplings of an orthogonally protected α-rhamnosyl 
acceptor with three different glycosyl donors (Scheme 5.5).  
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Scheme 5.5: Retrosynthesis of 67, tetrasaccharide fragment of rhamnogalacturonan II (RGII). 
 
 
The variation to the previous work was based on the use of a perbenzylated galactosyl moiety, as 
permanently protected galactosyl donor despite to the requirement of anchimeric assistance to build 
the β-linkage. Different activation conditions and participating solvents have been exploited in 
order to achieve a better yield and stereoselectivity in building the β-linkage at C3 of the α-
rhamnosyl acceptor. Attempts of synthesis of a β-rhamnosyl acceptor, whose anomeric 
configuration is the natural occurring one, have been unsuccessfully performed and glycosylation 
tests have been carried on its α-anomer. Using just one type of galactosyl donors would render the 
synthesis more straightforward, reducing the number of deprotection steps. Besides, this would 
open the way for a more ambitious project which involves the incorporation of the tetrasaccharide, 
as building block, into an higher fragment structurally closer to the RGII. 
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